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Abstract 
Calmodulin (CaM) is a ubiquitous calcium-binding protein responsible for the binding and 
activation of a vast number of enzymes and signaling pathways. It contains two lobes that bind 
two calcium ions each, separated by a flexible central linker. This structural flexibility allows 
CaM to bind and regulate a large number of diverse protein targets within the cell in response to 
Ca
2+
 gradients. 
Voltage gated calcium channels (CaVs), as main sources of extracellular Ca
2+
, are crucial 
for a number of physiological processes, from muscle contraction to neurotransmission and 
endocrine function. These large transmembrane proteins open in response to membrane 
depolarization and allow gated entry of Ca
2+
 ions into the cytoplasm. Their regulation is 
currently the subject of intense investigation due to its pharmacological and scientific 
importance.  
CaM has been previously shown to pre-associate and act as a potent inhibitor of one class 
of high-voltage activated (HVA) channels called L-type channels via its interaction with their C-
terminal cytoplasmic region. This interaction is primarily mediated by a conserved CaM-binding 
motif called the ‘IQ’ motif (for conserved isoleucine and glutamine residues), although the exact 
molecular details of its involvement in inactivation are currently unclear. Elucidation of these 
details was the primary objective of this dissertation.   
Recently, a novel sequence motif within this channel called ‘NSCaTE’ (N-terminal 
spatial calcium transforming element) has been described as an important contributor to calcium-
dependent inactivation (CDI) of L-type channels. It was presumed to be unique to vertebrates, 
but we also show its conservation in a distantly related L-type channel homolog of Lymnaea 
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stagnalis (pond snail). The interaction of CaM with a number of peptides representing the 
different regulatory motifs (IQ and NSCaTE) for both mammalian and snail isoforms was 
characterized in an attempt to better understand their role in CDI. Biophysical work with 
peptides as well as electrophysiology recordings with an N-terminal truncation mutant of 
Lymnaea CaV1 homolog were performed to expand our understanding of how the interplay 
between these channel elements might occur. In brief, the most striking feature of the interaction 
concerns the strong evidence for a CaM-mediated bridge between the N- and C-terminal 
elements of L-type channels. 
Further investigation of the CaM interaction with both IQ and NSCaTE peptides using 
Ca
2+
-deficient CaM mutants reveals a preference of both peptides for the Ca
2+
-C-lobe of CaM, 
and a much higher affinity of CaM for the IQ peptide, suggesting that the N-lobe of CaM is the 
main interaction responsible for the physiological effects of NSCaTE. These results are 
consistent with our electrophysiology findings that reveal a distinct buffer-sensitive CDI in wild 
type LCaV1 that can be abolished by the N-terminal truncation spanning the NSCaTE region. 
In addition to L-type channels, CaM has also been shown to have an indirect role in the 
regulation of low-voltage activated (LVA) or T-type channels (CaV3.x), via their 
phosphorylation by CaM-dependent protein kinase II (CaMKII). Using a primary sequence 
scanning algorithm, a CaM-binding site was predicted in a cytoplasmic region of these channels 
that was also previously shown to be important in channel gating. Biophysical experiments with 
synthetic peptides spanning this gating brake region from the three human and the single 
Lymnaea isoform strongly suggest that there is a novel, bona fide CaM interaction in this channel 
region, and also hint that this interaction may be a Ca
2+
-dependent switch of some sort. The 
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results confirm a possible new role for CaM in the direct regulation of these channels, although 
the exact mechanism remains to be elucidated. 
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Chapter 1: Background 
1.1 Introduction 
All living organisms are composed of cells – tiny droplets of biomolecules enclosed in 
vanishingly thin envelopes of lipid membrane. Since the concentrations of these biomolecules 
are crucial to sustaining cellular metabolism, the entry and exit of water, gases and solutes across 
the membrane must be tightly regulated. Ion channels are perfectly suited to fill the latter of 
these roles; these uniquely shaped, large protein structures span the thickness of the membrane 
(and often extend quite far into the cytoplasm), and precisely control the entry (or export) of only 
one or very few different ion species. Not every periodic element has a channel associated with 
it, but there is at least one channel associated with each of the more common ions (e.g. 
potassium, sodium, chloride and calcium). Some channels are highly selective, being virtually 
impermeable to all but their ‘chosen’ element. Yet others are not truly ion channels but more like 
aqueous pores that allow many ions and even small molecules through in response to specific 
stimuli. The opening behavior of different channel species is also quite diverse; some are open 
for prolonged durations, like the potassium leak channels; some are open for fleeting, several 
millisecond durations and closed the majority of the time (like many neurotransmitter receptors) 
(Rosenmund et al., 1995; Perez-Reyes, 1999, 2003). There are as many reasons to study ion 
channels as there are types of ion channels, for each one of them is uniquely suited to fill the role 
for which it evolved, and even slight changes in amino acid sequence or expression levels can 
result in anything from strange behaviors to severe and even lethal conditions (Figure 1.1) 
Electricity, that is, the movement of charged particles, has been observed by humans for a 
long time. Speculation aside, the first real experiments with ‘electrophysiology’ can be credited 
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to Jan Swammerdam in the 1600s, although he did not claim an electrical nature for the cause of 
muscle contraction; this idea was proposed (but not experimentally confirmed) by Sir Isaac 
Newton. It was not until the following century, and the more commonly recognized experiments 
of Luigi Galvani and his colleague-antagonist, Alessandro Volta, that a concrete idea for the 
electrical nature of neuronal impulses conducting muscle contraction emerged. Their work with 
frog muscle and electricity paved the way for modern day understanding of neurotransmission.  
As scholars refined their techniques and equipment, more elaborate experiments were conducted, 
and a more complex picture of the nervous system emerged.  
We are now able to measure single channel currents, whole cell currents, currents from a 
single channel type, their amplitude, frequency, open probability, current-voltage dependence 
and so on and so forth. We can dissect a channel’s biochemical profile and binding partners, 
measure their expression patterns, determine their primary sequence and genetic location, and 
observe crude (low-resolution) structures with electron microscopy. What we cannot yet do, in 
many cases, is obtain a high-resolution picture of the three-dimensional structure of these 
channels and point out how it correlates with their spatial and temporal regulatory mechanisms. 
Ion channels are simply too large, in most cases, and quite hydrophobic: two main qualities that 
make a protein difficult to purify and prepare for structural analysis by either X-ray 
crystallography or NMR spectroscopy. Since modern electrophysiology equipment is not quite 
automated and most labs do not have access to high-throughput recording equipment, detailed 
kinetic analyses of channel effectors are rather painstaking. The closest we can get to a ‘big 
picture’ is an integration of the current piecemeal approach of mutagenesis, biophysical 
characterization of channel fragments, molecular modeling and electrophysiology with various 
surrogate systems (e.g. liposomes or Xenopus eggs). Therefore it is important to take all work in 
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this field with a proverbial grain of salt: one can only infer so much about a room-sized puzzle 
based on a window-sized arrangement of pieces that seemingly fit together. So far, no single 
complete molecular model for channel regulation has been accepted, but several working models 
for various channel groups are being refined.  
Below is a brief introduction to the field of voltage gated calcium channels and may be 
helpful in putting the subsequent chapters into context. 
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Figure 1.1: Summary of phylogeny, function, architecture and common associated disorders of 
main types of ion channels.  
Left side: color coding indicates the approximate evolutionary timing of the divergence between the 
channel families (blue = basal metazoans, red = single-celled eukaryotes, green = prokaryotes, black = 
various/emergent/unknown). Right side: domain architecture, subunit organization.  Color coding 
indicates the individual distinct subunits. Separate polypeptide chains are different colors; pore-forming 
domains are denoted by cartoons with central ‘holes’. Family-unique features, such as CaM and 
nucleotide binding domains, are indicated. Cartoon design and phylogeny information adapted from 
(Jegla et al., 2009); neither are to scale. References for the channel functions and channelopathies are 
cited below, along with abbreviations and other relevant numbered notes. 
 
(1)(Al-Sayed et al., 2013) (2) (Perez-Reyes, 2003; Splawski et al., 2006) (3) (Cooper and Jan, 1999; 
Kullmann and Hanna, 2002) (4) (Wilson et al., 2011) (5) (Striessnig et al., 2010; Bidaud and Lory, 2011; 
Napolitano and Antzelevitch, 2011) Timothy syndrome is a multi-organ disorder characterized by cardiac 
abnormalities, webbed digits (syndactyly), facial dismorphy, ASD and developmental delay. It is typically 
lethal by early childhood. (6) TRP family of channels is very diverse (28 genes in humans), gated by any 
number of stimuli, from temperature to pH to cell volume to sometimes voltage. Not surprisingly, a large 
number (upwards of a 100) of human diseases is associated with one or more members of this family; the 
subject has received an excellent review (Nilius, 2007) (7) These channels bear some similarity to the 
CNG/HCN channels in having a cyclic nucleotide binding homology domain  or CNBHD, but are not 
actually regulated by cAMP (Haitin et al., 2013) (8) (Postea and Biel, 2011) (9) (Ashcroft, 2000; Heine et 
al., 2011) (10) (Hu et al., 2012) (11) (Davies et al., 2003) (12) (Sobey, 2001) (13) (Dalsgaard et al., 2010) 
(14) (Jentsch, 2000) (15) Ataxia (loss of muscle control) and myokymia (muscle rippling) of this disorder 
are also linked to the P/Q (CaV2.1) type Ca
2+
 channel (Shieh et al., 2000); KCNA1 is homologous to the 
well characterized Shaker channel from Drosophila  (16) (Beeton et al., 2006) (17) (Barel et al., 2008) 
(18) Bartter syndrome is a cluster of symptoms resulting from renal malfunction (hypokalemic alkalosis, 
hyperprostaglandinuria, hypercalciuria). Andersen–Tawil syndrome is a rare autosomal dominant disorder 
that manifests in a number of physical and neurological defects (periodic paralysis, arrhythmia, facial and 
limb abnormalities and developmental problems) (Pattnaik et al., 2012) (19) (Lerma and Marques, 2013) 
PSEP = post-synaptic excitatory potential (20) AMPA = α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (Glu analog) (Henley and Wilkinson, 2013) (21) (Corona et al., 2007) sALS 
(sporadic ALS) is associated with a mutation in one of the AMPAR subunits that renders the channel 
Ca
2+
-permeable when it normally isn’t (22) NMDA = N-methyl-D-aspartate (Rothman and Olney, 1995) 
(23) MS = multiple sclerosis (Burnstock et al., 2011) (24) GABA (γ-amino-butyric acid) and glycine 
receptors are anion-selective (thus inhibitory). nAChR (nicotinic acetylcholine receptors) are cationic 
(excitatory). Hyperekplexia is ‘excess surprise’ or startle disease, characterized by an exaggerated startle 
response and subsequent hypertonia (Sine and Engel, 2006; Pless and Lynch, 2008) (25) Bartter’s 
syndrome can also be caused by Kir mutations (different clinical form). Dent’s disease is a form of X-
linked recessive nephrolithiasis (kidney stones) and associated proteinuria, hypercalciuria and 
hyperphosphaturia (Jentsch et al., 2005; Puljak and Kilic, 2006; Planells-Cases and Jentsch, 2009)  
 
  
6 
 
1.2 Structure, Nomenclature, and Evolution of Ion channels 
The basic conducting pore subunit of an ion channel has existed in one form or another for 
hundreds of millions of years; there are prokaryotic ancestor forms for nearly every major 
channel family found in mammals (Anderson and Greenberg, 2001; Jegla et al., 2009). There is 
no one ‘template’ for an ion channel sequence, as there are at least 5 different basic protein 
subunit configurations in which the different channel types can meet the ion-conducting 
requirement. Nature’s ‘solutions’ to this range from a simple ‘transmembrane bundle’ in the 
manner of the Shaker potassium channel
1
 to the much more complex topology of the chloride 
channels (CLCs), which contain 2 identical subunits with a pore each. The lack of any similarity 
between even the most primitive members of each archetype suggests that channels evolved 
multiple times, independently, pointing to convergent evolution for ion selectivity in some cases 
(Jegla et al., 2009). The great diversity in ion channel isoforms (over 200 genes for most 
metazoan species) came about from gene duplication and specialization that accompanied the 
evolution of a more complex nervous system (Piontkivska and Hughes, 2003). This is especially 
evident in the case of the voltage-gated potassium and sodium channels; the general topology of 
these two is quite similar, but the former is a single-homology-domain channel (e.g. forms a 
tetramer) while the latter is a single polypeptide consisting of 4 highly similar TM domains, each 
of which bears homology to the voltage-gated potassium channel (Anderson and Greenberg, 
2001). It is quite likely that the sodium/calcium four-domain architecture is a result of serial gene 
duplication of a more potassium-channel-like ancestor.  While there is an apparent trend in the 
accumulation of channel diversity in higher organisms, there is no correlation between the 
size/complexity of the nervous system and the number of ion channel genes in metazoans (Jegla 
                                                 
1
 Shaker, a Drosophila gene, codes for a homolog of mammalian KV1.2 and is a homotetramer of 6TM helix 
subunits (see Figure 1.1) 
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et al., 2009); humans have twice those of a barnacle, but about 50% less than a puffer fish. In 
fact, most of the unique channel classes found in Mammalia are also found in most Cnidarian 
genomes, and there has been little ‘innovation’ to the basic subunit archetypes in the time since 
the divergence of cnidarians from bilateral metazoans. Presumably, this ‘core set’ represents a 
functionally non-redundant set of channel types required for basic functioning in modern 
metazoan life forms, while the gene diversification within channel families was a result of tissue-
specific requirements arising from higher life form complexity (Piontkivska and Hughes, 2003; 
Jegla et al., 2009).  
The nomenclature of voltage-gated channels has been a subject of much revision since 
their very discovery. Before the advent of molecular cloning techniques and amino acid sequence 
analysis, different channel types could only be distinguished by their functional or physiological 
characteristics, e.g. current properties and sometimes tissue distribution. The broad distinction 
between the different groups of calcium channels (high-voltage-activated and low-voltage 
activated) as well as the different current types (L, N, P/Q, R and T type) still gets plenty of use 
today. However, individual channel genes are typically referred to by one of the more common 
nomenclature types that aim to distinguish each unique isoform. The International Union of 
Basic and Clinical Pharmacology (IUPHAR, http://www.iuphar-db.org/index_ic.jsp) uses an 
intuitive naming convention, using selectivity and gating mechanism as identifiers, e.g. Kv for 
voltage-gated potassium channel. On the other hand, the Human Genome Organization (HUGO) 
Gene Nomenclature Committee (www.genenames.org) uses gene names and numbers 
approximately correlating to the order of discovery or localization (e.g. CACNA1S for the 
skeletal muscle CaV1.1). There is yet a third system for voltage gated calcium channels that 
identifies the pore-forming subunits (α1) approximately identified by their HUGO named 
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counterparts (e.g. α1s for CACNA1S). To reduce confusion and because most channel 
researchers use the IUPHAR system, this method will be predominantly used. A synopsis of 
channel and current nomenclature is available in Table 1.1 
 
Table 1.1: Nomenclature, current classification and tissue distribution of voltage-gated 
calcium channels.  
Adapted from (Kang and Campbell, 2003) 
Gene IUPHAR 
designation 
Primary tissues Current type 
CACNA1S CaV1.1 Skeletal muscle L-type 
CACNA1C CaV1.2 Heart, smooth muscle, brain, adrenal, 
pituitary 
CACNA1D CaV1.3 Brain, pancreas, kidney, ovary, cochlea 
CACNA1F CaV1.4 Retina  
CACNA1A CaV2.1 Brain, cochlea, pituitary  P/Q type 
CACNA1B CaV2.2 Brain, nervous system N-type 
CACNA1E CaV2.3 Brain, cochlea, retina, heart, pituitary R-type 
CACNA1G CaV3.1 Brain, nervous system T-type 
CACNA1H CaV3.2 Brain, heart, kidney, liver 
CACNA1I CaV3.3 Brain  
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1.3 Voltage-gated calcium channels: History and Background 
Despite their ubiquity and key roles in many physiological processes, voltage-gated calcium 
channels (VGCCs) were slow to emerge to the forefront of electrophysiology research, probably 
due to the much higher abundance and availability of Na
+
 and K
+
 channels, as well as a much 
smaller concentrations of calcium in both the cytoplasm and extracellular space (relative to Na
+
 
and K
+
). Their discovery was largely an accident, and came amidst a bustling new field that was 
still in its infancy. It took nearly two decades from the original paper by Fatt and Katz in 1953 
for the scientific world to accept Ca
2+
 channels as a rule rather than exception (Zamponi, 2005). 
Further studies revealed their pivotal role in neurotransmission, in addition to the previously 
described cardiac contraction and excitation-contraction coupling – soon after which VGCCs 
were at the forefront of neuroscience research. The channels were initially considered to be the 
same across all vertebrate species as well as tissues, but this soon proved to be inaccurate. They 
were later classified as either high-voltage-activated (HVA) or low-voltage-activated (LVA), 
first described as “type I and II” respectively by Hagiwara and colleagues while working with 
starfish eggs (Hagiwara et al., 1975). The evidence was entirely based on electrophysiological 
recordings; very little biochemistry had been done at the time to give a molecular basis to this 
distinction. HVA channels were distinguished by the much higher voltage step required for 
activation, speed of inactivation (faster than LVAs), resistance to ‘run-down’ or loss of activity 
following patch excision or dialysis of cytosol (LVAs are more resistant than HVAs) and 
sensitivity to cadmium (LVAs are more resistant). The L-type channels (HVA) were so named 
because of their large and long-lasting unitary conductance to Ba
2+
 (which was used as a charge 
carrier to avoid rapid inactivation associated with Ca
2+
 -- a very distinct property of several 
VGCCs discussed in a later section). The T-type (LVA) channels were named after their tiny 
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conductance to Ba
2+
 and had a transient average current with a characteristically slow 
deactivation following sudden repolarization; both T- and L-type were found in heart tissue. The 
third, new, category was essentially a designation for channels that did not exhibit typical L- or 
T-type properties and was primarily confined to neurons and had intermediate Ba
2+
 currents but 
required high voltage for activation and were thus neither L- nor T-type. It was thus aptly named 
N-type. The difficulty with the distinction was palpable due to the coexistence of various channel 
types in same cell and tissue types and furthermore a lack of any biochemical way of confirming 
a particular channel type. Nonetheless, research continued, aided by the discovery of compound 
families capable of modulating channel activity. Nowycky and colleagues showed that L-type 
channels are selectively affected by Bay K8644
2
, which belongs to the dihydropyridine class of 
drugs; these can act as either agonists or antagonists, depending on the particular activation state 
of the channel in which they bind most strongly (Sanguinetti et al., 1986). Furthermore, work 
with various paralytic toxins from cone snails and funnel web spiders led to the discovery of very 
specific peptide blockers of individual channel types, a pharmacological breakthrough that also 
greatly simplified the identification and isolation of VGCCs long prior to their eventual cloning 
and biochemical characterization. As a result of this work, new channel types were identified that 
had different pharmacological properties from any of the previously described types according to 
the tripartite model (N, L, T) – these were primarily isolated because of their resistance to drugs 
known to inhibit the known channels, not for unique electrophysiological characteristics. These 
were named P-type (found in Purkinje cells), Q-type (granular cells) and eventually R-type (for 
resistant; these currents remained even at saturating concentrations of all known blockers). 
Subsequent success with molecular cloning of the pore-forming α1 subunits of the channels 
                                                 
2
 Bay K8644, a structural analog of nifedipine, is both an agonist as an R-isomer (-), and an antagonist as a S-isomer 
(+). 
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revealed that P and Q type were different splice isoforms of the same gene product; additionally 
the actual subunit composition and interacting proteins (which differ for the P and Q channels) 
were found to greatly influence the electrophysiology of the complete channel structures 
(Zamponi, 2005). First to be cloned were the skeletal muscle L-type channels, likely due to their 
ready availability and abundance, using high-affinity binding antagonists.  The SDS PAGE 
revealed 4 distinct bands that co-migrate when the purified channels were separated; these were 
identified as the major channel subunits: α1, α2δ, β, and γ. Similar work was performed with 
cardiac L-type and brain N-type channels with similar results; however, no γ subunits were 
found with the latter two. The α1 subunits are highly homologous and have a significant degree 
of amino acid similarity to the pore-forming subunits in NaV and KV channels; it was correctly 
hypothesized that they constitute the main pore-forming subunit and voltage sensor of the 
channel (Catterall, 2000, 2011). An α1 subunit consists of four very similar domains (I-IV), each 
containing 6 transmembrane helices (S1-S6). The S4 segment contains positive residues in every 
third or fourth position (all facing in the same way) which allows it to respond to voltage 
changes and act as the gating sensor (described in more detail in a later section). The re-entrant 
P-loop between the S5 and S6 of each domain is believed to form the actual channel pore 
through which ions pass. Since the first α1 subunit was identified in skeletal muscle (α1S), 9 
others have been cloned, and eventually each has been assigned to one of the different described 
current types (e.g. L type, N type etc.) (Zamponi, 2005). The α1 subunit is sufficient to produce 
functional channels through heterologous expression but such channels exhibit low surface 
expression and abnormal gating kinetics (Perez-Reyes et al., 1989), which can be alleviated to a 
high degree by co-expression of the α2δ and especially the β subunits (see Section 1.3.1). 
Through a number of biochemistry techniques, it was shown that the β subunit is intracellular 
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and has no transmembrane domains, while the γ subunit is a transmembrane glycoprotein. The 
α2 subunit was thought to be another large anchored glycoprotein but was found to have no 
transmembrane domains; it is actually held in place by its interaction with the δ subunit through 
the latter’s short C-terminal transmembrane region (Robinson et al., 2011; Dolphin, 2013). The 
α2 and δ subunits are products of one gene that is post-translationally cleaved and held together 
by a disulfide bond (Catterall, 2011).  However, there are a number of different β and α2δ 
subunits, and each seem to confer slightly different kinetic properties when co-expressed with a 
given α1 subunit, with the β subunits causing the greatest variety of effects (Walker et al., 1998). 
More details regarding subunits and their properties can be found below. 
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1.3.1 Auxiliary Subunits 
T-type channels are monomeric (contain only the α1 subunit), while all other CaVs contain 
auxiliary subunits that modulate the currents of the pore-forming subunit with which they 
associate, or its expression. The functional effects of their interactions have been mostly 
characterized, but the mechanisms by which the regulation occurs are still not fully understood. 
Below is a brief overview of the three major subunit classes found in association with α1. 
1.3.1.1 α2δ  
HVA CaVs are typically composed of four subunits, α1 (pore-forming), β, γ and α2δ. The 
latter was initially believed to be a tight association of two different subunits but was later 
determined to be a single post-translationally cleaved gene product. The two resulting 
polypeptide chains remain linked by a disulfide bond. Of these, the C-terminal end of the δ 
fragment contains a single transmembrane motif which anchors the entire subunit, while the 
larger N-terminal product (α2) is wholly extracellular. Both δ and α2 are heavily glycosylated. 
Interestingly, the post-translational cleavage of α2δ is often incomplete in heterologous systems; 
only about 30% of the gene-product is found in the processed form when expressed alone 
(Davies et al., 2006). Very little is currently known about the mechanism or the role of this 
processing on the subunit function, and the cleavage link sequence is not very well conserved 
among the isoforms. Mutagenesis studies place the location of the cleavage recognition sequence 
between R941 and V946 and show reduced whole cell currents of the heterologously co-
expressed α1 subunits for unprocessed mutants, suggesting reduced surface trafficking (Andrade 
et al., 2007).  
There are currently 4 known vertebrate isoforms of α2δ, and there are also a number of 
splice variants of each of these. The isoforms are fairly well conserved (≥30% identity) and 
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structurally similar (Davies et al., 2007). The different isoforms can be reconstituted with a 
variety of α1 isoforms in vitro (heterologous expression) but are most likely less promiscuous in 
vivo. All α2δ subunits enhance Ca2+ currents through their associated α1 subunits, but the 
mechanism is still uncertain (Davies et al., 2007; Dickman et al., 2008). However, it seems that 
an associated α2δ is not always required for functional expression of α1 (at least in heterologous 
systems) (Davies et al., 2006). There appears also to be a pool of α1’s that are not associated 
with α2δ and so there could potentially exist an on/off equilibrium between the two states of α1, 
which in itself could represent a regulatory mechanism for specific channel kinetics (Obermair et 
al., 2008). Furthermore, glycosylation of consensus asparagines (N136 and N184) in α2δ is 
required for its current enhancing effects on α1, but has no effect on the channel 
gating/activation properties, as shown by mutagenesis studies (Sandoval et al., 2004). 
1.3.1.2 γ 
Gamma subunits were a late addition to the accepted VGCC archetype because for some time it 
was believed that their expression was required for proper channel function only in muscle but 
not neuronal tissue, and was thought to be a tissue-specific isoform requirement. However, it was 
subsequently shown that a second, neuronal isoform γ2 has a fairly severe “stargazer” phenotype 
in mice, characterized by uneven gait and random head elevations (Letts et al., 1998; Letts, 
2005). Subsequently, γ subunit mutations resulting in ataxia and epilepsy have fuelled scientific 
interest and 6 more isoforms have been identified by sequence alignment and cloned (Kang and 
Campbell, 2003). In addition, this very finding (the stargazer or stg mouse) brought the merely 
accessory role of the auxiliary VGCC subunits into question, particularly with respect to γ2. 
Surprisingly, the stg mice did not have any functional AMPA receptors on the post-synaptic 
membranes of cerebellar granule cells, a defect that was specifically attributed to the absence of 
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γ2 (Hashimoto et al., 1999). AMPA, or α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, 
is an artificial glutamate analog; its ionotropic receptor mediates fast synaptic transmission in the 
CNS (DiGregorio et al., 2002). Later, co-immunoprecipitation studies confirmed ‘stargazin’(γ2) 
binding to AMPARs, and knock-in experiments showed restoration of full AMPA glutamate 
signaling with re-introduced γ2 (Chen et al., 2000). If or how these effects pertain to CaV 
regulation is unclear. 
The biochemical aspects of γ subunits are not fully elaborated, which is in part due to 
lack of a crystal structure (typical roadblock for membrane proteins). Tissue expression profiles 
are known, but the specific combinations of γ and α1 subunits that occur in vivo are only known 
for a few isoforms. Electrophysiology studies have produced contradictory results; however most 
current research literature indicates that γ subunits in general act to inhibit channel activity by 
hyperpolarizing the inactivation curve
3
 and in some cases lowering the current densities (Kang 
and Campbell, 2003). More biochemistry studies are required to elucidate the mechanisms by 
which these effects take place. 
                                                 
3
 In this dissertation and most neuroscience literature, ‘hyperpolarization of a curve’ is set to mean that it is shifted 
to more negative potentials, e.g. requires a lower membrane potential for a particular effect. Conversely, a 
depolarized curve is one that is shifted to the right, to more positive membrane potentials. 
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1.3.1.3 β 
Perhaps the second best studied (after the α1 subunit), due to its vast number of regulatory 
effects, is the β subunit. It is also fairly small (~50kDa, varies with isoform) and completely 
cytosolic, and thus soluble, which has facilitated its (partial) structural determination– something 
that has not been achieved for other subunits, as of yet. Nonetheless, even with the amount of 
biophysical information available, many functional and mechanistic details of how β subunits 
regulate α1 subunits remain open to debate.  
 The first β subunit, much like its α1 counterpart, was cloned from human skeletal muscle 
(CaV1.1), and subsequently called β1a (Dolphin, 2003b). The β subunit family of VGCCs is 
highly diverse; while there are only 4 known genes (β1-4), their typical genomic structure is 
comprised of 13 exons and several of those can be alternatively spliced, giving rise to a large 
combinatorial potential (Dolphin, 2003a, 2009; Richards et al., 2004). The sequence alignments 
suggest a shared 5-domain structure (D1-5 or also A-E), with the second and fourth domains 
being highly conserved among the 4 β genes and the other three quite variable (Hidalgo and 
Neely, 2007). Homology modeling analysis places the β subunits into the family of membrane-
associated guanylate kinase proteins (MAGUKs), which are scaffolding proteins for various 
signaling complexes and contain multiple protein interaction domains (He et al., 2007). The two 
conserved domains in β are thought to mediate these interactions; a Src-homology 3 domain 
(SH3, binds proline-rich sequences) “B”, and the putative guanylate kinase domain “D”. Despite 
the name and proposed relationship to bona fide GKs, β subunits themselves do not appear to 
possess kinase activity, presumably because their ATP-binding domain residues are not 
sufficiently conserved (Dolphin, 2003a, 2003b). The GK domain also contains the consensus “β 
interaction domain” (BID), which is the region initially believed responsible for the β subunit 
17 
 
binding to α1 subunits at their “α1 interaction domain” (AID), located in the linker loop between 
transmembrane domains I and II of the α1 subunit. A few studies claim absolute requirement of 
BID for functional regulation of VGCC by the β subunits and that it is often obligatory for 
proper (heterologous) channel expression (Dolphin, 2009). However, structural studies of three β 
subunits alone and in complex with an AID point to there being a lack of accessibility of the BID 
region for binding and suggest that the AID binding occurs through a hydrophobic pocket 
formed by a distal region of the β subunit nucleotide kinase domain – see Figure 1.2 (Chen et al., 
2004; Opatowsky et al., 2004; Van Petegem et al., 2005). The authors suggest that the previously 
observed BID effects are more likely due to the disruption of proper β-subunit folding and/or 
function, rather than its interaction with the α1 subunit. One study examined several BID-
independent properties of α1-β binding, where two new “short” splice variants of β2 lacking the 
BID were described. These variants lack the BID and parts of SH3 and GK domains, yet they 
apparently bind and facilitate functional expression of α1c (CaV1.2) subunits, and to some extent 
modulate their biophysical properties (Harry et al., 2004). An interesting observation that raises 
additional questions from a study by Harry et al was that the lack of the ‘core’ B and D domains 
in the “ultra-short” β2 manifested as a complete loss of calcium-dependent inactivation (CDI) of 
CaV1.2 (Harry et al., 2004).  
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Figure 1.2: Crystal structure of β3 subunit bound to the AID of CaV1.2 
 The AID (residues 442-446) peptide is in red, with the view facing its N-terminus. Yellow is the HOOK 
domain, cyan is the SH3 domain, and blue is the guanylate kinase domain of the β3. The previously 
implicated "B-interaction domain” or BID is in orange; as can be seen here it is not accessible to the AID 
region as originally thought. The figure was generated in UCSF Chimera 1.8.1 using the PDB entry 
1VYT (Chen et al., 2004) 
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The mechanism by which β subunits modulate their associated α1 currents remains 
unclear; however, a number of studies suggest distinct roles for the chaperone effect associated 
with increased channel trafficking to the plasma membrane (Bichet et al., 2000), and the direct 
hyperpolarizing effect on channel activation and inactivation (Dolphin, 2003b). This likely 
pertains directly to the modular nature of the β subunit domains as well as the variety of the 
different possible isoform combinations of β and α1 subunits. An interesting attempt to answer 
these questions was made by Arias et al., who created chimeras of T-type channels with regions 
of the I-II linker of CaV2.2 (N-type or α1B). They conclude that IS6 (the sixth and last TM repeat 
in domain I) is important in the interaction with the β subunit, and given its prominent role in 
channel gating, propose a universal model by which channel regulation is achieved by the β 
subunits (Arias et al., 2005). Unfortunately, only a handful of different β isoforms were used in 
the study (and only the IS6 region from N-type channels); so the true universality of this model 
is uncertain.  
1.3.1.4 α1 
It is necessary to also describe the molecular and biochemical details of the actual channel pore if 
one is to talk about its regulation. The pore-forming subunit of VGCCs (α1) is undoubtedly the 
best studied; however it is also the most difficult to characterize biochemically because of its 
great size and hydrophobicity. Nonetheless, with the advent of electron microscopy and various 
labeling techniques it has been possible to determine a number of key features responsible for the 
function of this subunit and the channel as a whole.  
Since a crystal structure of a whole calcium channel is not currently available, all of the 
existing information here comes from either electron microscopy or, more commonly, homology 
modeling with other voltage gated channels (usually prokaryotic). Although the sequences 
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between the different channel groups are quite distinct, similar principles of gating and 
selectivity appear to govern all members of the 6TM family of channels. There are gross 
differences in the interdomain cytoplasmic regions, often even among different isoforms of the 
same channel gene, likely owing to their specific physiological roles and relevant regulatory 
mechanisms. Yet, the process by which the channels sense voltage changes, open, and pass ions 
through, despite individual channel adaptations, is similar for all of them. The actual pore of a 
channel contains three separate regions: the selectivity filter, followed by a water-filled cavity, 
which extends into a narrow gate region. The selectivity filter and gate are of primary interest, 
and each has a key role in channel conductance, described below.  
1.4 Selectivity 
How is it that a Na
+
 channel does not allow the passage of identically charged K
+
 ions and vice 
versa? If one uses ionic size as the only criterion, it only explains one and not the other. 
Furthermore, a hydrated Na
+
 is larger than a hydrated K
+
 while the reverse is true for the exposed 
ions. For a long time, this question has remained unanswered. It has recently been solved with 
the help of the KcsA crystal structure and molecular dynamics software. KcsA is a pH-gated 
potassium channel (“K+ crystallographically-sited activation channel”) from Streptomyces 
lividans (Doyle, 1998; Li et al., 1998), and has been used extensively as a template for modeling 
other voltage-gated ion channels (Sansom et al., 2002). 
The selectivity filter of KcsA is characterized by 5 ultra-conserved residues
4
, TVGYG 
(Lu et al., 2001). Interestingly, it is their backbone and not the side chains that form hydrogen 
bonds with the incoming ions (Figure 1.4) – a situation which is reversed in the four-homology 
                                                 
4
 The selectivity filter residues are usually highly conserved within channel groups. Thus nearly all voltage-gated 
potassium channels share the ‘TVGYG’ sequence, NaVs have DEKA, CaVs have either EEEE (HVA) or EEDD 
(LVA).  
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domain channels like NaVs and CaVs. In nearly all cases, however, the actual opening through 
which an ion must pass is smaller than the hydrated ionic radius of the cognate ion. This means 
that the ion must lose its hydration shell in order to pass through, which requires energy (but 
gains in entropy) (Corry et al., 2001). The energy is recovered when the ion makes bonds with 
the selectivity filter ligands, the residues in which are spaced precisely so as to maximize the 
favorability of this transfer (Lipkind and Fozzard, 2001, 2008). Hence a Na
+
 is too small when 
dehydrated to fully compensate for the energy it loses when dehydrating, to pass through a K
+
 
channel. It also explains why Cd
2+
 (cadmium), which is of a very similar ionic size (both 
hydrated and not) to Ca
2+
, is highly toxic and will block VGCCs. It also means that small neutral 
molecules (e.g. urea, glycerol, formamide, etc) can pass through pores larger than their radii 
(Huang et al., 1978). Interestingly, anion channels typically select for larger ions, but are 
generally far less selective than cation channels (Kunzelmann et al., 1991; Hille, 2001; Gillespie 
et al., 2002), likely because there are no other small anions to contend with, other than Cl- and 
HCO3
-
. 
There is also a question of how the ion actually travels down the channel pore. Various 
crystallography studies and modeling showed two possible conformations for the pore; one in 
which there were two ions in the filter and the other in which there were three, in exactly the 
opposite locations, sandwiched between water molecules (Sansom et al., 2002). This suggested 
that a ‘knock-on’ process was responsible, e.g. electrostatic repulsion of newly entering ions 
propelled the already present ions further into the channel (into the cavity), aided by the 
concentration gradient inward. This model requires that there be ions of the selected type already 
present in the channel for it to function; indeed, when a Ca
2+
 channel is reconstituted in a 
membrane without Ca
2+
 present in the environment, it will allow the passage of Na
+
 ions (which 
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are of a remotely comparable size) as well as small organic molecules but will not pass them if 
there is any Ca
2+
 present. There are some channels which are less selective than others; likely 
this has to do with the flexibility as well as the spacing of the ion coordinating residues and their 
side chains, as well as surrounding residues. Presumably, when a divalent ion is not present to 
offset the electrostatic repulsion between the coordinating glutamate carboxyl groups, they face 
away from the pore and the channel becomes more ‘open’ and thus more permeable (Lipkind 
and Fozzard, 2001). The model presented by Lipkind and Fozzard has a conical outer vestibule 
about 18Å tall that tapers from around 20Å at its widest down to sub 6Å within the glutamate 
‘circle’ of the selectivity filter formed by the P-loops (re-entrant helix/loop/helix motif in 
between S5 and 6 segments of each domain), in which all four glutamates are perfectly 
positioned to interact with a single Ca
2+
 ion.   
The selectivity filter sequence in (most) VGCCs is EEEE, one conserved glutamate from 
each of the four domains, e.g. E393, 736, 1145 and 1446 in rabbit CaV1.2. In NaVs it is DEKA, 
and substituting one for the other is usually sufficient to convert one channel selectivity into the 
other (Lipkind and Fozzard, 2001). Ryanodine receptors, which are specialized Ca
2+
 channels in 
the sarcoplasmic reticulum, have DDDD (Gillespie et al., 2005). The actual side chains form 
hydrogen bonds with the cations, in contrast to what is seen with KcsA and KV channels. 
Intriguingly, extant bacterial sodium channels (NaChBac) that share ancestral homology with the 
major voltage-gated ion channel families (KV, NaV and CaV) have a domain architecture 
reminiscent of KVs (four-homology domain, e.g. homo-tetramers) yet their selectivity filter 
sequence (EEEE) is closer to CaVs. Molecular dynamics and energy calculations for single 
residue mutants in this region of NaChBac suggest that the size of the pore and thus, the number 
of indirect metal ion-water-carboxyl contacts, determines the relative selectivity of a pore 
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between Na
+
 and Ca
2+
 (Dudev and Lim, 2012). Essentially the pore length, charge distribution 
and volume are all commensurate with the channel’s permeability to a monovalent vs. a divalent 
ion (Malasics et al., 2009). In contrast, the cause of discrimination of a channel among different 
size monovalent ions is less clear. For instance, KcsA and similar KV channels require a K
+
 ion 
for structural stabilization of their selectivity filters, and removal of K
+
 entirely results in pore 
collapse, converting the channel into a non-conductive, inactivated state (“C-inactivation” 
similar to that seen at low pH) (Bhate and McDermott, 2012). NaChBac is permeable to both 
Na
+
 and K
+
 and has a selectivity filter containing TVGDG/A instead of the consensus TVGYG 
of KcsA. It also  does not require ionic ‘support’ to maintain its pore in a conductive state (Shi et 
al., 2006). Presumably, the difference in Na
+
/K
+
 selectivity is due to geometric, rather than 
electrostatic constraints in the amino acid stacking surrounding the ion binding site (Malasics et 
al., 2009).  
This thermodynamic/electrostatic explanation has held true to a large extent: consider 
that if a channel is bathed in a mixed solution of all possible monovalent ions (Li
+
, K
+
, Na
+
, Rb
+
, 
Cs
+
) in equimolar amounts, 120 possible orders of preferential selectivity are possible. Of those, 
only 11 have been found in nature (the so-called ‘Eisenman sequences’), with the most common 
being the straight forward size prohibition series (Li
+
 > K
+
 > Na
+
 > Rb
+
 > Cs
+
) (Krauss et al., 
2011). This model, along with the currently accepted ‘textbook’ explanation of channels’ ion 
selectivity (Hille, 2001), is based on a barrier model, where individual ions get passed along 
from site to site within the selectivity filter, similar to the free energy wells of the transition 
states in a reaction profile. A similar approach is taken by most molecular dynamics simulations 
where the number of modeled particles is limited and can be predicted with some accuracy. 
There are issues with this model, however, as it does not take into account the frictional forces 
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associated with ion-ion and ion-fluid interactions while passing through a narrow pore (Gillespie 
and Boda, 2008). Additionally, a more recent crystal structure of a bacterial sodium channel 
NaVAb (from Arcobacter butzleri) in its closed state shows that it passes Na
+
 ions in at least a 
semi-hydrated state. In fact, the entire KcsA selectivity filter could fit inside that of NaVAb 
(Payandeh et al., 2011). The selectivity filter of NaVAb contains a narrow, negatively charged 
opening at the top of the pore, thus making an inverted funnel shape, with the narrowest point 
being extracellular – in contrast to the ‘right side up’ funnel shape seen in KcsA and most other 
voltage gated channels. The rest of the vestibule is larger and accommodates a Na
+
 ion with its 
primary hydration shell, and presents a hydrophobic surface over which the ions disperse rapidly, 
thus accounting for the high conductance of these channels. A very recent review suggests there 
is a high level of correlation between the structural features of NaVAb and what is known about 
the gating kinetics of vertebrate NaVs (Catterall, 2014). Much of the future advancement in this 
field rests on the availability of structural data from a vertebrate four-domain channel. 
Some channels that can pass more than one ion type display a behavior called the 
‘anomalous mole fraction effect’ or AMFE, which occurs when the conductance of the channel 
changes non-linearly with the relative concentration of that ion in the bath while the total ionic 
strength of the bath is kept constant (Friel and Tsien, 1989; Nonner et al., 1998; Gillespie and 
Boda, 2008). Previously, the consensus explanation for this effect was related to the multi-ion 
occupancy model of the selectivity filter as in the KcsA channel (Hille, 2001); the AMFE was 
supposed to reflect the varying relative binding affinity of the several ion binding sites. In this 
regard, having an AMFE for a channel would be synonymous to having a multi-ion pore. 
However, several discrepancies have since shown this assumption to be false. Firstly, all 
mutagenesis studies point to CaVs as having a single high-affinity Ca
2+
 site (the coordinating 
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glutamates) rather than the single-file multi-ion pore seen in potassium channels, or any multi-
pore or multi ion combination (Corry et al., 2001; Hille, 2001; Lipkind and Fozzard, 2001; 
Zamponi, 2005; Gillespie and Boda, 2008; Malasics et al., 2009; Dudev and Lim, 2012; Park et 
al., 2013). Furthermore, an AMFE can be observed in simple 50Å plastic nanopores in mixed 
solutions, evidently without the requirement of multiple ion binding sites, ion 
interaction/hydration or single file permeation (Gillespie et al., 2008). The latter finding 
essentially invalidates everything previously generalized for all channels about the nature of 
AMFE and permeation. Mathematical models of bulk ion movement in fluids have been applied 
to this problem, with a modified Poisson-Nernst-Planck (PNP) equation being successfully used 
to predict the AMFE in both an artificial oligopeptide channel (Chen et al., 1997) and more 
complex systems such as the ryanodine receptor RyR (Gillespie et al., 2005; Gillespie and Boda, 
2008). Essentially, the model treats the channel as a series of resistors formed by depletion zones 
resulting from electrostatic effects of localized ion binding at the different affinity sites inside the 
pore. This model does not call for ion single file passage through the pore (and thus accurately 
predicts the AMFE in nanopores), but obviously requires some knowledge of the pore interior 
for accurate predictions – and in many cases extensive mathematical modeling.  
Calcium channels vary in their permeability; however, all HVA CaVs are largely 
impermeable to Na
+
 in the presence of at least 1µM Ca
2+
, but are quite permeable to Na
+
 in the 
absence of Ca
2+
, and are typically at least twice as permeable to Ba
2+
 as to Ca
2+
 (Hille, 2001; 
Zamponi, 2005). They are not permeable to any particles larger than tetramethylammonium 
(TMA), but can pass ions smaller than it, in a selectivity sequence of Ca
2+
 > Ba
2+
 > Li
+
 > Na
+
 > 
K
+
 > Cs
+
. LVA or T-type channels (CaV3.x) have a different selectivity filter sequence (EEDD), 
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and have different permeability/selectivity ratios in their various isoforms (Perez-Reyes, 2003; 
Talavera et al., 2003; Shcheglovitov and Shuba, 2006; Park et al., 2013).  
1.5 Voltage Sensing and Gating 
Gating is the process of opening (activation) of the channel in response to a specific stimulus, 
and is tightly linked to inactivation. Thus, gating is an even more complex subject than 
selectivity due to the great deal of controversy regarding the molecular mechanisms involved.  
Most voltage-gated channels have similar topology, in which the first four helices of their 
basic domain unit constitute a voltage sensing domain, with the fourth helix (S4) of every 
domain serving as the main voltage sensor. Sequence alignments show that the S4 
transmembrane helix in all voltage-gated cation channels is structured so that about every third 
residue is positively charged, creating a molecular ‘strip’ of positive charge along one face of the 
helix. The importance of these positive charges, and surprisingly some of the neutral residues 
around them, was pointed out in a number of different mutagenesis studies (see Hille 2001, 
Tombola et al. 2006, Bezanilla 2006, and the references therein). Interestingly, not all mutations 
had a similar effect: some are hyperpolarizing, while the rest are depolarizing
5
. A change in 
membrane potential (e.g. depolarization), causes a corkscrew-like movement in S4, resulting in 
translocation of charged residues across portions of the membrane – a recordable phenomenon 
known as ‘gating current’ (Peterson et al., 1999; Hille, 2001; Doyle, 2004; Bezanilla, 2005, 
2006; Zamponi, 2005; Chanda et al., 2005; Long et al., 2005; Tombola et al., 2006; Elinder et al., 
2007; Catterall, 2011). Initially, gating mechanisms were modeled based on the structures of 
bacterial and archaeal channels, namely KcsA, MthK and KvAP (from Streptomyces lividans, 
                                                 
5
 One would expect that removing the positive ‘sensor’ charges from S4 would reduce the open probability (Po) due 
to reduced voltage sensing and cooperativity; however it appears that some changes actually increase Po by 
lowering the threshold potential (hyperpolarizing the current-voltage curve).  
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Methanobacterium thermoautotrophicum, and Aeropyrum pernix, respectively) (Tombola et al., 
2006), although their structural similarity to eukaryotic channels is modest. There is a dearth of 
structural data for 4-domain channels (e.g. NaV and CaV), and eukaryotic channels in particular. 
The most commonly used structure for homology modeling is the KV1.2 channel (Chen et al., 
2010), which, like other KV channels, has a single domain architecture and forms a tetramer.  
Whereas mutagenesis and modeling studies involving the known structures of single TM 
domain channels (e.g. various potassium channels) affect each of the four monomers  identically, 
the same cannot be said of the S4 segments in each domain of the 4-TM domain channels (e.g. 
NaV, CaV). Several mutagenesis studies in sodium channels point to the S4 of domain IV (DIV-
S4) as being the slowest to respond to depolarization, and thus rate-limiting for activation, and 
suggest a degree of cooperativity between the S4 helices of the four domains. This might explain 
the fast kinetics of the sodium channel, a necessary feature of action potential propagation 
(Bezanilla, 2006). 
Voltage sensing is fairly well understood: the change in membrane potential results in 
gating currents caused by rearrangement of the sensor charges in response to the electric field 
disturbance. The molecular details of how this movement occurs, and more importantly, how it is 
transduced into the gating region to actually open the channel, are less clear. Numerous kinetic 
models have been developed that treat the opening process as any biochemical reaction, with a 
number of energy lows and highs, with discrete equilibrium constants governing the probability 
of the channel occupying each state versus the membrane potential. These models are usually 
empirically derived, as very few structural models exist to confirm and correlate a particular 
kinetic step to a physical state of the channel. The larger the number of these elementary ‘steps’, 
the smaller the individual gating current associated with each ‘step’ should be. In contrast, early 
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work with sodium (Conti and Stühmer, 1989) and potassium (Mika and Palti, 1994) channels in 
patch clamp experiments suggests that the actual number of discrete gating states is low.  
So how does the S4 helix actually move to open the channel? Several models have been 
developed, although most of the early ones (full translocation and moving orifice, and later the 
‘paddle’ model) did not bear out with the growing body of evidence, with the notable exception 
of the helical screw model (Keynes and Elinder, 1999), which is still widely discussed today 
(Elinder et al., 2007; Broomand and Elinder, 2008; Nishizawa and Nishizawa, 2008; Catterall 
and Yarov-Yarovoy, 2010).  The ‘paddle’ model was introduced using a crystal structure in 
which the S4-5 linker ‘paddle’ was immobilized using monoclonal antibodies in several 
configurations, which suggested there was a large transverse motion of this linker within the 
membrane (Jiang et al., 2003b). However, it has since been demonstrated that the antibody-
bound conformation changes are distorted and not representative of native channel states. The 
helical screw model was proposed by studies using cysteine substitutions in S3 and S4 with 
subsequent monitoring of disulfide bridge formation during S4 motion (reviewed in Catterall and 
Yarov-Yarovoy, 2010), in which S4 rotates slightly about its axis in response to depolarization. 
Contrasting these results, various fluorescence studies that have quantitated the motion of the S4 
helices report that the depolarization-associated movement (either radial or translational) is 
remarkably low (2-4Å), a finding that is hard to reconcile with even the most conservative 
predictions of a helical screw model (Chanda et al., 2005; Posson et al., 2005). In an attempt to 
reconcile all these findings, a modified model incorporating the ‘rotation-in-place’, ‘moving 
orifice’ and charge translocation has been suggested, called the ‘transporter’ model (Bezanilla, 
2006; Tombola et al., 2006). Here the charges in S4 are in contact with two different aqueous 
reservoirs, a large interconnected internal crevice (in the closed state) and a shallower externally 
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connected one (in the open state). Depolarization presumably results in a rearrangement of the 
hydrogen bond network of S4 and these reservoirs. In a series of elegant studies by Bezanilla and 
his group, Arg-to-His substitutions in the gating-charge-carrying S4 residues converted the 
voltage sensing domain (VSD) of the Shaker potassium channel into a proton shuttle (Tombola 
et al., 2006), strongly supporting their ‘transporter’ model. This is another instance where a 
complete solution structure of the channel may go a long way in settling the debate, although it 
would be difficult to obtain structures of a channel in the resting state since neither NMR nor X-
ray crystallography are amenable to maintaining an intact cell membrane at resting potential.  
What constitutes the actual ‘gate’ of the pore and how does S4 cause it to open? 
Crystal structures of KcsA, MthK and KvaP present us with a general shape reminiscent of an 
‘inverted teepee’ (Doyle, 1998; Jiang et al., 2002, 2003a), with an internal water filled cavity 
beneath the selectivity filter (Figure 1.4), followed by the ‘gate’ formed by the crossing of the 
S6 helices at the ‘peak’ of this teepee bundle (Figure 1.5). Experimental evidence shows that 
quarternary ammonium (QA) compounds used intracellularly block potassium currents, but can 
be ‘trapped’ in the aqueous cavity by a strong and rapid hyperpolarization (which closes the 
channel), locking it ‘open’ (Swartz, 2004a; Elinder et al., 2007). This led to the idea that a 
swiveling motion of the S6 helices about the ‘tip’ of the cone constitutes the opening process of 
the channel. Mutagenesis studies with various S6 residues changed to cysteines and subsequent 
probing by thiol-reactive agents (methanethiosulfonates or MTS as well as the silver ion Ag
+
), in 
the open and closed states, largely supported this ‘pivot’ model. Additional crystal structures 
from MthK show a much larger opening in the ‘gate’ region than that of KcsA. KcsA was 
crystallized ‘locked open’ by an artificial Cys-Cd2+-His bridge, which is impossible for the 
distance observed in MthK (≈12Å). This indicates a higher degree of rotational movement at the 
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‘hinge’ region of the gate and a more ‘bent’ S6 in MthK. The ‘hinge’ region appears to be a 
conserved glycine residue in the S6 of prokaryotic channels, and either the glycine or a ‘PVP’ 
motif further down the S6 helix in Shaker and Kv channels (Swartz, 2004a; Long et al., 2005; 
Tombola et al., 2006; Elinder et al., 2007). Mutation of the second proline of this motif in Shaker 
(a Drosophila KV1.2 homolog) uncouples it from its VSD, resulting in a constitutively active 
channel (Sukhareva et al., 2003). The distal end of S6 and the residues downstream of PVP 
appear to serve as a coupling site for the actual mechanical transduction of activation for the S4-
5 linker and the VSD (Swartz, 2004a, 2004b; Long et al., 2005; Tombola et al., 2006; Elinder et 
al., 2007). The linker crosses over the ‘bent’ S6 from a neighboring subunit, making several 
contacts in Kv1.2 (Long et al., 2005); chimeric channels with mismatched S4-5 linkers and C-
terminal S6 sequences (from different channels) show very little voltage regulation (Lu et al., 
2001; Lu, 2002). Whether the mutations render the channel constitutively closed or open appears 
to depend on the resulting change in the angle at which the S6 helices converge, thus further 
supporting the idea of the C-terminal ends of S6 as being the functional ‘gate’.  
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Figure 1.3: Structural depiction of the 'gate' region (one subunit) in KV1.2.  
Generated using Chimera (PDB ID#: 2A79) (Long et al., 2005) 
The gating transduction pathway is not fully understood, but so far has been shown to 
involve the S4-5 linker, several contacts between the S4 and S5 helices themselves , as well as an 
isolated ‘gating’ motion of S4 that occurs as the final step in the sequence of ‘opening steps’ 
involved in gating charge motion (Tombola et al., 2006). This last ‘gating’ step carries little 
charge and can be isolated from actual voltage sensing in Shaker through conservative 
mutagenesis of several hydrophobic S4 residues (the “ILT” mutant V369I, I372L, S376T), and it 
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is this final motion of S4 that supposedly imparts cooperativity to the opening of the channel 
(Ledwell and Aldrich, 1999; Pathak et al., 2005). The extent to which we can extrapolate this 
information onto four homology domain channels like NaV and CaV remains to be seen 
(Bezanilla, 2006). Lack of structural data for these larger channels has been a major roadblock in 
obtaining a functional model. Furthermore, there are additional layers of regulation imparted by 
the presence of auxiliary subunits (see section 1.3.1) and calcium-binding proteins such as 
calcium binding proteins (CaBP1-4) and calmodulin (CaM). The latter is nearly universal for all 
HVA channels (Peterson et al., 1999; DeMaria et al., 2001; Erickson et al., 2001), regardless of 
species, and is the main subject of the research covered by this dissertation. Thus, it follows that 
a brief introduction to this crucial protein is necessary, and can be found in the next section. 
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Figure 1.4: Ribbon-format structure of KcsA.  
Transverse inverted view (e.g. looking into the bottom of the channel, where the S6 helices converge). 
Generated using Jmol viewer on the PDB web site (KcsA entry ID: 1K4C). The different chains are color 
coded. The pore-forming domain at the center is comprised of S5 and 6 helices from each subunit, while 
the pH-sensing/activation domains roughly corresponding to the VSDs of voltage-gated channels are 
positioned on the outside in an opposing manner – see also Figure 1.1 for architectural diagrams. 
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Figure 1.5: A 'dissected' view of KcsA pore-domain (S5-6).  
Three of the four subunits shown for clarity (color coded). K
+
 ions are purple. Selectivity filter (P-loop) 
sequence TVGYG is in cyan, only one is annotated for clarity. Generated using UCSF Chimera molecule 
modeling software (http://www.cgl.ucsf.edu/chimera/) and the PDB entry for KcsA (1K4C). 
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1.6 Calcium and Calmodulin 
1.6.1 Calcium 
Calcium, while being present at much lower concentrations in biological systems than either 
potassium or sodium, has a much greater chemical gradient across the plasma membrane, by at 
least three orders of magnitude
6
(Simons, 1988; Hille, 2001; Tuckwell, 2012). It is very 
ubiquitous in nature, being the fifth most common element in the lithosphere, and many of its 
salts have low solubility. Ca
2+
 tends to cross-link macromolecules resulting in aggregation and 
precipitation (Zhou et al., 2013), which is likely the reason why evolution has favored its 
exclusion from the intracellular space and carefully maintained distribution and storage 
(Berridge et al., 2000). Free internal calcium concentrations range anywhere from 20 to 200nM, 
comparable to that of protons (Berridge et al., 2000; Hille, 2001). This is achieved by the 
existence of several plasma membrane Ca
2+
-ATPases and Na
+
-Ca
2+
 exchangers, as well as Ca
2+
 
pumps in the mitochondria and endoplasmic reticulum (Clapham, 2012). Chemical interaction of 
metal ions becomes more covalent across the periodic table, favoring interaction with less 
electronegative ligands such as sulphur and nitrogen. Ca
2+
 and the metals in its group, in 
contrast, are highly ionic in their character, favoring interaction with oxygen based ligands 
(carbonyl, carboxyl, alcohols and ethers), a flexible coordination geometry (4-8) and fast binding 
kinetics (Grabarek, 2005; Zamponi, 2005; Gifford et al., 2007; Zhou et al., 2013). This 
combination of features makes it excellently suited for its role as a cellular messenger; indeed, 
the number of regulatory pathways in which Ca
2+
 is involved is staggering (Berridge et al., 2000; 
Clapham, 2012; Zhou et al., 2013). Of course, having a Ca
2+
 binding motif in every potential 
                                                 
6
 Exact numbers are cell-specific, but most never exceed 1µM free internal Ca
2+ 
(Berridge et al., 2000), whereas 
plasma concentrations are usually around 1mM free Ca
2+
, in contrast to the 140/10 and 20/100 mM (out/in) range of 
concentrations found for Na
+
 and K
+
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regulatory target protein would be physiologically costly (and redundant). Fortunately, nature’s 
solution to this problem was the evolution of ‘translator’ proteins that bind Ca2+ as well as 
diverse protein targets; this allows a small number of conserved Ca
2+
 motifs to have a vast 
number of downstream targets depending on what combination of ‘detector’ and ‘effector’ 
domains are present.   
1.6.2 The EF hand motif 
There are several common calcium-coordinating motifs in proteins, but the most 
ubiquitous of those is the EF hand motif, at least among cytoplasmic proteins.  There are five 
other types of Ca
2+
 binding proteins found outside the cell, and a number of different ER/SR-
localized proteins, phospholipid-binding ‘annexins’, C2-domain proteins like PKC and 
synaptotagmin inside the cell, suggesting that Ca
2+
 binding proteins may have arisen more than 
once in evolution (Clapham, 2012). The first study to characterize the EF hand motif in carp 
parvalbumin used alphanumeric indexing of the protein helices, A-F (only the C-terminus of this 
protein binds Ca
2+
). The helix-loop-helix structure formed upon Ca
2+
 binding resembles a pair of 
hands facing each other with thumbs perpendicular to the index fingers, thus giving the motif its 
characteristic name (Figure 1.6). Each Ca
2+
 binding loop contains 12 residues, 6 of which 
provide seven coordinating ligands: 3-4 side chain carboxyl groups of acidic residues (positions 
1,3,5, typically Asp), a backbone carbonyl of a rather variable residue (pos7), an Asp-polarized 
water (9) and both side chain oxygens of the final Glu residue (12).  Interestingly, two non-
coordinating residues also appear to be crucial, or at least, invariable in most EF hands: a Gly in 
(6), likely to accommodate the bend in the loop necessary for proper geometry, and a 
hydrophobic residue in (8) (Ile, Leu or Val) (Gifford et al., 2007). The latter is proposed to be 
needed to make inter-helix van der Waals contacts in the collapsed apo-form, and hydrogen 
37 
 
bonds (via backbone) between the 2 loops in the Ca
2+
-replete holo form of CaM (Grabarek, 
2005). The strength of the inter-helix coupling appears to be a factor in the cooperativity of Ca
2+
 
binding (Linse et al., 1991; Nelson et al., 2002), thus in nearly all known EF-hand containing 
proteins these motifs happen to occur in pairs. The actual arrangement of EF-hand domains, 
however, especially their relative orientation and linker flexibility, is quite variable in nature and 
is the salient feature of all Ca
2+
-signal transducing proteins, to which they owe their vast 
regulatory target repertoire – CaM in particular (Chou et al., 2001; Hoeflich and Ikura, 2002; 
Vetter and Leclerc, 2003; Yamniuk and Vogel, 2004; Gifford et al., 2007). Ca
2+
 binding to EF 
hands realigns the two helices from nearly anti-parallel to more perpendicular (e.g. opens the 
‘hand’, see Figure 1.6), and allows the exposure of hydrophobic side chains which are often 
involved in subsequent target binding (Zhang et al., 1995; Ikura, 1996; Hoeflich and Ikura, 
2002).  
1.6.3 Calmodulin: general background 
Calmodulin is the prototypical EF hand protein, belonging to a family collectively termed 
‘CTER’ for each of the most abundant four members: calmodulin, troponin C and essential and 
regulatory myosin light chains. CaM contains two EF hand domains, each containing a pair, for 
a total capacity of four Ca
2+
 ions. The CaM EF domains share a 46% sequence identity, 
separated by a 27 residue flexible linker, roughly resembling a ‘dumb bell’ shape (Chou et al., 
2001). Calcium binding to EF hands in CaM is thought to occur in the sequence of III-IV-I-II, in 
a cooperative manner, although unusual target-bound conformations where only the N-lobe is 
Ca
2+
-saturated do exist (Vetter and Leclerc, 2003) (see Table 1.2). The C lobe has a 6-fold higher 
affinity for Ca
2+
 than the N-lobe (Linse et al., 1991), which gives CaM an additional level of 
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regulatory complexity by increasing the effective range of cellular Ca
2+
 concentrations to which 
it can respond (Zhang et al., 2012).  
CaM is an essential protein; its knockouts are lethal in Drosophila and yeast (Davis et al., 
1986; Heiman et al., 2010), although maternal CaM sustains fruit fly larvae for up to 2 days. 
Intriguingly, gross behavioral abnormalities in CaM knockouts of Drosophila (spontaneous 
backwards movement) parallel some CaM mutation effects in Paramecium (aberrant backward 
motion) (Hinrichsen, 1992). This observation supports the role of CaM in regulation of neuronal 
activity related to Ca
2+
 current modulation – although this was not directly confirmed until nearly 
the turn of the century (Peterson et al., 1999). Not surprisingly, given CaM’s essential role, its 
expression in mammals is multi-genetic: there are three non-allelic mammalian CALM genes, all 
sharing a high degree of nucleotide sequence identity (≈80% in humans), which all translate into 
the same amino acid sequence. At first glance, this arrangement would seem like a good 
‘backup’ strategy for an essential protein, but a closer inspection reveals a high degree of 
variation in their untranslated regions (UTRs), typically associated with protein transcriptional 
control (Toutenhoofd and Strehler, 2000). This would suggest that the different CALM genes 
may actually serve as a way of controlling the availability of local CaM pools for different 
targets. The expression of CaM is highly variable and appears to be finely regulated, with the 
highest levels of total CaM found in the brain and testis (Kakiuchi et al., 1982) and typically 
ranging from 1 µM (erythrocytes) to 30 µM (cerebral cortex).  
In terms of its biochemistry, CaM is a relatively small (16.7 kDa), ubiquitous, highly 
soluble, acidic (pI ≈ 4) protein of 148 amino acids. It has a high frequency of methionines (9 
total, making up ≈ 6% of the protein), greater than the average for the animal proteome (2-3%) 
(DePristo et al., 2006). The methionines are thought to be crucial to CaM’s versatility in target 
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binding (Gellman, 1991; Zhang et al., 1994; Yuan and Vogel, 1999; Yamniuk and Vogel, 2004) 
and almost half of holo-CaM’s hydrophobic solvent accessible surface area (SASA) is 
contributed by these Met residues (O’Neil and DeGrado, 1990). Not surprisingly, Met oxidation 
is associated with a loss of target binding by CaM and increased proteasomal degradation (Gao 
et al., 1998; Snijder et al., 2011), although the effect may be residue- and target-specific 
(Montgomery et al., 2003). 
1.6.4 CaM target binding 
Actual CaM binding target sequences range widely but have a few common properties 
and several conserved motifs, typically differing in the arrangement and spacing of their 
hydrophobic anchor residues that interact with CaM (hence names like 1-5-8-14, as in 
smMLCK). Some representative examples and sequences are outlined in Table 1.2 
A common feature of these sequences is their propensity to form an amphipathic, basic α-
helix, with the bulky anchor residues presumably facing the same way on one side of the helix 
(Vetter and Leclerc, 2003; Yamniuk and Vogel, 2004), at least for the majority of the ‘canonical’ 
type recognition sequences (Rhoads and Friedberg, 1997). Admittedly, an increasing number of 
new CaM target structures reveal unusual conformations not consistent with the Ca
2+
 binding 
mechanics of CaM (e.g. the small conductance SK channel, B.anthracis edema factor protein, 
etc.). There are instances of CaM being reciprocally regulated by its actual target. For example, 
the IQ motif of the voltage gated sodium channel NaV1.2 actually preferentially binds the C-lobe 
of apo-CaM over holo-CaM (either lobe), and subsequently reduces its affinity for Ca
2+
 by over 
2 orders of magnitude (Feldkamp et al., 2011). Interestingly, this channel also binds Ca
2+
-CaM at 
an alternate site upstream of the IQ motif, and the two are likely in competition in vivo, serving 
as a molecular Ca
2+
-dependent switch. Similar Ca
2+
-affinity tuning effects have been observed 
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with other targets as well (Putkey et al., 2008; Zhang et al., 2012), as well as targets that increase 
CaM’s affinity for Ca2+ (reviewed in Jurado 1999). Hence the availability of CaM, in any of the 
Ca
2+
-bound forms (0, 2, or 4- Ca
2+
 ions) is subject to its retention by different cell-specific and 
common high-affinity targets. Several studies point to CaM-dependent kinase II as being one 
such ‘CaM-trap’ molecule (Kim et al., 2004b; Sanabria et al., 2008). CaMKII is dodecameric, 
with at least as many high-affinity Ca
2+
-CaM binding sites, and is able to increase its own CaM 
affinity via auto-phosphorylation upon CaM binding. Not all CaM ‘traps’ are high-capacity, 
however. Strong, nearly irreversible binding of CaM to certain targets can also reduce the pool of 
available CaM, especially if the concentration of these targets is high. These ‘constitutive’ CaM 
binding proteins essentially treat CaM as an integral subunit. An example is the inducible nitric 
oxide synthase (iNOS), which binds CaM at basal Ca
2+
 levels but requires Ca
2+
 for full 
activation, and is highly expressed in macrophages upon immune activation by cytokines (Cho et 
al., 1992; Censarek et al., 2004; Spratt et al., 2006). In fact, iNOS cannot even be heterologously 
expressed at a practical level without any CaM present, due to severe aggregation, suggesting 
CaM might also be acting as a chaperone in this case (Wu et al., 1996). Another low-capacity, 
high-affinity CaM sequestering protein is neurogranin (NG), which contains an IQ-motif and, 
like NaV1.2, attenuates the Ca
2+
 affinity of CaM (Kubota et al., 2007). NG is responsible for the 
fine-tuning of long-term potentiation (LTP) in post-synaptic neurons, although the exact 
mechanism is still unclear. 
As a result of such regulatory controls, CaM availability appears to be limiting in the cell 
(Persechini and Stemmer, 2002), with one study involving cardiomyocytes proposing a [CaM]free 
range of 50-75nM, which is only 1% of total CaM in those cells, even at resting Ca
2+
 (Wu and 
Bers, 2007). Another study in kidney cells using a biosensor that binds both apo- and holo-CaM 
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estimates the total available CaM for resting cells to be in the micromolar range, with an 
approximately 50-fold decrease upon cellular [Ca
2+
]free elevation (Black et al., 2004). This allows 
for selective activation of specific CaM-mediated signaling networks that is both spatially and 
temporally controlled in response to Ca
2+
, as a complex function of the number of targets and 
Ca
2+
 gradients (Slavov et al., 2013). On the other hand, overexpression of CaM can also lead to 
pathological effects, although there are comparatively few studies that have been done to 
characterize them
7
.  
Considering that perturbations in CaM Ca
2+
 binding can have devastating consequences, 
such as recurrent cardiac arrest in infants (Crotti et al., 2013), understanding the mechanism by 
which CaM exerts its effects is paramount. As a first step in this direction, biophysical 
characterization of the target binding sites in voltage-gated ion channels has been largely 
successful, with a number of published structural and functional studies revealing several 
conserved CaM binding sites in a number of channels (reviewed in Kovalevskaya et al., 2013). 
That number is poised to increase yet further, aided by the findings contained within this 
dissertation. The three main groups of voltage-gated calcium channels (CaV1,2,3.x) are all 
represented here (with more emphasis on L- and T-type channels than others). Established, 
canonical binding sites (e.g. the IQ motif) are compared, and novel, moderately conserved 
binding sites are explored and characterized, all with the ultimate goal of understanding how 
CaM may affect the (in)activation profiles of these large, essential proteins.    
  
                                                 
7
 CaM overexpression in pancreatic β-cells results in Ca2+-induced cell apoptosis and subsequent diabetic symptoms 
(Yuzawa et al., 2008). CaM overexpression in cardiomyocytes leads to hypertrophy via a calcineurin/CaMKII-
dependent pathway (Obata et al., 2005). 
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Figure 1.6: Schematic representation and structural view of the EF hands of CaM.  
(left) EF 'hand' as represented by a pair of hands; the right index finger is 'E' and thumb is 'F' (middle), 
corresponding to the PDB structure for the EF hand from CaM of Paramecium (PDB code 1EXR) (right), 
visualized with Jmol. The helices are in green, whereas the short inter-helix anti-parallel β-sheet (only one 
hand shown for clarity) is in pink. Coordinating oxygens are red; peptide bonds in black, the coordinating 
water molecule is blue and Ca
2+
 ion is yellow. 
 
Table 1.2: Brief overview of prototypical (and some atypical) CaM binding targets and 
their defining features.  
Content adapted from (Rhoads and Friedberg, 1997; Vetter and Leclerc, 2003; Yamniuk and Vogel, 
2004). Sequences for the first 5 peptides are taken from one of those three references. Hydrophobic 
anchor residues are bolded; consensus ‘IQ motif’ sequences are underlined. Special notes and source 
references: (1) The ‘CaM binding database’ (Yap et al., 2000) as well as (Yamniuk and Vogel, 2004), list 
CaMKK (both α and β isoforms) as a 1-16 motifs, not as 1-5-16 as in (Vetter and Leclerc, 2003). (2) The 
initial PMCA-CaM structure study used a shorter PMCA fragment that only bound the C-lobe of CaM 
(reflected in Vetter and Leclerc, 2003) in a different conformation than seen in the more recent NMR 
study with a larger peptide (Juranic et al., 2010). (3) (Schumacher et al., 2001). (4) The sequence is 
actually a prediction from the edema factor of B. anthracis adenylyl cyclase gene (GB ID M24074.1) 
CDS analyzed by the prediction search algorithm of the CaM binding database (Yap et al., 2000) and 
structure obtained from (Drum et al., 2000). (5) The study actually reveals a reduction of CaM C-lobe 
affinity for Ca
2+
 when bound to the NaV1.2 IQ peptide (Feldkamp et al., 2011) (6) (Van Petegem et al., 
2005) (7) (Kim et al., 2008) (8) based on a crystal structure from (Houdusse et al., 2006); myosin V 
contains multiple IQ motifs with quite variable sequences; the more variable residues in the second (C-
terminal) half of the IQ motifs make contacts with the N-lobe of CaM and alter its relative orientation.  
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CaM Target Sequence (Target / CaM) 
structural 
conformation 
Motif 
name  
CaM lobes 
bound to 
#(Ca
2+
) ions 
smMLCK RRKWQKTGHAVRAIGRLS
SS 
Helix /collapsed  
antiparallel 
1-8-14 N, C (4) 
skMLCK KRRWKKNFIAVSAANRFK
KISS 
Helix/ collapsed 
antiparallel 
1-5-8-14 N, C (4) 
CaMKII FNARRKLKGAILTTMLATR Helix /collapsed 
antiparallel 
1-5-10 N, C (4) 
CaMKKβ IPSLATVILVKTMIRKRSFG
NPF 
Helix –β hairpin loop 
/parallel 
1-16
1
 N, C (4) 
Ca
2+
 pump LRRGQILWFRGLNRIQTQI
KVVKAFHSS 
Helix /collapsed 
antiparallel 
1-18
2
 N, C (4) 
K
+
 channel TQLTKRVKNAAANVLRET
WLIYKNTKLVKKIDHAKV
RKHQRKFLQAIHQLRSVK
MEQRKLNDQANTLVDLA
K
3
 
3 helix/ extended 2:2 
complex 
Non 
classsical 
N (2) 
Anthrax 
edema factor 
HIFSQEKKRKISIFRGIQAYN
EIEN 
4
 
? /Extended non-
classical 
Unknown  C (2) 
NaV1.2 IQ 
domain 
KRKQEEVSAIVIQRAYRRY
LLKQKVKK 
 
Helix/ ‘open’ ‘parallel’, 
C-lobe only
5
 
Canonical 
IQ motif 
Apo-CaM 
Myosin V 
motor 
domain  
1) 
ACIRIQKTIRGWLLRKRY 
2) 
AAITVQRYVRGYQARCYA 
Helix / antiparallel 
Semi-open C-lobe, 
Closed N-lobe 
Canonical 
IQ motif 
(x2) 
Apo-CaM 
L-type IQ 
(CaV1.2) 
VGKFYATFLIQEYFRKFKK
RKEQ 
Helix/ compact 
Parallel
6
 
IQ-like 
motif 
N, C (4) 
P/Q type IQ 
(CaV.2.1) 
VGKIYAAMMIMEYYRQSK
AKKLQ 
Helix /compact 
Anti-parallel
7
 
IQ-like 
motif 
N, C (4) 
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1.7 CaM regulation of other channels 
While voltage-gated calcium channels and their modulation by Ca
2+
/CaM are certainly the best 
studied, they are not alone in being subject to CaM control. A large number of other channels 
from rather distant lineages (see Figure 1.1) are all subject to direct modulation by CaM. Many 
more are subject to some indirect control of CaM, such as a phosphorylation pathway, but the 
latter are beyond the scope of this dissertation and will not be touched upon. Among those 
directly regulated by CaM are (in order of most related/similar to CaVs, and also the best studied, 
to least): voltage-gated sodium channels (NaVs), ryanodine (RyR) and inositol triphosphate 
(IP3R) receptors, voltage-gated potassium channels (KV11.1 and KV7.4), small conductance 
Ca
2+
-activated K
+
 channels (SK or KCNN), transient receptor potential channels (TRPV1,5,6), 
cyclic nucleotide-gated channels (CNGs) and certain ligand-gated channels (NMDA and 
metabotropic Glu receptors) (Kovalevskaya et al., 2013). CaM also regulates the plasma 
membrane Ca
2+
 ATPase (PMCA), although it is not strictly an ion ‘channel’ (Boschek et al., 
2008; Juranic et al., 2010). The interactions are quite diverse and so is our level of understanding 
regarding their mechanisms and effects. Below is a brief summary of what is known regarding a 
select number of representative examples; for a more comprehensive examination the reader is 
directed to several reviews (Saimi and Kung, 2002; Kovalevskaya et al., 2013) and the 
references therein.  
 
1.7.1 Voltage gated sodium channels 
As mentioned earlier in this chapter, NaVs are closely evolutionarily related to CaVs (Anderson 
and Greenberg, 2001; Goldin, 2002; Piontkivska and Hughes, 2003). It is therefore not surprising 
that these channels also possess two EF hands and an IQ motif in their C-terminus. At present, 
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the textbook description of inactivation in NaVs is a similar process to that in KVs, in that a 
cytoplasmic region of the channel (DIII-IV linker, or ‘lid’) swings over the inner mouth/pore of 
the channel rapidly and inactivates it (‘hinged lid’ mechanism) (Catterall, 2000; Hille, 2001; Yu 
and Catterall, 2003; Zamponi, 2005). Interestingly, the III-IV linker also contains a CaM-binding 
site (Sarhan et al., 2012), which preferentially binds the Ca
2+
-C-lobe of CaM and has a 
prominent attenuating effect on channel inactivation. This region is also a hotspot for disease-
associated mutations affecting channel gating kinetics (Potet et al., 2009; Sarhan et al., 2012). In 
contrast, the IQ motif in these channels preferentially binds apo-CaM (Potet et al., 2009; 
Feldkamp et al., 2011) and its effects on inactivation appear to lack Ca
2+
 dependence.  
 
Figure 1.7: Model summarizing the proposed CaM regulation of NaV1.5 
In resting Ca
2+
, apoCaM remains tethered to the IQ motif via its C-lobe, allowing the ‘lid’ region (blue 
circle) to freely interact with the docking site, causing rapid channel inactivation. When cellular Ca
2+
 
rises, its binding to the C-lobe of CaM causes it to dissociate from the IQ motif and bind instead to the 
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CaM binding site in the III-IV linker (crescent moon), which destabilizes the lid-pore complex and results 
in increased channel opening (higher Po) (Sarhan et al., 2012; Van Petegem et al., 2012). 
 
 The effects of the two CaM binding sites (IQ and III-IV linker) on the calcium/CaM 
dependent modulation of the channel remain controversial, however, as conflicting results have 
been obtained in different studies, depending on isoform, mutation, and even cell lines used for 
expression, with the general consensus that the IQ motif is not actually essential for the Ca
2+
-
specific effects on inactivation (Van Petegem et al., 2012). The NaV IQ motif has also been 
shown to bind CaM with a few variable, isoform-specific differences in conformation, such as 
NaV1.5 (Sarhan et al., 2012) vs. NaV1.6 (Reddy Chichili et al., 2013), something that is also true 
for the CaM-IQ structures of various CaVs (Kim et al., 2008). The most recently proposed model 
describes the C-terminal NaV1.5 IQ motif as a ‘tether’ for apo-CaM, whereby the apo-C-lobe 
interacts with the C-terminus in absence of Ca
2+
, for which it has a higher affinity than the apo 
N-lobe (Figure 1.7). But as soon as allosteric Ca
2+
 signals (either from nearby CaVs or RyR-ER 
activation) allow Ca
2+
 to bind the C-lobe of CaM, which has a higher Ca
2+
 affinity than the N-
lobe, there is structural rearrangement leading to the relocation of the Ca
2+
-C-lobe to the III-IV 
linker, and an opening for the N-lobe to now bind the C-terminus. This bridging of the two 
intracellular domains presumably leads to a destabilization of the inactivation gate from its 
putative docking site in the S4-5 linkers of DIII and IV, leading to a depolarizing shift (e.g. 
increased channel availability) in the activation curve. In simplified terms, CaM acts as a ‘clamp’ 
on the inactivation ‘lid’, reducing its mobility or occluding the docking site, and allows the 
channels to remain open longer or at more negative potentials (Van Petegem et al., 2012). This is 
especially interesting in regard to its potential similarity to the regulation of CaVs, albeit with 
different molecular elements (the domain I-II linker, NSCaTE, etc. – see Chapters 2 and 3). It 
47 
 
will be interesting to see whether some form of this model holds true for all ‘lid’ type 
inactivating channels. 
 
1.7.2 Calcium-gated potassium channels 
Despite being loosely grouped within the voltage gated channel family, the small conductance 
potassium channels (SK, or KCa2.1-3) are solely activated by Ca
2+
 via a constitutively bound 
CaM. These channels are tetramers of the standard S1-6 TM architecture, with a distinct 
regulatory Ca
2+
/CaM binding domain in their cytoplasmic C-terminus, immediately downstream 
of the pore-forming domain. SK channels are fairly unique in their regulatory mechanism and 
structural interaction with CaM (as explained below), far different from the more ‘canonical’ 1:1 
complexes seen with CBDs of other channels, showing yet again just how flexible CaM is as an 
effector molecule.  
There are two striking features of CaM regulation of SK channels. First, is that upon Ca
2+
 
level increase, only the N-lobe of CaM binds Ca
2+
, while the C-lobe remains in the apo form, 
although some of its hydrophobic residues do get repacked differently in the transition 
(Schumacher et al., 2001, 2004; Lee et al., 2003b). Note that the Ca
2+
 source has to be a nearby 
Ca
2+
 channel
8
 or global cellular Ca
2+
 elevation, since SK channels do not pass Ca
2+
. Secondly, is 
that while the apoCaM C-lobe interacts with a relatively small (~10 residue) region of the SK2 
CBD, the rest of which remains unbound and flexible, binding of Ca
2+
 induces large scale 
rearrangement leading to dimerization of the CBDs of adjacent subunits. In the much less 
flexible dimer form, the Ca
2+
-N-lobe of one CaM interacts with a C-terminal region of the 
adjacent CBD, while the C-lobe repacks itself to cross-link two of the helices in its own CBD, 
                                                 
8
 There is evidence of T-type channels being physically and/or functionally coupled to certain potassium channels, 
such as KV4 and SK (Wolfart and Roeper, 2002; Anderson et al., 2013) 
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resulting in an unusual two CaM, three helix structure (Schumacher et al., 2004). The proximity 
of this complex to the S6 (and therefore, the channel ‘gate’) presumably destabilizes the 
inactivated state and results in the opening of the channel, although this motion has not yet been 
verified.  
1.7.3 Ryanodine Receptors 
RyRs are Ca
2+
 release channels found on the sarcoplasmic or endoplasmic reticulum, and often 
found coupled to voltage gated calcium channels (e.g. CaV1.1 in skeletal muscle) that direct their 
opening. These massive (approximately 10 times larger than NaV and CaVs) cation-selective 
channels are homotetramers of ~5000 residue subunits, large N-terminal portions of which are 
facing into the cytoplasm in a roughly square pattern (Zalk et al., 2007). The majority of the 
sequence is associated with regulatory functions, whereas only about the last 10% of the protein 
contains the transmembrane segments; a truncated ~1000 C-terminal residue subunit was 
sufficient to create a Ca
2+
 sensitive pore in one study (Bhat et al., 1997).  
Remarkably, CaM is a multi-tier regulator of the RYR1 isoform found in skeletal muscle, 
via its C-lobe binding directly to the 3614-43 region of RYR1, as both apo and holo CaM, as 
well as by competing for binding of the CaV1.1 C-terminus to this region (Sencer et al., 2001; 
Maximciuc et al., 2006). The 3614-3643 region of RYR1 binds CaM in an anti-parallel fashion 
in a novel ‘1-17’ conformation, with the two CaM lobes binding with relative independence of 
each other (Maximciuc et al., 2006). The N-lobe of CaM is also thought to bind to a more 
upstream region (1975-1999, ‘site 1’) of an adjacent RYR1 subunit. Furthermore, CaM competes 
for binding to 3614-43 (‘site 2’) with a downstream region of RYR1 (4064-4210, ‘site 3’), which 
is predicted to have a CaM-like fold (Xiong et al., 2006), and may play a role in channel 
activation by blocking CaM from its interaction with site 2. Even more bewildering is that CaM 
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is also able to bind to this third site itself, in the apo state, with very high affinity (Lau et al., 
2014), although the physiological effect of this interaction is unknown. Interestingly, CaM 
binding site 3 (CBS3) is very weakly conserved and does not appear to affect the Ca
2+
/CaM 
regulation of RYR1 gating in deletion studies; thus it may simply be a CaM tethering site, or 
have another, isoform-specific role. Additionally, all three RYR isoforms contain one or more 
EF hands in various locations (in RYR1, there are three tandem EF hands just downstream of the 
third CaM binding site), although their roles are still not fully understood. Ca
2+
 has a bimodal 
effect on the gating of RYR1; at low concentrations (nanomolar) it is stimulatory and at higher 
(micromolar) concentrations, it is inhibitory. In contrast, in cardiac RYR2, CaM is inhibitory at 
all Ca
2+
 concentrations (Zalk et al., 2007). Whether or not this is a consequence of different 
CaM-RYR interactions, or the differences in the position and properties of the RYR EF hand 
motifs, or a combination of these and other effects remains to be elucidated. 
 
1.7.4 Transient Receptor Potential Channels 
TRP channels are essentially the cell ‘sensors’ towards various external stimuli, and comprise a 
large number (over 20 different isoforms in mammals) of different genes, broadly categorized 
into seven groups. They share a similar topology (6TM, heterotetramer) with other voltage-gated 
channels but are typically not gated by voltage. Instead, they are often capable of responding to 
numerous (and often seemingly disparate) physiological stimuli, and display an impressive range 
of cation selectivities and cytoplasmic domain diversity. They are also often found associated 
with other channels as effectors, and in many cases this interaction is essential for the TRP 
function (e.g. the IP3 receptors) (Venkatachalam and Montell, 2007). Many human inherited 
diseases are associated with mutations in this channel family (see Figure 1.1). 
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At least three isoforms are thought to interact with CaM (Numazaki et al., 2003; 
Kovalevskaya et al., 2012), TRP1, 5 and 6. TRPV1 is the ‘classical’ TRP channel and responds 
to heat, capsaicin, camphor and several other pharmacological agents. It thus acts as a generic 
polymodal ‘pain receptor’, and is the primary TRP channel in sensory neurons. Pain 
desensitization via capsaicin application is thought to be a result of inactivation of TRPV1 
currents, and is a Ca
2+
-dependent process attributed to CaM binding to TRPV1 at a 35 residue 
site in the C-terminus (E767-T801). Intriguingly, this interaction occurs in both presence and 
absence of Ca
2+
, but the desensitization process requires extracellular Ca
2+
 (Numazaki et al., 
2003). The process may prove to be qualitatively similar to CDI in L-type channels, or the CaM 
regulation of NaVs; the exact molecular mechanisms of this process remain to be elucidated. 
TRPV5 and 6 are the most Ca
2+
-selective of the group and may have involvement with 
store-operated Ca
2+
 currents; TRPV5 mutations are associated with high urinary Ca
2+
 excretion 
and osteoclast Ca
2+
 resorption defects (Nilius, 2007; Venkatachalam and Montell, 2007). Little is 
known about the effects of Ca
2+
 and CaM on the current/voltage properties of these channels. 
However, there has been at least one study suggesting that up to five CaM binding sites may be 
involved (Kovalevskaya et al., 2012), thus the process is likely quite complex if these are all 
indeed physiologically relevant. So far, only their in vitro CaM binding properties have been 
analyzed.  
 
1.7.5 NMDA receptors 
Neurotransmission is a complex process involving several different classes of channels: sodium 
and potassium channels for action potential propagation, voltage gated calcium channels for 
neurotransmitter release, and finally, neurotransmitter receptors on the post-synaptic neuron 
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membrane (Bezanilla, 2006). The latter are highly specialized among neurons and even by 
location, and, unsurprisingly, have highly complex architectures. Glutamate is a key 
neurotransmitter in excitatory signaling. NMDA is an analog of glutamate, and its receptors are 
heterotetramers of two types of subunits: NR1 and NR2(A-D), with additional variation 
contributed by splice isoforms of NR1
9
. NMDARs are one of the most Ca
2+
-selective ligand 
channels, and are subject to regulation by CaM. Binding of CaM to NMDARs reduces their open 
probability and mean open time (Rosenmund et al., 1995; Zhang et al., 1998) 
Interestingly, CDI in NMDARs is also strongly affected by cytoskeleton-disrupting 
agents, suggesting that physical coupling of the channel domains to the cytoskeleton may be 
involved in their inactivation. In fact, addition of α-actinin2, an actin associated protein, 
abolishes CaM-induced CDI (Zhang et al., 1998). There has been controversy regarding the 
binding between NR1 and α-actinin2, with one study suggesting that a direct interaction is 
responsible (Merrill et al., 2007), and another showing a lack of any interaction (Wang et al., 
2008); thus, a clear model is lacking. Furthermore, the interaction between CaM and CBS1 of 
NR1 is Ca
2+
-dependent and does not likely support a pre-association mode for CaM. 
Additionally, CaM may bind CBS1 with a 1 : 2 (CaM : CBS) stoichiometry, suggesting that 
functional channel dimerization (in a Ca
2+
-dependent manner) drives CDI. Only the C-lobe of 
CaM needs to be Ca
2+
-replete for the interaction with CBS1, and likely proper folding of the C-
terminus, but either lobe is sufficient to displace α-actinin2. Additionally, the regulation by Ca2+-
CaM may be at least in some part attributed to the action of CaMKII, which is able to bind to 
NR1 C0 if α-actinin2 is first displaced (Merrill et al., 2007). Much additional research is still 
                                                 
9
 The three mammalian NR1 exons (C0-2) are known; C0 is invariant (and contains the first CaM-binding site 
CBS1) and C1 and 2 are developmentally regulated (Wang et al., 2008). C1 contains the higher affinity CBS2 that 
appears to lack any effect on CDI. 
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needed to decipher the exact role CaM plays in the regulation of NMDARs, and settle the 
controversy. 
1.7.6 Summary 
As evident from this section, the regulation of different channel types by CaM is both intricate 
and varied, and may rely on anywhere from just one to many binding sites. The prevailing 
molecular mechanism archetypes are either A) several short, contiguous motifs, typically in the 
C-terminus, with distinct Ca
2+
 dependences and therefore, functional effects, or B) distinct, 
distant binding sites that may be brought close in vivo by their interaction with holoCaM, with 
direct biophysical effects on channel activity. As only a handful of channel proteins have had 
their structural elements and biochemical properties of CaM binding sites elucidated, at this time 
it is nearly impossible to derive a ‘template’ for channel CaM regulation that can accurately 
predict a particular model solely from primary sequence. However, if we were to obtain such 
information for a much greater repertoire of channels, perhaps a clearer trend could be observed.    
1.8 Research Objectives 
The main goal of this thesis is to further our understanding of voltage gated calcium channel 
regulation by calmodulin. The main hypothesis concerns the role of NSCaTE, which is a novel 
N-terminal CaM-binding motif in L-type channels, in global or local CDI, as well as the extent 
of its conservation. We propose that this motif is present in Lymnaea and performs a conserved 
role in all L-type channels. The questions to be answered in this dissertation are: 
1. What are the effects of NSCaTE on L-type channel regulation of diverse phyla? 
Hypothesis: NSCaTE is a conserved motif involved in some type of CDI in L-type 
channels of diverse phyla.  
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2. How do NSCaTE and/or IQ motif interact with CaM to elicit CDI? This is to be answered 
using biophysical analysis with various CaM mutants and through peptide binding 
studies. Hypothesis: CaM interacts with NSCaTE, in a way or conformation that is 
distinct from its interaction with the IQ motif, and consistent with its role outlined in 1) 
3. Does CaM regulate other channels through other possible mechanisms? (HVA or LVA). 
Hypothesis: CaM is a universal regulator of CaVs.  
To complete these objectives, a combination of biophysical studies using peptides corresponding 
to the regulatory motifs (IQ and NSCaTE) of their cognate channels were performed, as well as 
electrophysiology recordings with an NSCaTE deletion mutant of LCaV1. These studies include 
spectropolarimetry (circular dichroism), native PAGE studies, steady-state fluorescence and 
isothermal calorimetry. The results obtained in this thesis will help further our understanding of 
the molecular mechanisms governing the Ca
2+
-CaM regulation of voltage-gated calcium 
channels.  
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Chapter 2: Characterization of a Novel Short Linear Motif in the N-
terminus of an Invertebrate L-type Channel 
2.1 Introduction 
L-type calcium channels (CaVs) have key roles in a number of physiological processes (Catterall, 
2011). The molecular endpoints of both voltage-dependent inactivation (VDI) and calcium-
dependent inactivation (CDI) of CaVs have both been extensively studied, and although no 
universal model exists, many key elements have been determined and characterized (Zühlke et 
al., 2000; Kim et al., 2004a; Cens et al., 2006; Barrett and Tsien, 2008; Findeisen and Minor, 
2009; Cui, 2010; Tadross et al., 2010). Calmodulin (CaM), a small (16.7 kDa) bi-lobed Ca
2+
 
signal transducing protein, is an essential factor for CDI (Tang et al., 2003; Tadross et al., 2008; 
Guo et al., 2010) and is found pre-associated with these channels in vivo, regardless of its Ca
2+
-
binding state (Erickson et al., 2003). The difficulty of working with holo-channels has precluded 
a detailed structural analysis of this interaction, but various mapping studies have pointed to the 
IQ motif and surrounding sequences in the C-terminus and a small region of the N-terminus of 
CaVs as likely targets of CaM binding and regulation (Ivanina et al., 2000; Dick et al., 2008; 
Benmocha et al., 2009; Asmara et al., 2010; Liu and Vogel, 2012). The N-terminal region of CaV 
1.2 and 1.3 has been described as an “N-terminal spatial calcium transforming element” or 
NSCaTE (Dick et al., 2008), because of its dominant-positive ‘knock-in’ effect when fused to 
CaV2.2, resulting in robust, buffer-insensitive CDI that is not normally present in this channel 
(Peterson et al., 1999). Despite this profound effect, the actual role of NSCaTE in vivo is unclear. 
Several key mutations (W82, I86 and R90) do not greatly affect CDI even if they affect CaM 
binding (Benmocha et al., 2009), but the deletion of the entire N-terminus has an attenuating 
effect on CDI (Ivanina et al., 2000). To clarify the role of NSCaTE in CDI, we have 
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characterized a homologous sequence in the L-type channel of Lymnaea stagnalis (pond snail) or 
LCaV1. This channel has been previously characterized and shown to have a very strong 
resemblance to mammalian CaV1.2 (Spafford et al., 2006; Senatore et al., 2011a), including all 
the hallmarks of CDI in vivo as well as when heterologously expressed in HEK cells. It has 
striking sequence homology to α1c and α1d in the C-terminal region, particularly the IQ motif, 
and a distinct yet similar ‘NSCaTE’ motif. Wild type LCaV1 and a deletion mutant (ΔNT LCaV1, 
without the first 112 residues) were recorded in the whole-cell voltage clamp mode, using both 
Ca
2+
 and Ba
2+
 as charge carriers to distinguish the effects on CDI and VDI, respectively. In 
addition, biophysical studies using synthetic peptides corresponding to the IQ and NSCaTE 
motifs of both LCaV1 and CaV1.2 with wild type mammalian CaM were performed in an attempt 
to establish a molecular mechanism for the effects observed with electrophysiology recordings. 
We confirm the existence of NSCaTE in invertebrates and show its conservation coincides with 
the evolution of the IQ motif to a much greater extent than previously thought, and show it has a 
weak binding affinity for CaM as well as a modest and buffer-sensitive attenuating effect on 
Ca
2+
 currents. 
2.1.1 Lymnaea as a model organism 
Lymnaea stagnalis, or the great pond snail, is an excellent model organism for neuroscience 
research. Like all invertebrates, it has a relatively simple nervous system. It is inexpensive to 
maintain, has a low generation time, has had most of its already sequenced and is in the process 
of having its genome sequenced (Feng et al., 2009; Sadamoto et al., 2012). The genome of the 
marine gastropod Aplysia, its close relative, is already known. In contrast to Aplysia, however, 
Lymnaea is significantly easier to keep in a modest laboratory setting. Furthermore, many 
Lymnaea neurons have been identified with specific behaviours, and detailed neural networks 
56 
 
with corresponding behavior maps have been described (Ito et al., 1999; Feng et al., 2009 and the 
references therein). Just as early electrophysiology studies with squid giant axon have paved the 
way towards our understanding of the electrochemical gradient and the action potential, 
subsequent work in Aplysia (Eckert and Tillotson, 1981) and then Lymnaea (Byerly and 
Yazejian, 1986) were the first to illustrate the basic mechanisms governing calcium channel 
currents. There is a high level of conservation, both mechanistic and at the sequence level, 
among the regulatory elements of L-type channels (Spafford et al., 2006); in fact it is not unusual 
to co-transfect mammalian accessory subunits with a Lymnaea channel for recording to simplify 
the analysis. Another advantage of using the Lymnaea model is that it has only one isoform of 
each channel type (L-type, non-L-type HVA and T-type, corresponding to LCaV1, 2 and 3 
respectively), in contrast to its numerous vertebrate homologs (there are 10 total human CaV 
isoforms, see Chapter 1,  
 
Table 1.1). This simplifies recordings in neurons where only a single Ca
2+
 current may be 
present, and fewer splice isoforms complicate the picture. The obvious downside to this is that 
subtle isoform-specific effects present in mammalian systems cannot be inferred from their 
counterparts in Lymnaea.  
 
2.1.2 Current overview of mechanisms involved in CDI and VDI 
Before covering the controversial subject of the molecular relatedness of these two processes, it 
is first necessary to describe the method by which currents passing through channels are 
measured, that is, electrophysiological recording. The basic setup of an electrophysiology 
recording rig is shown in Figure 2.1. Different techniques can be used to gather different types 
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of information regarding the channel in question. Firstly, one can monitor currents while keeping 
the voltage across the cell membrane constant, - the so-called voltage patch clamp. Alternatively, 
voltage changes associated with injecting current into the cell via an electrode can be measured, 
e.g. ‘current clamp’. The former is much more commonly used to study the behavior of channels, 
whereas the latter is more featured in neurotransmission research. The term “patch clamp” refers 
to the fact that only a small portion of the cell membrane (a ‘patch’) is targeted for recording; 
only the channels found in this region of the membrane will be studied. There are also more 
exotic alternatives of patch clamp that involve disconnecting it from the cell (basically ripping 
out the patch from the plasma membrane), e.g. inside-out-patch, outside-out-patch. If a patch is 
small enough, or the level of channel expression is sparse, unitary channel currents can be 
measured. Single channel recording is perhaps the most sensitive and arguably the most valuable 
(and also difficult) method in the study of channel behavior. However, since the channel current 
is usually a fixed value, depending on the number of channel ‘open states’, the magnitude of 
whole-cell currents cannot be measured this way unless exact expression levels and open 
probability and mean open time are known. For this purpose, whole-cell voltage clamp can be 
used. In this case the glass pipette containing the electrode is introduced into the cell through a 
disruption of the membrane patch (‘breakthrough’) and continuity between the electrode solution 
(‘internal’) and the cell cytoplasm is achieved. Because of this electrical connection, the currents 
now measured by the electrode reflect the currents of the whole ensemble of channels found in 
the cell. There is a caveat to this: unless all other possible currents are blocked or cell expression 
is limited to only the channel under study, the whole cell current can be a mixture of different 
ion/current types. This is the main reason HEK293 and other non-electrically active cell lines are 
most often used as surrogate channel expression systems.   
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Since unitary channels cannot effectively describe inactivation
10
, whole-cell currents are 
typically used. In this regard, the time-profile of inactivation is seen as a reduction of whole-cell 
current from its peak. Whether the reduction in current is due to increased channel inactivation 
(via gating or allosteric mechanisms) or a reduction of activation can be further determined by 
measuring the change (if any) in gating currents (see Chapter 1, section 1.5). Allosteric 
inactivation mechanisms (e.g. pore occlusion by mobile cytoplasmic domains, as in the ‘ball and 
chain’ mechanism of KV channels) do not typically alter gating currents.  
The driving force for a particular ion current is directly proportional to that ion’s gradient 
across the cell membrane, as described by the Nernst equation: 
   
  
 
  
[  ]   
[  ]  
 
 
Where R is the universal gas constant, T is temperature and F is the Faraday’s constant, and E is 
the equilibrium potential (also ‘reversal’ potential) for that ion. As there are several important 
ions both inside and outside the cell, the resting membrane potential is slightly different from the 
equilibrium potential for each ion, and can be summarized by the Goldman equation: 
   
   
    
    
    
    
     
    
    
     
Where    is the membrane potential, PX is the relative permeability of ion X (typically in 
Siemens) and Ptot is the total ion permeability of the membrane for all three ions, and EX is the 
reversal potential of that ion (see previous equation). 
As per Ohm’s law, current is directly proportional to voltage (e.g. membrane potential), 
and inversely proportional to resistance. The resistance in the case of ion channels is described 
                                                 
10
 “Inactivation” for a single channel means a reduction in the open probability or mean open time, which cannot be 
seen on a time course due to the stochastic opening behavior of single channels 
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by the conductance and density of channels, as well as their open probability. As for the ion 
gradients, in vivo concentrations of Ca
2+
 are very low, but the membrane gradient is very high 
(low milimolar range in extracellular space and nanomolar in resting cytoplasm) (Berridge et al., 
2000; Hille, 2001; Clapham, 2012; Zhou et al., 2013). Electrophysiology recording often 
involves over-activation of ion channels and much larger Ca
2+
 load into the cells than 
physiological for achieving maximal current amplitude. Thus for maintaining the high Ca
2+ 
gradient, as well as staving off the Ca
2+
-associated cytotoxicity, intracellular recording solutions 
usually contain Ca
2+
 chelators (EDTA, EGTA, BAPTA). Depending on the rate of Ca
2+
 entry 
into the cell, this may also prevent the CaM N-lobe from binding Ca
2+
 and initiating processes 
requiring higher cellular [Ca
2+
]free. The concept of ‘local’ and ‘global’ Ca
2+
 sensing via the 
magnitude and spatial distribution of Ca
2+
 gradients was partially uncovered by reducing the 
concentration of these internal Ca
2+
 buffers during recording such that ‘low buffer’ inactivation 
due to a rise in whole-cell ‘global’ calcium was permitted (Liang et al., 2003). This ‘local/global’ 
idea was extensively modeled by the Yue lab  (Peterson et al., 1999; DeMaria et al., 2001; Liang 
et al., 2003; Dick et al., 2008; Tadross et al., 2008, 2010; Tadross, 2009). It suggests that CaVs 
are able to differentiate (via CaM) the Ca
2+
 signals occurring through single channel events 
(local, transient, nanodomain Ca
2+
) from higher Ca
2+
 accumulations due to multiple 
depolarizations and/or channel clustering (global, microdomain Ca
2+
). While there is evidence to 
support this model in many cases, the scope of its applicability remains to be established. 
In the case of HVA channels, which are characterized by a much more depolarized 
current-voltage relationship (I-V curve) than the LVA (T-type) channels, inactivation can occur 
by at least two separate mechanisms. When Ca
2+
 is used as the charge carrier, L-type channels 
inactivate much more rapidly (calcium-dependent inactivation, or CDI), than when Ba
2+
 is used 
60 
 
as a charge carrier (reviewed in Tuckwell, 2012). The latter is thus commonly referred to as 
‘voltage-dependent’ (VDI), since Ba2+ does not effectively bind CaM yet passes through the 
selectivity filter at least as well as Ca
2+
. Whether or not inactivation can occur in absence of any 
ions has not been determined (unless closed state inactivation is considered), thus Ba
2+
 serves as 
the approximate surrogate. The term ‘VDI’ is really a misnomer; it should instead be termed 
‘generic current dependent inactivation’ or at least ‘Ca2+-INdependent inactivation’, but VDI 
seems to be the de facto term in literature.  
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Figure 2.1: Typical electrophysiology rig setup.  
The top figure represents the mechanistic basis for patch clamp recording (not to scale), including a stock 
image of a patched cell. The bottom image is a generic stock picture of an electrophysiology rig, where 
the culture dish and recording pipette/electrode can be seen along with the microscope; the entire set up is 
placed on a specialized vibration dampening table, and often within a Faraday cage to minimize 
interference. 
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CaM, as well as a functional IQ motif and a ‘derelict’, e.g. non-Ca2+ binding EF hand in 
the C-terminus of L-type channels are required for CDI (Peterson et al., 1999, 2000; Zühlke et 
al., 2000; Pitt et al., 2001; Kim et al., 2004a; Van Petegem et al., 2005; Fallon et al., 2009; 
Halling et al., 2009). While apoCaM pre-association with CaV1.2 is known to occur in the 
channel’s C-terminus (Erickson et al., 2001), the exact localization of this interaction is 
unknown. Three putative regions
11
 have been implicated, and while some of the constructs partly 
encompass the IQ motif, the IQ motif itself is not sufficient for the interaction with apoCaM 
(Tang et al., 2003; Kim et al., 2004a).  
VDI is less rapid than CDI and is strongly modulated by the β-subunit of CaVs binding to 
a region of the I-II linker in the α-subunit called AID (α-interaction domain), with isoform-
specific effects (see Chapter 1, section 1.3.1.3) (Dafi et al., 2004; Opatowsky et al., 2004; Zhang 
et al., 2005; Lao et al., 2008). There is some experimental evidence that hydrophobic residues 
lining the inner ‘mouth’ of the channel pore are important in VDI, which may hint that a pore-
occlusion type mechanism may be involved, possibly through the docking of the linker to this 
hydrophobic region, much like the ‘hinged lid’ mechanism in NaVs (Shi and Soldatov, 2002; 
Stotz et al., 2004; Tadross et al., 2010). 
VDI is also dependent on the formation of a rigid α-helix by the region encompassing the 
sequence between the IS6 (last TM segment of domain I) and the AID, which binds the β subunit 
(Findeisen and Minor, 2009). Most interesting, however, is that not only do mutations disrupting 
this linker helix affect VDI; they also reduce the apparent CaM effects (CDI and CDF
12
 in P/Q 
                                                 
11
 In human CaV1.2, regions‘A’ = residues 1609-1628, ‘C’ = 1627-1652, and the IQ motif = 1665-1685 (Tang et al., 
2003) 
12
 CDF (Ca
2+
-dependent facilitation) is normally only observed in CaV2.1 (P/Q type), although current enhancement 
due to β-adrenergic activation of cardiomyocytes (which pass primarily L-type current via CaV1.2) and 
phosphorylation of β subunit by CaMKII has been observed. 
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type channels). Additionally, removing pre-associated CaM ablates CDI and accelerates VDI 
(Liang et al., 2003). To complicate matters further, one study points at the defunct EF hand of 
CaV1.2 as also reducing VDI (Bernatchez et al., 1998), although the mechanism is unclear. This 
study also used Xenopus oocytes for recording, which express other channels that may have 
complicated the analysis. 
Altogether, these studies suggest that VDI shares at least some structural determinants 
with CDI and cannot be treated independently as once suggested (Cens et al., 2006; Barrett and 
Tsien, 2008; Minor and Findeisen, 2010; Tadross et al., 2010).  
2.1.3 Review of literature and experimental goals 
Several key studies provided the context from which the experimental framework of this chapter 
was built. In 2008, a groundbreaking study by Yue and colleagues revealed an unexpected effect 
of CaM binding to the N-terminus of L-type channels when the latter was genetically fused to N-
type channels (CaV2.2), which resulted in its name ‘N-terminal Spatial Calcium Transforming 
Element’ or NSCaTE (Dick et al., 2008). N-type channels do not normally show CDI in standard 
recording (with ‘high’ or 10mM EGTA or BAPTA in the internal solution), but they do when 
NSCaTE is present, regardless of EGTA or BAPTA. Furthermore, NSCaTE appears to act this 
way via binding to the N-terminal lobe of CaM, as shown by using CaM mutants deficient in 
Ca
2+
 binding to either the N or C lobe
13
. Intriguingly, CaM binding to the N-terminus of L-type 
channels has been shown before (Ivanina et al., 2000), but not in the context of its effects on 
CDI. Yue attributes the fast CDI component to the N-lobe of CaM acting via NSCaTE, and the 
slow component, which is spared by high buffering, NSCaTE deletion and CaM12 mutations, to 
the C-lobe of CaM. While the binding of NSCaTE to CaM has been studied further (Benmocha 
                                                 
13
 CaM12 and CaM34, respectively 
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et al., 2009; Asmara et al., 2010; Guo et al., 2010; Liu and Vogel, 2012), the effects on CDI and 
VDI remain controversial. The goal of the experiments covered in this chapter was to 
demonstrate that NSCaTE is far more conserved that originally suggested, as well as its ability to 
bind CaM (either apo, holo, or both) alone or concurrently/competitively with the L-type IQ 
motif. Biophysical characterization of CaM interaction with NSCaTE and IQ motifs from both 
mammalian and snail L-type channels was completed. Electrophysiological recording of wild 
type LCaV1 and a truncated mutant (ΔNTLCaV1, sans first 112 residues) was performed to lend 
relevance to the biochemistry results and attempt to reconcile the findings with those previously 
published. 
2.2 Methods 
2.2.1 Cloning of the L-type N-termini from LCaV1 and CaV1.2 
Both CaV1.2 and LCaV1 N-termini were PCR-amplified from their respective wild type plasmid 
constructs (in PMT2 and pIRES2 vectors, respectively – See Appendix Figure A.3) using the 
following primers: 
 
CaV1.2 FW 5'-CTT TAA GAA GGA GAT ATA CAT ATG GTC AAT GAA AAC ACG AGG ATG TAC  
CaV1.2 RV 5'- GTG GTG GTG GTG GTG GTG CTC GAG CCA TTC AAC AAT AGA GAT GCA TGC -3' 
LCaV1 FW 5'-CTT TAA GAA GGA GAT ATA CAT ATG GCC AGT TCG CCA ACA GGG GTT CAC  
LCaV1 RV 5'- GTG GTG GTG GTG GTG GTG CTC GAG TAT TCT GCA ACC TGT ATA CAA AAT -3' 
 
These primers contain both the restriction sites (NdeI and XhoI) and part of the sequence for 
pET22b (C-terminal 6HIS-tag, T7 promoter, Novagen) expression vector for either restriction-
free (van den Ent and Löwe, 2006) or standard cloning. Amplification of NSCaTE was done 
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using AccuTaq polymerase (Sigma Aldrich). Reaction conditions: 0.25µL of each primer 
(0.1µM stock) 0.4mM dNTPs, 2.5mM MgCl2, ammonium sulfate PCR buffer at 1X and 200-
500ng of template, 25µL final volume. Cycle conditions for the first stage amplification: hot start 
(3min @94ºC) 1 unit of AccuTaq (0.2µL of 5U/µL); touchdown section: 30s @ 94ºC, 30s @ 
5942ºC(Δ-2ºC), 60s @ 72ºC; amplification section: {30s @ 94ºC, 30s @ 54ºC, 60s @ 
72ºC}x10, {30s @ 94ºC, 30s @ 50ºC, 60s @ 72ºC}x10; final extension: 5min @ 72ºC. Second 
stage (restriction-free cloning/amplification) reaction conditions: 1µg template (pET22b), 
0.4mM dNTPs, 80ng of gel-extracted 1
st
 stage product as primer, 1X Expand PCR buffer 
(without MgCl2) (Roche), 1mM MgSO4. Cycle conditions: 3min @94ºC hot start, added 0.3µL 
of Pwo polymerase (Roche). Touchdown: 30s @ 94ºC, 30s @ 58  42(Δ-2ºC), 10min @ 68ºC. 
Amplification: same as touchdown but instead 10 cycles each where the annealing step was 1min 
@ 48, 56 and 66ºC (30 total).The product was then DpnI digested and transformed into XL1 blue 
electro-competent E.coli (originally from Invitrogen) for screening. The second stage PCR was 
only successful for CaV1.2. LCaV1 was cloned into pET22b the ‘old school way’
14
 with NdeI and 
XhoI. All constructs were sequence verified by The Centre for Applied Genomics (Sick Kids, 
Toronto).  
2.2.2 Protein Expression 
Wild type rat calmodulin was purified using Phenyl Sepharose 6 fast flow high sub from GE 
Healthcare, packed to approximately 10mL volume, by gravity flow at 4ºC. pET9d (a T7 E.coli 
expression vector, with kanamycin resistance marker, from Novagen) containing the codon-
optimized CaM ORF was transformed into BL21 DE3 E.coli using electroporation and plated on 
kanamycin media at 37ºC. Overnight cultures of ~50mL LB supplemented with kanamycin were 
                                                 
14
 Using standard DNA restriction and ligation techniques 
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used to inoculate 1L of either LB or superbroth with 30mg/mL kanamycin (10mL of inoculum 
per1L) and grown at 37ºC and 200rpm to OD of 0.4 – 0.6 (for LB) or 0.5-0.9 (for SB), at which 
point they were induced by 1mM added IPTG and grown for another 4 (for SB) to 6 (for LB) 
hours. Robust expression of soluble CaM was confirmed by SDS PAGE. Cells were collected by 
centrifugation at ~4000g, then lysed in high salt buffer (0.1M Tris-Cl pH 7.5, 0.5M NaCl, 0.5M 
ammonium sulfate, 1mM DTT) using an Avestin Emulsiflex homogenizer at 15-20 000 psi with 
jacketed water cooling, through which the cells were passed about three times on average. The 
cell lysate was clarified by centrifugation at 20000rpm in SS-34 rotor (approx. 50000g) at 4ºC 
for 30min. To the cleared lysate, CaCl2 was added to a final concentration of 10mM; this lysate 
was then applied to the gravity phenyl sepharose column equilibrated with the same high salt 
buffer (and 1mM CaCl2). It was extensively washed with high-salt buffer and CaM was then 
eluted using 10mM Tris-Cl and EDTA solution (pH 7.5).  The highest fractions were pooled, 
concentrated, and applied to the prep grade Superdex 75 16/60 column (GE Healthcare) on an 
AKTA FPLC system. Typical injection volume was 1mL, and the gel filtration buffer (50mM 
Tris-Cl pH 7.5, 150mM NaCl, 1mM CaCl2) was set to flow at 1mL/min. Wild type CaM 
reproducibly elutes at ~68mL on this column. Elution peak width is dependent on the amount of 
CaM present; routinely up to ten 1mL fractions were obtained of concentrations 200-400µM; 
these were pooled and concentrated using the spin-concentrators from Sartorius or Amicon 
(10,000 MWCO). Extinction coefficient of 3006 M
-1
cm
-1
 at A276 was used  (Potet et al., 2009) 
and the final protein stock was aliquotted to 500µL and stored at -80ºC.  
RN (rat NSCaTE) and LN (Lymnaea NSCaTE) HIS fusion constructs in pET28a (N-
terminal 6xHIS T7 expression vector from Novagen) were expressed in a similar manner to 
CaM, except that growth was done at 25ºC, in Superbroth. Collected cells were resuspended in 
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lysis buffer (20mM sodium phosphate 500 mM NaCl, 20 mM imidazole, 1 mM MgCl2, 1 mM 
PMSF, and lysed using the Avestin Emulsiflex homogenizer. Inclusion bodies containing the 
protein constructs were collected by centrifugation at 20000 rpm in the SS-34 tubes (~50000g), 
and resuspended further in 8M urea IMAC buffer (8M urea, 20 mM TrisHCl, 500 mM NaCl, 5 
mM imidazole, 1 mM β-mercaptoethanol). This solution was applied to the 1mL His Spin-Trap 
(IMAC) columns from GE Healthcare, washed with the same buffer, and eluted with the same 
buffer supplemented with 500mM imidazole. Step-wise dialysis was then done to remove urea 
from the sample, by solution changes in 2M increments (6, 4, 2, 0) down to 0M Urea, 20mM 
Tris pH 7.5, 500mM NaCl and either 20µM CaCl2 or EDTA. When no exogenous CaM was 
added, His-RN did not remain in solution throughout the steps, precipitating more and more 
along each step. When CaM was added, but the dialysis was done in EDTA, similar results were 
seen. However, when CaCl2 and CaM were used, HisRN remained visibly more soluble (see 
Figure 2.7). Typically a large molar excess of CaM was added, as judged by the BioRad protein 
assay of the His-RN fusion construct. Despite comparable treatment of HisLN, it did not appear 
to remain in solution in detectable amounts by SDS PAGE (data not shown).  
2.2.3 Bioinformatic analyses of oligonucleotide and peptide sequences 
Oligonucleotide design was performed using the wild type sequences for LCaV1 (Spafford et al., 
2006) and rat CaV1.2 (GI 158186632), and codon optimization and hairpin/dimer analysis was 
done using the tools found on the Integrated DNA Technologies web-site (www.idtdna.com). 
Protein parameters (pI and MW) were determined using the prediction tool in ExPaSy 
(http://web.expasy.org/protparam/) and the aggregation propensity was determined using the on-
line software at Centre for Genomic Regulation (http://tango.crg.es/). All phylogenetic 
alignments were done using variations of the BLAST tool on the GenBank web site. The CaM 
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binding site prediction database (http://calcium.uhnres.utoronto.ca/ctdb/contacts/index.htm) was 
used to search for other possible ‘hits’ in the channel ORFs (Yap et al., 2000) and to design 
optimal peptide sequences for synthesis. 
Table 2.1: List of L-type peptides ordered from CanPeptide 
Name Sequence Position MW  pI 
rat-long (RN) SWQAAIDAARQAKLMGS 22-38 1804.07 8.46 
snail-long (LN) GWSTALAAAQGAATVRK 93-109 1658.89 11 
Rα1c-long (IQc) KFYATFLIQEYFRKFKKRKEQ 1466-1486 2799.34 10.12 
LC1-long (LIQ1) KFYATFLIQDYFRRFKKRKEQ 1551-1571 2813.27 10.28 
 
Table 2.2: List of L-type peptides ordered from Genscript 
Name  Sequence Position MW pI 
CaV1.2 IQ (IQc) KFYATFLIQEYFRKFKKRKEQ 1466-1486 2799.34 10.12 
LCaV1IQ (LIQ1) KFYATFLIQDYFRRFKKRKEQ 1551-1571 2813.27 10.28 
LCaV2IQ (LIQ2) KIYAGLLISENWKAYKASQNA 1592-1612 2368.7 9.4 
 
2.2.4 Gel Shift Mobility Assay 
All gels with L-type channel peptides (Table 2.1 and Table 2.2) were run in native, urea-free 
buffer. 15% acrylamide separating and 4% stacking gels were used. Running buffer: 192mM 
glycine, 50mM Tris-Cl pH 8.3. Separating gel buffer (2x): 0.7M Tris-Cl pH 8.8, 1mM CaCl2 (or 
EDTA); stacking buffer (2x): 0.5M Tris-Cl pH 6.7 (1mM CaCl2 or EDTA). Peptides were 
incubated with CaM for ≥ 1hour at 4ºC in gel filtration buffer (150mM NaCl, 50mM Tris-Cl pH 
7.5, 1mM CaCl2) prior to loading; 50% glycerol in gel filtration buffer and <0.1% bromophenol 
blue (as tracker dye) was used at 1:2 sample volume just prior to loading for each sample. Gels 
were run at 100V in 4ºC jacketed /ice bath conditions for 6-8 hours as needed.  
2.2.5 Native Trp fluorescence 
Steady state measurements were obtained using a Photon Technologies International (PTI) 
Quantamaster Fluorimeter (London, ON) in a 50µL 1mm fluorescence cuvette from Hellma at 
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room temperature. The same buffer was used as for gel filtration and ITC experiments (50mM 
Tris-Cl pH 7.5, 150mM NaCl) with either 1mM CaCl2 or 10mM EDTA where indicated; buffer 
was used as a baseline for subtraction. To the cuvette containing the starting peptide solution 
(25µM), increasing amounts of CaM were added (in increments corresponding to ~2.5µM). 
Emission scans from 300 to 400nm using a 280nm excitation wavelength and 1nm slit width 
(averaging over 1s each) and step size were performed. Traces were exported to .csv format and 
analyzed with MS Excel. 
2.2.6 Dansyl-CaM fluorescence 
Dansyl (5-(dimethylamino)naphthalene-1-sulfonyl chloride) is an amine-reactive fluorescent dye 
(see Figure 2.2).  Dansyl-CaM was prepared as previously described (Kincaid et al., 1982). CaM 
(1 mg/ml) was transferred into 10 mM NaHCO3, 1 mM EDTA, pH 10.0, at 4°C. 30 μl of 6 mM 
dansyl-chloride (1.5 mol/mol of CaM) in DMSO was added to 2 ml of CaM, with stirring. After 
incubation for 12 hours at 4°C, the mixture was first dialyzed against 500 volumes of 150 mM 
NaCl, 1 mM EDTA, 20 mM Tris-HCl, pH 7.5, at 4°C, and then exhaustively dialyzed against 
500 volumes of water. Labeling yields were determined from absorbance spectra using the ε320 of 
3,400 M
-1
cm
-1
 and were compared to actual protein concentrations determined using the 
Bradford method with wild-type CaM used as the protein standard (Chen, 1968). ESI-MS was 
used to confirm successful dansyl-labeling of CaM protein. The concentration of dansyl-CaM in 
all experiments was 2 μM. 
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Figure 2.2: the dansylation reaction (for a Lys residue). 
 
Steady state fluorescence was performed in a similar manner as the Trp experiments, except that 
a newer Florolog3-22 (Horiba Scientific, Ltd.) fluorimeter (kindly offered by Dr. Elizabeth 
Meiring’s lab) was used, and the buffer used was 10mM HEPES (pH 7.0) with supplemented 0.1 
mM CaCl2 
2.2.7 Circular Dichroism 
CD measurements were performed using the Jasco-715 spectropolarimeter (Jasco Instruments, 
NS), using the following parameters: 250-190nm range, 20nm/min speed, 1s response time, 
0.5nm bandwidth and 100mdeg sensitivity at room temperature. Recordings were made in a 
1mm cuvette, in 10mM sodium phosphate buffer with 0.1mM added CaCl2, and used as baseline, 
which was subtracted from each recording. For CaM+peptide spectra, the same solution of 10µM 
CaM was scanned before stock (1mM) peptide was added in incremental amounts before being 
scanned again. The resulting spectra were subtracted (e.g. CaM+peptide – CaM alone) to extract 
the spectrum corresponding to the change associated with adding the peptide. Every recording 
was an average of at least 16 accumulations and subsequently corrected for protein concentration 
(converted to units of mean residue ellipticity or MRE). These were smoothed and exported into 
ASCII format for analysis with Excel and either SOMCD (http://geneura.ugr.es/cgi-
bin/somcd/index.cgi) or Dichroweb K2d algorithm (http://dichroweb.cryst.bbk.ac.uk). 
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Trifluoroethanol (TFE) recordings were performed using pure 2,2,2-trifluoroethanol (Sigma 
Aldrich) at 10%, 25% and 50% after thorough pre-mixing and incubation with peptides in the 
phosphate buffer, baseline corrected against the same TFE/buffer solution without peptide. 
2.2.8 Cloning and Expression of ΔNT-LCaV1 
PCR was used to create LCaV1 with an alternative start site 112 amino acids downstream of the 
long form of the channel, removing a predicted NSCaTE sequence at positions 90 to 101 in the 
existing full-length LCaV1 (Genbank: AF484079) cloned in mammalian expression vector, 
pIRES2-EGFP plasmid (Spafford et al., 2006; Senatore et al., 2011a). pIRES2 is a bicistronic 
vector which generates an EGFP reporter for easy detection of LCaV1 expressing channels using 
green fluorescence on an epifluorescence microscope. Plasmid sequences were verified by 
sequencing (TCAG, Sick Kids Hospital, Toronto, ON). LCaV1 channels were transiently 
transfected along with required α2δ1 and either β1b or β2a subunits in HEK293T cells using 
calcium phosphate precipitation (Senatore et al., 2011b). Plasmids for rat α2δ1 (NM_012919), 
rat β2a (NP_446303) and rat β1b (NM_017346) were a generous gift from Terry Snutch (Univ. 
British Columbia) via Gerald Zamponi (Univ. of Calgary).  
2.2.9 Electrophysiology 
Electrophysiological recordings were carried out at room temperature with an Axopatch 200B or 
Multiclamp 700B amplifier (Axon Instruments, Union City, CA) through a PC computer 
equipped with a Digidata 1440A analog-to-digital converter in conjunction with pClamp10.1 
software (Molecular Devices, Sunnyvale, California). Cells were bathed in external solution 
containing barium (10 mM BaCl2) or calcium (10 mM CaCl2) as the charge carrier and 1 mM 
MgCl2, 10 mM HEPES, 40 mM tetraethylammonium chloride (TEA-Cl), 80 mM CsCl, 10 mM 
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glucose, pH adjusted to 7.2 with TEA-OH, filtered through 0.22 µm filter). Patch pipettes (World 
Precision Instruments, Sarasota, Florida were filled with internal solution (106 mM Cs-
methanesulfonate, 4 mM MgCl2, 9 mM EGTA, 9 mM HEPES, 2 mM MgATP adjust pH to 7.2 
with CsOH, filtered through a 0.22 µm filter) and had resistances of 2–5 MΩ. For the low EGTA 
experiments, the internal solution was 114.5 mM Cs-methanesulfonate, 4 mM MgCl2, 0.5 mM 
EGTA, 9 mM HEPES, 2 mM MgATP pH adjusted to 7.2 with CsOH. 
Recorded currents were digitized at a sampling frequency of 2 kHz and filtered at 10 kHz using a 
low-pass Bessel filter. Only recordings with minimal leak (<10%) were used for analysis, and 
offline leak subtraction was carried out using the Clampfit 10.1 software (Molecular Devices, 
Sunnyvale, California). Series resistance was compensated to 70% (prediction and correction; 10 
ms lag). All values are expressed as the mean ± SEM, with statistical analyses using a one-way 
ANOVA. Current-voltage relationships were obtained by holding cells at -60 mV before 
stepping to test potentials ranging from +25 to +60 mV for 300 ms. Cell culture, transfection and 
data analysis was performed as described previously (Senatore et al., 2011a, 2011b). 
2.2.10 Data-mining and Computational Analyses of L-type Orthologs 
N-termini and C-termini sequences were gathered for orthologs of L-type channels by BLAST 
data-mining of available genomic databases such as NCBI (Bethesda, MD), Joint Genome 
Institute, Department of Energy and University of California (DOE-JGI), Washington University 
in St. Louis (Genome Institute at WUSTL), Baylor College (HGSC), Broad Institute of MIT and 
Harvard. Multiple alignments of amino acid sequences and gene tree making were conducted 
using Phylogeny.fr (Dereeper et al., 2008). Running window of amino acid similarity of multiple 
aligned sequences was conducted using Plotcon within EMBOSS (Rice et al., 2000). 
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2.2.11 qRT-PCR of LCaV1 and ΔNT-LCaV1 N-termini 
mRNA was extracted from embryos, identified by morphological features of animals within egg 
capsules, and by the shell lengths (1–1.5 cm and 2–2.5 cm respectively) of juvenile and adult 
snails respectively (Marois and Croll, 1992; McComb et al., 2005). LCaV1 transcripts were 
amplified by quantitative RTPCR (qPCR) with a forward and reverse primer pair designed 
against LCaV1 to amplify a 138 bp sequence just upstream of the NSCaTE sequence, 
respectively (LCaV1-Met1f: 5’ GAGGTAGAGGAAGGAGGAGGAG 3’ and LCaV1-Met1b: 5’-
GCCAGAGTCTGTTGTATTCAGAG-3’), and a primer pair designed to amplify a 145 bp 
sequence just downstream of NSCaTE: (LCaV1-Met2f: 5’ 
TACAGGTTGCAGAATACAAAGCAT 3’ and LCaV1-Met2b: 5’ AAGACATATTCAAT 
CCGATCCAGT 3’). Amplification efficiencies (E values) for each primer pair was determined 
by generating standard curves using 1:5 serial dilutions of pooled cDNA from all RNA extracts 
as template. By plotting the cycle threshold (CT) values
15
 vs. log of template concentration (copy 
number) and determining the slope, one can determine the efficiency (slope = -1/logE). CT 
values for each amplicon were averaged (n = 4) and normalized against averaged CT data for 
control gene HPRT1 using the ratio 
       
               
        ⁄  (Pfaffl, 2001). 
  
                                                 
15
 CT is the cycle number at which a particular fluorescence level (e.g. detection) is achieved. 
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2.3 Results 
2.3.1 Conservation of NSCaTE in L-type channels 
The alignments in this section were compiled by Dr. JD Spafford, and were published recently 
(Taiakina et al., 2013). They show a ubiquitous presence of an NSCaTE motif in L-type channels 
of most bilateral animal phyla (Figure 2.4, top panel). NSCaTE appears to be missing in several 
arthropod species, notably Drosophila and certain vertebrate L-type isoforms. Interestingly, 
nematodes and mosquitoes may have evolved an NSCaTE region independently, based on the 
clustering of their sequence variation, divergence of position of NSCaTE within the N-terminus, 
and presence of an additional intron in nematodes. The actual position of NSCaTE within the N-
termini of L-type channels, as well as the degree of sequence conservation (WxxAI/LxAx) are 
quite variable, which may explain why previous studies have underestimated its evolutionary age 
and/or missed it entirely. Indeed, only the tryptophan residue seems invariably conserved, which 
most likely means it is crucially involved in CaM binding and explains why it strongly affects 
CDI (Dick et al., 2008; Benmocha et al., 2009; Asmara et al., 2010; Guo et al., 2010). The other 
likely hydrophobic anchor candidate is the conserved I/L in the middle of NSCaTE; the 
remainder of the sequence is highly variable among phyla. The key feature of this sequence is 
the high content of Ala, which is known for its tendency to occur in α-helices, as well as basic 
Arg/Lys residues – also one of the defining characteristics of CaM targets (O’Neil and DeGrado, 
1990; Vetter and Leclerc, 2003). Conserved flanking residues surrounding NSCaTE could 
provide the fine tuning of affinity and regulatory effects of CaM binding.  
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2.3.2 NSCaTE as an optional motif 
Another interesting outcome of the multiple sequence alignments and conservation plots of IQ 
and NSCaTE motifs is that for the vast majority of NSCaTE-containing channels, there is a 
downstream Met with an alternate Kozak sequence which produces an NSCaTE-less channel. 
Indeed, this shortened isoform was used in the electrophysiology recordings of LCaV1 (the 
‘short’ isoform was generated using PCR to amplify the rest of the CDS from the second, 
downstream-of-NSCaTE methionine as the start codon). Upon further inspection, it was 
observed that a second start site was also present in the rat L-type homolog CaV1.2, and human 
CaV1.2 and CaV1.3. Translational read-through has recently become more recognized as a source 
of protein diversity and regulatory network complexity (Bazykin and Kochetov, 2011), and has 
already been described in TRP channels before (Honoré, 2008). To verify that both ‘short’ and 
full-length (e.g. Met2 and Met1, respectively) forms are expressed natively, we would need to 
perform Western blots using NSCaTE-specific and generic, LCaV1-specific antibodies with L-
type channels purified from Lymnaea tissues. Considering that purification of ion channels is 
already fraught with practical limitations of expression and solubility, the generation of such 
antibodies was a daunting task we were too time-constrained to undertake. Instead, we sought to 
eliminate the possibility that there was any regulation at the transcriptional level.  
Quantitative reverse-transcription PCR (qRT-PCR) of snail tissues and whole animals 
(embryos, juveniles and adults) has been applied previously to map expression and gain clues to 
protein function (Senatore and Spafford, 2010, 2012; Senatore et al., 2013). In this case, it was 
used to find whether both +NSCaTE (Met1) and –NSCaTE (Met2) channels were being generated 
transcriptionally through mRNA editing or alternate splicing (although no intron junctions in this 
channel exist in the cytoplasmic N-terminus). The results clearly indicate that no such 
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transcriptional selection exists, and approximately all LCaV1 transcripts contain the Met1 
sequence (Figure 2.3). These experiments were carried out by Julia Fux (M.Sc candidate) and 
Adriano Senatore (Ph.D.) under the supervision of Dr. JD Spafford. 
 
Figure 2.3: qRT-PCR of Met1 and Met2 LCaV1, showing lack of transcriptional differences.  
A: location of primer sets. B: fold difference in mRNA levels relative to those of a housekeeping gene, 
HPRT1.  
 
77 
 
 
Figure 2.4: Sequence alignment of NSCaTE and Pre-IQ/IQ motifs across animal phyla. 
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2.3.3 Electrophysiology recordings of LCaV1: Met1 and Met2. 
Whole-cell voltage patch clamp recordings of HEK293T cells expressing either full-length, wild 
type LCaV1 (Met1) which contains NSCaTE, and a truncated NSCaTE-less LCaV1 (ΔNT-LCaV1, 
Met2), were performed by Dr. Adrienne Boone. Their analyses were performed by Dr. Boone 
and Dr. Spafford, using ClampFit 10.1 and Origin software, with a one-way ANOVA (analysis 
of variance).  
The initial recordings of the ‘short’ LCaV1 (Met2) were discouraging; no significant 
difference in CDI, VDI or any other biophysical parameter were found from wild type (‘long’ or 
Met2) LCaV1. The only exception is the recovery of channels from inactivation after a 1s 
depolarization in Ca
2+
 (Table 2.3, Figure 2.5), which appears to be slightly higher with NSCaTE 
present. NSCaTE deletion corresponds to a lower recovery from inactivation in Ca
2+
, which 
makes it near-identical to that of Ba
2+
, but the effect is small. However, when standard recording 
solution (9mM EGTA) was replaced with a low-EGTA recipe presumably resembling a 
‘physiological’ level of Ca2+ buffering (0.5mM EGTA) (DeMaria et al., 2001; Liang et al., 2003; 
Dick et al., 2008), a significant effect on CDI was observed in Met2 channels (Figure 2.5, Table 
2.3). Ba
2+
 currents and VDI were not affected. R300 values, which correspond to the fractional 
amount of      present at 300ms of a test pulse, are typically used to quantitate inactivation, 
since absolute currents can vary greatly. Quantitation of CDI is routinely reported as an f-value 
(e.g. f300), which is the ratio of R values at that time point (e.g.            
        
    ⁄ ). Thus, f300 
for the wild type (Met1) LCaV1 is 0.21 ± .026 and for the truncated (Met2) LCaV1 is 0.435 ± 0.04, 
a twofold reduction of CDI. Perhaps even more importantly, the R300 values in Ca
2+
 for Met2 are 
comparable in both low and high internal EGTA (0.37 and 0.31, respectively), whereas for Met1 
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the R300 for Ca
2+
 goes down almost two-fold in low EGTA (from 0.32 to 0.18). This strongly 
suggests that NSCaTE acts to accelerate CDI under high-Ca
2+
 load conditions, potentially 
through a similar CaM N-lobe-mediated mechanism as that of mammalian CaV1.2 NSCaTE 
(Dick et al., 2008). 
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Figure 2.5: Electrophysiology traces and summary of results of wild type and ΔNT LCaV1. 
A) Each cell that was recorded (in both Ca
2+
 and Ba
2+
) had its current normalized to the peak Ba
2+
 
current, and for each recording condition (Ca
2+
, Ba
2+
, low and high EGTA, Met1 or Met2) the 
corresponding normalized traces from a representative number of cells were averaged.  B) Overlaid 
traces from A (left), summarizing the results in bar graph form (right). See also Table 2.3, including n 
values. Met1 = wild type LCaV1. Met2 = ΔNT LCaV1. 
 
 
Table 2.3: Summary of N-terminal deletion effects on LCaV1 currents. 
Similar but expanded data from Figure 2.5. LCaV1Met1 = wild type Lymnaea CaV1. LCaV1Met2 = 
ΔNTLCaV1, lacking the first 112 amino acids including NSCaTE (93-109). 
  
LCav1Met1 LCav1Met2 LCav1Met1 LCav1Met2
n mean SEM n mean SEM n mean SEM n mean SEM
[EGTA]in = 9 mM EGTA
  Activation:
     V1/2 (mV)  10 -3.31 0.28 10 -3.13 0.32 10 5.17 0.26 10 5.12 0.36 n.s. n.s. *** ***
    slope 10 5.90 0.33 10 5.92 0.28 10 6.49 0.20 10 6.83 0.32 n.s. n.s. *** ***
  Inactivation:
     V1/2 (mV)  10 -19.78 1.12 10 -20.69 1.18 6 -25.69 1.14 6 -25.32 1.10 n.s. n.s. *** ***
    slope 10 8.14 0.99 10 8.67 1.04 6 7.74 1.03 6 6.61 0.96 n.s. n.s. *** ***
   Inactivation recovery:
     % recovery at 1 sec 4 41.88% 2.56% 4 40.87% 3.30% 4 46.87% 3.31% 4 39.82% 2.33% n.s. * * n.s
  Imax amplitude:
     Ba:Ca size ratio 10 2.02 0.19 6 1.91 0.12
  Inactivation kinetics:
     R300 5 0.91 0.023 5 0.89 0.038 5 0.32 0.013 5 0.31 0.034 n.s. n.s. *** ***
[EGTA]in = 0.5 mM EGTA
  Inactivation kinetics:
     R300 5 0.85 0.012 5 0.86 0.020 5 0.18 0.023 5 0.37 0.034 n.s. *** *** ***
n.s. not significant;
*p<0.05;
**p<0.005;
***p<0.001.
n.s.
Statistical significance
[Caex] 
Met1 Met2
[Baex] vs [Caex][Caex] = 10 mM[Baex] = 10 mM
Met1 vs Met2
[Baex]
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2.3.4 Expression of N-terminal HIS-tag fusion construct of CaV1.2 and LCaV1 
Attempts were made to study the interaction of CaM with both mammalian and snail NSCaTE.  
In theory, having an expression system for the larger NSCaTE-containing N-terminal region 
would facilitate pull-down assays, mutagenesis studies, and potentially even a solution NMR 
structure down the road. To this end, cloning attempts were made for the rat NSCaTE (CaV1.2) 
and Lymnaea CaV1 using synthetic oligos spanning the entire N-terminal cytoplasmic tail of each 
channel, codon optimized and flanked by appropriate restriction sites for cloning into a pET 
expression vector (pET28a). After a series of many expression attempts, it was found that the 
solubility of the rat NSCaTE protein construct was very poor in native conditions; typical 
protocols allowed only a small fraction of the expressed protein to be collected, or none at all in 
the case of snail NSCaTE (Figure 2.6). Using 8M urea improved the yield, but the process of 
removing urea from solution caused aggregation and precipitation of the NSCaTE fusion protein.  
As a last resort, in an attempt to maintain solubility of the protein, pure wild type recombinant 
CaM was added in various amounts to the IMAC-purified NSCaTE prior or during the removal 
of urea. Satisfyingly, the soluble fraction was greatly enriched in the protein expressed by the 
HIS-NSCaTE construct as a result (Figure 2.7). Notably, this enhancement was only observed 
under Ca
2+
-replete conditions, suggesting that NSCaTE binding to CaM is Ca
2+
-dependent, an 
observation that was subsequently supported by other experiments, and indeed a number of later 
published studies (Benmocha et al., 2009; Asmara et al., 2010; Guo et al., 2010; Liu and Vogel, 
2012).   
In the meantime, similar treatment of the Lymnaea NSCaTE construct proved 
unsuccessful. While it was presumably well-expressed, it did not appear to be stable enough in 
solution under the conditions used to isolate the mammalian NSCaTE construct. 
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The SDS PAGE and expression experiments and gel images in this section were done by Erica 
Lee as part of her CHEM 494 project for the Department of Chemistry at University of 
Waterloo. 
 
Figure 2.6: SDS-PAGE results of snail NSCaTE purification using IMAC.  
Legend (from left to right) – unpurified sample (1), 1st flowthrough (2), 2nd flowthrough (3), 3rd 
flowthrough (4), 1st wash (5), 2nd wash (6), 3rd wash (7), 1st elution (8), and 2nd elution (9). The most 
pronounced band corresponds well to the NSCaTE construct size (~15kDa); however it appears to be 
near-absent in the elution fractions (last two lanes), suggesting poor protein stability, column binding, or 
solubility. 
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Figure 2.7: Purification of soluble rat NSCaTE is aided by Ca
2+
-CaM.  
Legend: ladder, (1) CaM in CaCl2,  
(2) CaM in EDTA,  
(3) HisRN, supernatant of HisRN - CaM sample dialyzed in CaCl2,  
(4) supernatant of HisRN - CaM sample dialysed in EDTA, and ladder 
 
As a follow up to these experiments, we attempted to generate shorter NSCaTE constructs with 
fewer hydrophobic regions. The downside of such truncation was that the new DNA constructs 
were at the limit of what can be reasonably purified with a gel-extraction kit (QIAGEN), e.g. sub 
200bp. Upon further consideration, the cloning attempts and expression trials were suspended in 
favor of more readily amenable biophysical studies using synthetic peptides corresponding to 
both IQ and NSCaTE motifs from both CaV1.2 and LCaV1. They are subsequently denoted 
“LIQ1” for LCaV1 IQ, “IQc” for CaV1.2 IQ (rat α1c), RN for rat NSCaTE and LN for Lymnaea 
NSCaTE (Table 2.1 and Table 2.2).  
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2.3.5 Gel Shift Mobility Studies of L-type channel peptides 
L-type channel peptides were ordered from CanPeptide, specified to >95% purity. Subsequently 
it was found that some of these peptides, LN in particular, were not fully soluble in water. As a 
result, DMSO was added in varying amounts (up to 5% v/v) to aid in solubilization. 
Unfortunately, this caused a number of artifacts to be observed with fluorescence and circular 
dichroism. In addition, IQ peptides starting with the conserved Ile were found to be lacking 
several residues required for CaM binding and did not appear to interact with CaM (as 
determined by gel shift assays, CD and fluorescence with dansylated CaM). Eventually, new 
peptides were ordered including a portion of the “pre-IQ” region (5 residues preceding the Ile 
and +2 C-terminal residues), as well as slightly longer (+4 C-terminal residues) snail and rat 
NSCaTE peptides, specified to >98% purity. These new peptides (see Table 2.1 and Table 2.2) 
were ordered from CanPeptide as well, and appeared to be fully water soluble and capable of 
binding CaM as determined by gel shift and fluorescence results (see sections 2.3.5 and 2.3.6). 
Peptides corresponding to the IQ motifs of LCaV1 and rat CaV1.2 (IQc) were ordered from 
Genscript, specified to >98% purity, and were found to be soluble in water. 
2.3.5.1 Conformation 
It has been observed that CaM has different mobility in PAGE depending on its conformation 
(e.g. apo vs. holo forms, or peptide-bound vs. free). To make use of this property, wild type CaM 
was incubated with increasing amounts of each peptide and each combination was run on a 
native PAGE (no urea) and semi-native PAGE (4M urea). In the presence of EDTA, no shift was 
observed with any of the peptides (data not shown). In the presence of CaCl2 (1mM), both IQ 
motif peptides (IQc and LIQ1) were seen to have a distinct reduction of CaM mobility (Figure 
2.9). In contrast, no shift was seen with either LN or RN peptides, regardless of CaCl2, EDTA, 
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urea or native conditions. To determine whether this was due to a lack of binding or a lack of 
conformational change in CaM, subsequent biophysical studies (such as fluorescence, CD and 
ITC) were performed. These confirmed that CaM is indeed binding to both rat and snail 
NSCaTE, albeit with a low affinity. The gel pictures in this section do not utilize urea, as there 
appears to be no urea effect on the peptide interaction with CaM. It was also noted that none of 
the previous studies including gel-shift experiments and NSCaTE or IQ/CaM used urea in their 
methods (Peterson et al., 1999; DeMaria et al., 2001; Erickson et al., 2001; Liang et al., 2003; 
Dick et al., 2008). 
 The gel shift and spectropolarimetry data together suggest that the binding of CaM to IQ 
and NSCaTE peptide is fundamentally different: in the case of the latter, there is little change in 
CaM itself and significant change in the conformation of the peptide. This is indicated by a lack 
of a gel mobility shift in CaM upon binding NSCaTE, yet significant change in α-helical content 
upon peptide addition to CaM. In contrast, the conformation of CaM when binding to IQ is 
altered enough to cause a gel mobility shift, and modest changes in peptide conformation. This is 
consistent with the previously published structure of CaM and CaV1.2 IQ peptide (Figure 2.8) 
(Van Petegem et al., 2005) 
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Figure 2.8: Crystal structure of CaV1.2 IQ bound to Ca
2+
-CaM  
(Top-down view facing the N-terminus of IQ). Ca
2+
 ions are in black. Generated with UCSF Chimera 
using the 2BE6 PDB entry (Van Petegem et al., 2005) .  
 
 
 
Figure 2.9: Effects of peptide binding on CaM conformation in PAGE mobility.  
First lane in each gel is CaM alone control; subsequent lanes have an increasing amount (indicated by the 
relative ratio number at the top) of each peptide. IQ peptides cause a shift in CaM’s mobility (arrow), 
while NSCaTE peptides do not. 
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2.3.5.2 Competition Experiments 
To further demonstrate an effect of LN and RN peptides on CaM mobility in PAGE, 
displacement experiments using combinations of IQ and NSCaTE peptides were performed. In 
each set, an IQ peptide from the respective mammalian or snail channel was pre-bound to holo-
CaM at an empirically determined ratio that facilitated a complete shift to the slower CaM 
mobility (approximately 1.5 peptide to 1 CaM for both IQc and LIQ1). To this mixture, 
increasing amounts of corresponding channel’s NSCaTE were added, incubated further, and then 
run on the gel. As expected, high excess of NSCaTE peptides resulted in a reversal of CaM 
mobility to the faster-migrating non-IQ-bound state. This further supported the idea that 
NSCaTE is capable of binding CaM, albeit at a lower affinity and in a different conformation 
than the IQ motif.  
 
 
Figure 2.10: Competition gel shifts of NSCaTE vs. IQ bound to CaM.  
First lane in each gel is CaM alone; second lane is CaM + IQ peptide (at 1.5x) with no NSCaTE. 
Subsequent lanes each contain an increasing amount of competing NSCaTE peptide (ratio relative to CaM 
indicated at the top). Both NSCaTE peptides partially return CaM to the native (faster) mobility when 
present in excess. In all cases native 15% gels and Coomassie staining was used (see section 2.2.4).  
Ca2+-CaM(1x)
1x 2x 4x 8x 12x 20x
NSCATE peptide
Ca2+-CaM /IQLCav1 + NSCATELCav1
Ca2+-CaM /IQCav1.2 +  NSCATELCav1
Ca2+-CaM /IQCav1.2 + NSCATECav1.2
IQ peptide (1.5x)
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2.3.6 Fluorescence studies of L-type peptides 
Fluorescence measurements can offer a substantial amount of insight into protein-protein or 
protein-peptide interactions in terms of the types of interactions involved, orientation, and even 
kinetics and binding affinities (Brown and Royer, 1997; Park and Raines, 2004; Roder et al., 
2004; Sharma and Deo, 2005; Ciruela, 2008). Typically synthetic fluorophores are covalently 
linked to the protein under investigation, and its excitation-emission spectra monitored using a 
spectrofluorimeter. Steady-state fluorescence is most often used to determine simple binding 
parameters such as stoichiometry and changes in the fluorophore’s local environment. Stopped-
flow fluorescence, fluorescence correlation spectroscopy (FCS), fluorescence polarization and 
other variations of combined kinetic and spectroscopic techniques allow for a more detailed 
quantitative assessment of the interaction, such as binding kinetics (on/off rates) and affinities; 
however they are more difficult to set up and analyze correctly. The following section details the 
spectroscopic studies performed with the peptides corresponding to the L-type channel fragments 
from rat and Lymnaea to study their interaction with CaM, both via native Trp fluorescence of 
the NSCaTE peptides, and using dansyl-labeled CaM. 
2.3.6.1 Tryptophan fluorescence 
Steady-state fluorescence experiments were performed with wild type unlabeled CaM and 
NSCaTE peptides at varying ratios with both Ca
2+
 and EDTA. Both rat and snail NSCaTE have 
an invariable Trp in their N-termini. Native tryptophan fluorescence has been used to monitor 
protein interactions previously (Kilhoffer et al., 1992; Vivian and Callis, 2001; Li et al., 2003; 
Ciruela, 2008). This method relies on the sensitivity of the indole ring moiety of the residue’s 
side chain to its environment; significant changes in emission maxima can be observed upon 
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altering the solvent accessibility of the Trp due to protein-protein interaction (Vivian and Callis, 
2001). Thus, it was no surprise that the emission peaks of both rat and snail NSCaTE were 
considerably blue-shifted from about 355nm to 320nm for LN and 325nm for RN, and enhanced, 
from ~40% increase for RN to over 100% increase for LN (Figure 2.11 and Figure 2.12). Base 
fluorescence was higher for RN than LN, but the increase observed was much more significant 
for LN (Figure 2.13). As expected, no increase or shift was observed with EDTA, confirming the 
interaction with CaM as Ca
2+
-dependent. To control for the possible background fluorescence 
from CaM (which has no Trp, but several Tyr residues), emission scans of holo-CaM alone were 
done (data not shown). As expected, the peaks were near 310nm as expected for tyrosine, and 
substantially lower in intensity than tryptophan (around 45000 RFUs at the highest concentration 
of CaM used in any titration, e.g. ~25µM) and thus did not contribute significantly to the 
NSCaTE peptide spectra.  
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Figure 2.11: Native Trp fluorescence of LN with addition of CaM.  
To the cuvette containing 25µM LN, incremental amounts of Ca
2+
-CaM were added (2.5µM steps; each 
step produced an increase in signal, thus a legend was omitted for clarity). Highest fluorescence (light 
purple dashed) value obtained was with 30 µM CaM, corresponding approximately to a 1:1 CaM : peptide 
ratio. No CaM added trace (LN peptide only) is in cyan. +CaM and +EDTA (30µM and 20mM, 
respectively) trace is in maroon. This confirms the binding of CaM to NSCaTE and that it is a Ca
2+
-
dependent process. 
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Figure 2.12: Native Trp fluorescence of rat NSCaTE with CaM.  
Rat NSCaTE (RN) was scanned at 25µM just as with Lymnaea NSCaTE (LN) in the previous figure, then 
wild type Ca
2+
-CaM incrementally added to a maximum of 25µM (dappled green, top trace). RN alone 
(no CaM) is in red, CaM+RN+EDTA (25µM-25µM-20mM, respectively) is in yellow. 
 
 
Figure 2.13: Summary plot of fluorescence vs. the amount of CaM added to the NSCaTE 
peptides. 
NSCaTE peptides were scanned first at 25µM, and increasing amounts of stock CaM (0.3mM) were 
added. All conditions were the same for each peptide. The resulting maximum fluorescence (at 320nm) 
value for each trace was plotted vs. the concentration of CaM.  
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2.3.6.2 Dansyl-CaM fluorescence 
The IQ peptides do not contain a tryptophan, thus a similar native fluorescence experiment (as 
NSCaTE) could not be performed. Instead, we dansyl-labeled wild type CaM, and performed 
steady-state fluorescence experiments with both IQ peptides. Dansyl is an amine-reactive label 
that is also sensitive to its environment; it absorbs maximally (when covalently bound) at around 
340nm and emits anywhere from 450 to 550nm. In contrast to the much greater blue-shifts 
observed with the Trp of NSCaTEs, the fluorescence change we observe in dans-CaM upon IQ 
peptide addition is much smaller (10% increase or less), even at four-fold molar excess of 
peptide (Figure 2.14). The small effect is likely due to the low labeling yield of CaM (about 
1/10) and possibly heterogeneous labeling (it is not really possible to control which amines 
dansyl reacts with). 
 
Figure 2.14: Dansyl-CaM fluorescence with IQ peptides.  
The same 2µM dans-CaM was used in each trace, and stock (1mM) peptide was added to a final 4 fold 
molar excess, up to 8µM final (intermediate titrations not shown for clarity).   
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2.3.7 Circular Dichroism of L-type peptides 
The principle of spectropolarimetry is fairly simple: chiral molecules, such as the amino acids 
making up a polypeptide chain, absorb circular left (counter-clockwise) and right (clockwise) 
plane-polarized light differently. The effect is quantitated on a spectropolarimeter in machine 
units or millidegrees, but typically converted to “mean residue ellipticity” (to normalize for 
protein content) in published work and calculation algorithms. 
The application of spectropolarimetry for rough estimate of secondary structure content 
of proteins and peptides has been extensively examined (Kelly et al., 2005). It is fast and 
relatively straightforward, except sometimes where the analysis of complex spectra is involved. 
Different algorithms employed by software can give widely ranging outputs for actual fractional 
content of each secondary structure type for the same data set. Most of these algorithms rely on 
an existing reference set of proteins for which crystal structures and CD data are precisely 
known. There is less consistency between the different algorithms for proteins whose α-helical 
content is low and/or combined with significant β-sheet content or random coil. Often 
complications arise from high background absorbance of buffer components, especially in far-
UV (≤ 200nm).  
α helices have characteristic CD spectra with a maximum of ~190 nm, and minima at 208 
and 222 nm, which are due to the electronic transition of π0  π* and  n   π*, respectively, in 
the amide bond. Most proteins contain a mixture of different secondary structures, and rather 
than quantitating each, the studies that are performed are of a more qualitative nature (e.g. 
observing changes due to ligand binding or mutations). In the case of CaM, however, the 
secondary structure is largely composed of α helies (Chou et al., 2001; Zhang et al., 2012), and 
thus CaM has a very distinctive CD spectrum characteristic of an α helix. In contrast, most of its 
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target peptides are unstructured in solution, although this may not necessarily be the case where 
they are part of a larger protein (O’Neil and DeGrado, 1990; Vetter and Leclerc, 2003; Yamniuk 
and Vogel, 2004; O’Donnell et al., 2009). Irregular structures appear as a weak and broad 
negative peak around 200nm (cf. Figure 2.21, blue trace). Often, however, CaM induces a 
conformational change in its target peptide, resulting in the peptide adopting a more helical 
conformation (Brokx et al., 2001; Hoeflich and Ikura, 2002; Vetter and Leclerc, 2003; Lang et 
al., 2005; Radivojac et al., 2006; Spratt et al., 2007). This effect can be quantitated by subtracting 
the spectrum for the same solution of CaM from one with the peptide in question added; the 
resulting difference is then indicative of the changes occurring as a result of CaM-peptide 
binding
16
. The values also need to be corrected for total protein content and reported in units of 
‘mean residue ellipticity’ (MRE) deg · cm2 · dmol-1.  
Unfortunately, since the ellipticity change is typically subtle, even modest noise results in 
fairly large errors in all the structure calculation algorithms. There are also problems with 
calculation of CaM-induced changes in peptides that are already α-helical. Nonetheless, even by 
visual inspection it is possible to observe a change in ellipticity at 222 nm, and to a lesser extent 
at 208 and <200 nm.  
Addition of trifluoroethanol (TFE) aids in helix formation, presumably by accelerating 
the dehydration of key residues involved (Kelly et al., 2005). If a peptide is capable of forming 
an α-helix, TFE at concentrations of up to 50% (v/v) will promote its transition, but only up to 
what is physiochemically possible at the backbone level. In other words, if the peptide does not 
have a sequence conducive to helix formation (α-helical propensity), the observed structural 
change will be relatively small. However, if the peptide regularly undergoes random coil – helix 
                                                 
16
 It is not easily possible to distinguish the secondary structure changes in CaM from those in its target peptide 
using the subtraction method; it is therefore advisable to look at both the CaM and TFE data together. 
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transitions, such as many CaM binding targets in vivo, it will show a profound change in the 
ellipticity signal at 208 and 222 nm (Moorthy et al., 1999; Vetter and Leclerc, 2003; Whitmore 
and Wallace, 2008). Indeed, this is what was generally observed with all L-type channel 
peptides, albeit to a varying extent for each (see section 2.3.5).  
For helical content calculation, two different online analysis programs were used, 
SOMCD (self-organizing method CD) (Unneberg et al., 2001) and the K2D algorithm on the 
Dichroweb server developed by Drs. Whitmore and Wallace from the University of London 
(Whitmore and Wallace, 2004, 2008). Additionally, relative increase in signal at 208 and 222 nm 
(vs. peptide only signal) was used for comparison, although these metrics were somewhat 
difficult to correlate with the two software-based methods above due to the differences in the Y-
axis scale. For the SOMCD and K2D algorithms, the Y-values represent fractional structure 
content (e.g. a total sum of 1 for all possible states). For the 222 nm data, a logarithm of the fold 
increase in ellipticity had to be used to maintain a reasonable scale for comparison. The 208 nm 
values are fold differences of the machine unit ellipticities at that wavelength. Overall, we see 
similar trends between all three methods, but since the use of a buffer caused significant 
background absorbance at < 200nm, accurate quantitation of secondary structure content in our 
case was not truly possible. Instead, we use the fold increase at 208 nm and log fold of 222 nm 
versus the molar ratio of peptide to CaM for the comparison of all of the peptides.  
The IQ peptides show a maximum in α helical content at a 1:1 ratio with CaM (Figure 
2.15 and Figure 2.16). This makes sense, since the greatest amount of α helix should be present 
when all of the peptide is in its CaM-bound conformation; any more peptide that can bind to 
CaM is then simply diluting the signal. However, the situation for NSCaTE peptides is more 
complicated since the Lymnaea peptide (LN) is unstructured and has a slight negative slope in 
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the % α-helix/[peptide] plot (Figure 2.17) which was not consistent with the increase seen in the 
IQ peptides. There was no clear ‘maximum’ unless the 5µM point is considered (lower ratios 
were not assayed), but visual inspection of the scan suggests there may be an issue with the 
signal/noise ratio that affected that particular trace (5µM – purple trace in Figure 2.17). The fold 
difference in MRE signals (both at 208 and 222 nm) for LN with CaM is much greater than for 
RN, likely because the actual intrinsic α-helical content of RN peptide is much greater (Figure 
2.18 and Figure 2.22). LN is also much less affected by TFE, see Figure 2.21. In general terms, 
this suggests that the structural changes induced by CaM in NSCaTE or vice versa are minor. 
Moreover, there does not appear to be a consensus in the TFE-induced alpha helical change 
between the two NSCaTE peptides. While LN continues to gradually increase its α-helical 
character with addition of more TFE (Figure 2.21), the same is not strictly true for RN, which 
maintains a consistent level of secondary structure starting with 10% TFE (Figure 2.22). LN has 
a lower alpha-helical propensity, as it does not approach a detectable level of α helix until 25% 
TFE is added. The IQ peptides and RN, in contrast, readily respond to TFE and achieve an early 
maximum at low (10-25%) concentrations of TFE.  
Comparing the relative α-helicity of the peptides using both varying concentrations of 
TFE and their maximal α-helical content with CaM presents a somewhat contrasting picture (see 
Table 2.4 for a summary). Both NSCaTEs appear to reach a higher maximal % α-helix with CaM 
(on the order of 60% - Figure 2.17 and Figure 2.18), whereas the IQ peptides are not as strongly 
affected by CaM (~30%) (Figure 2.15 and Figure 2.16). In contrast, the IQ peptides and 
mammalian NSCaTE respond more easily to the addition of TFE (Figure 2.22, Figure 2.19 and 
Figure 2.20), and reach higher α-helical content at lower TFE concentrations. One explanation 
might be that the subtracted CaM spectra do not take into account the actual α-helical changes 
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that could be occurring within CaM itself, e.g. the flexible linker region. It is also possible that 
greater noise at the lower peptide concentrations used with CaM (and the lack of reliable < 
200nm data) affect the K2D calculations.  
Together these data suggest a significant difference in the modes of binding of IQ and 
NSCaTE peptides by CaM, as well as a modest difference between the Lymnaea and mammalian 
NSCaTEs. A more in-depth biophysical dissection of the interaction with CaM was performed 
and analyzed in the following chapter. 
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Figure 2.15: CD spectra of IQc with CaM.  
Subtracted spectra of (peptide+CaM) – CaM alone, corrected/smoothed. Inset: helical content according 
to various algorithm calculations vs. peptide concentration. All recordings were done with the same 10 
µM CaM in the cuvette. Algorithms are described in Methods. Inset: alpha-helical content vs. the 
concentration of added peptide, calculated using the 4 different algorithms described in Methods. Here, 
‘0’ is actually CaM-free peptide at 50µM (see TFE plots below), not peptide-free CaM, calculated with 
the K2D and SOMCD algorithms. The 208 and 222 nm data are fold and log fold increases (respectively) 
over the CaM-free peptide values, which is why they do not contain a data point at 0. 
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Figure 2.16: LIQ1 with CaM.  
Same methodology as Figure 2.15 
 
 
Figure 2.17: LN with CaM.  Same methodology as Figure 2.15 
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Figure 2.18: RN with CaM.  
Same methodology as Figure 2.15 
 
 
Figure 2.19: LIQ1 with TFE.  
Trifluoroethanol (TFE) is an organic solvent used to induce alpha-helical transition in peptides 
(concentrations used in each trace are indicated). The 50% trace could not be obtained due to 
peptide aggregation. In all cases 50µM peptide was used. 
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Figure 2.20: IQc with TFE.  
 
 
Figure 2.21: LN with TFE.  
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Figure 2.22: RN with TFE.  
 
 
Table 2.4: Summary of CD results. 
 The K2D method was used for the fractional helical content calculation. Since the 50% TFE trace was 
not obtained with LIQ1, some of the calculations were not applicable. 
Peptide % α helix when 
free in solution 
(no TFE or 
CaM) 
Maximum % α-
helical content 
(50% TFE) 
% of 
maximum 
at 10% 
TFE 
% of 
maximum at 
25% TFE 
Maximum α-
helical content 
(as%) with 
CaM 
RN 9 41 49 93 58 
LN 7 23 30 39 57 
IQc 11 31 55 90 29 
LIQ1 8 N/A N/A N/A 37 
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2.4 Discussion 
The goal of the experiments in this chapter was to establish the existence of, and characterize, an 
invertebrate NSCaTE homolog from CaV1 of Lymnaea stagnalis. The effort was largely 
successful, and interesting new insights into the complex interaction scheme of CaM and L-type 
channels have been gained, although some findings raise new questions. The latter, and the 
attempts to answer them, are covered further in the next Chapter. 
The conservation of the NSCaTE motif is far more extensive than previously thought; all 
but the most primitive (basal) metazoans possess an NSCaTE motif in one or more of their 
channels. Importantly, NSCaTE appears only to occur in L-type channels (but not all isoforms), 
all of which also contain a highly conserved IQ motif. This IQ motif only binds Ca
2+
-CaM, 
unlike the canonical IQ motifs of myosins and NaVs, which bind apoCaM (Houdusse et al., 2006; 
Feldkamp et al., 2011). It is absent in Drosophila, but present in Culicidae (mosquitoes). 
NSCaTE is conspicuously absent in CaV1.1 and 1.4, all the more intriguing because those are 
‘unusual’ L-type channels that do not exhibit the same kind of regulatory feedback (via CDI and 
VDI) as the ‘canonical’ L-type channels CaV1.2 and 1.3 (Peterson et al., 1999; Catterall, 2000; 
Zamponi, 2005; Striessnig, 2007; Griessmeier et al., 2009). They still possess an IQ motif, which 
is essential for the excitation contraction coupling role of CaV1.1 (Stroffekova, 2011), 
presumably also through an interaction with CaM. In contrast, no channel containing an 
NSCaTE but lacking an IQ motif is known to exist.  
NSCaTE is somewhat atypical for a CaM binding target: it has a relatively low alpha-
helical propensity on its own (or with TFE), yet a strong alpha-helical change with CaM (Brokx 
et al., 2001). The lack of a gel shift effect on CaM by NSCaTE binding can thus be explained by 
two possibilities. One, there is no conformational change in CaM upon NSCaTE binding 
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(consistent with the spectropolarimetry results). The other is that the affinity of NSCaTE for 
CaM is quite low and the fraction of CaM-bound NSCaTE (and the lifetime of the interaction) is 
too low to be detectable with a gel-shift method. While the results presented in this chapter lack a 
quantitative description for the affinities of NSCaTE and IQ motifs for CaM (to be addressed in 
the following chapter), there is clear evidence that both interactions do, in fact, occur. Gel shift 
data indicates that there is at least some level of competition occurring between the two peptides 
(or co-interaction, a question we sought to address further), with a clear interaction observed 
with the IQ motif and either a blocking effect or a weaker interaction occurring with the 
NSCaTE motif. Secondary structure changes in NSCaTE upon addition to CaM were consistent 
with a CaM interaction. Most indicative, however, was the strong blue-shift observed with 
tryptophan fluorescence in NSCaTE upon CaM addition, in a Ca
2+
-dependent manner. The 
solubility enhancement of a mammalian NSCaTE fusion construct upon Ca
2+
-CaM co-incubation 
is also solid evidence of a persistent CaM binding. Exposed hydrophobic residues in the 
construct likely contribute to its aggregation; masking of these hydrophobic regions by CaM is 
the most likely explanation for this effect. 
It is possible that NSCaTE fine-tunes CDI, principally acting in response to large Ca
2+
 
influxes from prolonged opening or high local density of L-type channels (such as in synapses). 
This is strongly supported by our results; removal of NSCaTE from LCaV1 renders it insensitive 
to internal buffer conditions, and modestly reduces the recovery from inactivation in Ca
2+
 after a 
prolonged depolarization. This is consistent with previously published NSCaTE deletion and 
CaM mutant experiments in mammalian channels (Ivanina et al., 2000; Dick et al., 2008; 
Benmocha et al., 2009; Asmara et al., 2010; Guo et al., 2010). Thus, NSCaTE fulfills the 
presumed role of a ‘global’ Ca2+ sensor, likely via the less-Ca2+ sensitive N-lobe of CaM. 
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Meanwhile the IQ motif is arraigned as the ‘first responder’ to transient Ca2+ pulses in the 
immediate channel vicinity, due to its relatively slower off-rate for Ca
2+
 (Tadross et al., 2008). 
The crystal structure of CaV1.2 IQ motif bound to CaM shows a parallel (unusual for IQ) 
orientation with both lobes bound, and half CaM/IQ calorimetric titrations suggest a preference 
for the C-lobe (Van Petegem et al., 2005). Whether a N(0)-C(2) Ca
2+
 CaM
17
 conformation is 
actually found bound to the IQ motif in vivo remains questionable; live-cell FRET studies with 
large fluorophores (GFP variants, all much larger than CaM) are unlikely to be true 
representations of a native conformation. Furthermore, it is unclear what constitutes a 
‘physiological’ level of buffering: 0.5mM EGTA is an arbitrary number (the relative amounts of 
free and bound cellular Ca
2+
 at any given time are controlled by a myriad of factors, from high 
capacity ‘buffer’ proteins to Ca2+ pumps in both plasma and organellar membranes), and is 
compounded by the artificial recording conditions. While the relative effects of ‘high’ and ‘low’ 
internal EGTA appear to play a significant role on L-type CDI, the extent of the buffer effect and 
its relationship with NSCaTE and CaM lobes may be much greater in vivo, under native 
conditions – but quite challenging to actually determine. It is plausible to consider NSCaTE as a 
secondary switch or ‘safeguard’ for neurons and cells that are highly electrochemically active, 
where it can prevent excess Ca
2+
 influx when intracellular levels reach a certain threshold. In this 
regard, it would be interesting to determine if there is indeed a tissue-biased distribution of L-
type channel variants of the same isoform with and without NSCaTE, if the translational 
regulation (alternate start sites) we observe is indeed physiologically significant. Of course, this 
would require extensive immunohistochemistry profiling with very specific sets of antibodies: a 
minimum of a Master’s level project all in its own. 
                                                 
17
 Here the notation represents the number of Ca
2+
 ions in the indicated lobe, e.g. 0 in the N-lobe and two in the C-
lobe 
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2.5 Conclusions 
The primary objective of this chapter was to investigate the Lymnaea NSCaTE homolog as a 
functional regulatory motif of LCaV1, and verify its role in CDI to be similar to that of 
mammalian NSCaTE. This was indeed accomplished, as we have shown a strong buffer-
sensitive component of CDI imparted to LCaV1 by its own NSCaTE, which is qualitatively 
different from what is seen in the mammalian isoforms (CaV1.2 and 1.3) by (Dick et al., 2008). 
Nonetheless, there is a clear interaction between CaM and Lymnaea NSCaTE, and even a 
possibility for co-interaction between NSCaTE, IQ and CaM although we lack concrete evidence 
for such a complex. We see a possibility of a chaperone effect of CaM due to the improved 
solubility profile of an NSCaTE-HIS fusion construct when exogenous CaM is applied during 
refolding. Further experiments with full channel expression as a function of NSCaTE truncation 
will be necessary to confirm this. 
There appears to be a fundamental difference in how NSCaTE and IQ motifs bind CaM; 
this can be seen with both the native PAGE gel shift and spectropolarimetry results. While CaM 
exhibits a strong shift in native PAGE with IQ peptides, it does not alter its mobility with 
NSCaTE to an observable extent. This might suggest that while CaM essentially ‘wraps around’ 
the IQ motif, it binds NSCaTE with a much subtler conformational change – perhaps even with a 
single lobe. A detailed solution structure of CaM-NSCaTE has not yet been published, but 
solving one may be a possibility in the future. 
Additionally, we show that nearly every NSCaTE-containing L-type isoform has a 
downstream Met that could potentially serve as an alternative start site, resulting in an optional 
NSCaTE motif that is translationally regulated (we see no difference at the transcript level). In 
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essence, NSCaTE may serve as a fine-tuning element in CDI that is both tissue and isoform-
specific, possibly as a failsafe against excessive Ca
2+
 entry into the cell. 
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Chapter 3: Thermodynamic analysis of CaM binding to IQ and 
NSCaTE peptides 
3.1 Introduction and Summary 
Based on the results of experiments presented in Chapter 2, where we show NSCaTE binding to 
CaM using gel-shift and fluorescence, the next step was to quantitate this interaction and its 
thermodynamic parameters using isothermal calorimetry and Ca
2+
-deficient CaM mutants 
(CaM12, CaM34). These mutants have critical DA substitution in the indicated EF hands (e.g. 
hands 1 and 2 for CaM12, etc.), thus impairing Ca
2+
 binding in one or both lobes. Experiments 
with these mutants allowed us to dissect the interaction with L-type channel peptides in detail 
and to test the relevance of the local-global model
18
 to the relative contributions of IQ vs. 
NSCaTE, based on their CaM lobe preference and relative affinity. We also attempted to 
determine whether the two peptides could bind CaM simultaneously, although due to a very 
weak and transient interaction between CaM and NSCaTE, only indirect supporting evidence 
could be obtained (with ITC).  
3.1.1 Isothermal Calorimetry of L-type peptides 
Isothermal calorimetry is a biophysical technique used for characterizing the association or 
disassociation of macromolecules, typically proteins and their ligands, or protein-protein 
complexes. It relies on the summative changes in the enthalpy of reactants and products, and the 
total change in system heat; entropy can be inferred from knowing the enthalpy and binding 
constant. The instrument is described in Figure 1.1. The heat in this case is measured indirectly; 
the ITC200 system uses a specific reference power, which is set by the user (range from 0-
                                                 
18
 Proposed originally by Yue and Tadross (DeMaria et al., 2001; Dick et al., 2008; Tadross et al., 2008) 
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12µcal/s) that is supplied to both the sample and the reference cell. Deviations from the reference 
power due to the sample cell either requiring less (for exothermic binding) or more (for 
endothermic binding) heat to maintain at the set temperature is reflected in the direction of the 
injection peaks. The peaks are integrated and with the information regarding the concentration of 
the ligand in the cell, and the protein in the syringe, the experiment is plotted as µcal vs µmol 
injectant, typically forming a sigmoidal plot. OriginLab, SigmaPlot or similar fitting software 
with functions pertaining to relevant kinetic models
19
 can then be used to fit the resulting data 
through iterative least-squares type regression. From one experiment, all the relevant interaction 
data can be obtained: stoichiometry (N), affinity (Kd or Ka), and the enthalpy (ΔH) and entropy 
(TΔS) associated with the binding. The equation for the corrected heat observed during an 
injection is: 
                                                    
Where       is the actual heat associated with the binding from one injection,       is the 
measured heat on the instrument,             is the heat associated with the dilution of ligand 
upon being titrated into the cell,                   is the small heat associated with the dilution 
of the macromolecule in the cell, and       is the heat associated with the friction from buffer 
molecules mixing (buffer into buffer injections), which should be negligible in most cases. Often 
the correction can be done by subtracting the baseline heats which occur after saturation of the 
macromolecule with ligand. Errors in software fitting can be mostly avoided by constructing a 
proper baseline.  
The heat per injection (Qinj) can be used to determine the enthalpy ΔH: 
                                                 
19
 Standard models are ‘one set of sites’, ‘two sets of sites’, ‘dissociation’ or ‘competitive binding’; more complex 
kinetic models have to be written by the user 
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The stoichiometry is roughly the x-coordinate where the slope of the titration curve is maximal. 
The relationship describing the shape of a simple single binding event isotherm (‘one-set-of-
sites’ model) can be expressed as: 
    
[ ]  
  [ ]  
 
   [ ]     ∑   
 
   
    
where Θj is the fraction of site j occupied by ligand, Lt is the total ligand concentration, [L] is the 
free ligand concentration, Pt is the total macromolecule concentration, Kj is the binding constant 
of process j, and nj is the total stoichiometric ratio for process j, each of the equations is defined 
for all potential binding sites, and solutions for any number of sites can be defined. Substitution 
of    from the top equation into the bottom one yields a (k + 1) degree polynomial. Thus, to 
solve for a one-set-of-sites process, roots of a second degree polynomial must be found (Freyer 
and Lewis, 2008). Origin is capable of solving up to third degree polynomials, more complex 
models likely have to be fitted with at least some of the parameters known (or at least 
empirically estimated). Solving for [L] allows one to find  : 
       (∑  
 
   
     ) 
Where Q is the total heat evolved in the process j, V0 is the initial volume of the sample cell and 
   is the molar enthalpy for process j. Using a non-linear least squares regression on the 
differential heats for each injection one can fit the parameters K, N and   , to which the 
universal gas law can be applied to obtain TΔS.  
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Weakly binding ligands require a much higher experimental concentration to get a good 
fit than high affinity ligands; however the downside of the latter is that depending on the heats of 
injection, it is often difficult to have a dilute enough sample to get a good signal-to-noise ratio, 
especially if the enthalpy of reaction is low. The ‘c-value’ or N·Kd·Mt (where Mt is the total 
macromolecule concentration, N is the stoichiometry and Kd is the affinity of binding) defines 
how ‘good’ the curve is (how amenable to being fitted) and should fall in the range of 1 to 1000 
for reliable Kd calculation (Turnbull and Daranas, 2003; Broecker et al., 2011), which puts a 
practical limit on direct Kd determination for very high-affinity and/or low enthalpy binding. In 
contrast, very weak binding requires ligand/ macromolecule concentrations that are not 
achievable or practical in the typical micro-calorimeter, such as the ITC200. Fortunately, such 
weak interactions (>50µM) between proteins are not usually biologically relevant, at least in the 
context of CaM interactions. For very high-affinity interactions, it is sometimes possible to 
determine the Kd indirectly, by having a known concentration of a competing ligand with a 
precisely known Kd in both cell and syringe, thus reducing the apparent Kd for the experiment 
and enabling the back-calculation of the actual Kd.  
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Figure 3.1: The typical components of a calorimeter; not to scale. 
  
Syringe spin motor 
Injection syringe (spins inside cell) 
Reference cell Sample cell 
Heat jacket 
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3.1.2 Nuclear Magnetic Resonance Spectroscopy (NMR) 
One of the two most common techniques in macromolecular structure determination is solution 
NMR, in which the macromolecule under study is analyzed in native or near-native conditions 
(contrary to X-ray crystallography). While high degree of conformational flexibility and 
movement impedes accurate structural assignment by NMR, it can yield information on which 
areas of the protein are constrained as a result of binding to a target during titration. Furthermore, 
the degree of solvent exposure under different conditions can yield information regarding the 
solvent-accessible surface area (SASA), which can be used as an indirect measure of target 
binding. Finally, full residue assignment of a multi-dimensional NMR spectrum or of a 
combination of several spectra can lead to a high-resolution atomic structure of the 
molecule/complex.  
The theoretical basis of the methodology in NMR is quite complex and will not be fully 
explained here; however, a basic introduction to the concepts will be attempted.  
The basis of an NMR signal is the free-induction decay (FID) that occurs when a 
transverse magnetization applied via a radio frequency or RF pulse to nuclei that aligned within a 
strong external magnetic field. The resulting change in the spin precession of magnetically active 
(spin I > 0) nuclei is temporary, but since the oscillation (‘transverse relaxation’) is very well-
defined by a specific frequency, it can be amplified and detected, and then Fourier transformed 
to give a single Lorenzian peak. This peak is the basis of the ‘chemical shift’ often discussed in 
NMR literature, which is standardized for every nucleus type and can be looked up from a table 
to assist in residue assignment. Shielding from magnetic fields by aromatic electrons, as well as 
spin-spin coupling of neighboring nuclei, all have an effect on chemical shifts which can be used 
to correlate them and also disperse the spectra of larger proteins with many instances of the same 
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amino acid. Using several different pulse sequences such as heteronuclear single quantum 
correlation (HSQC), total correlation spectroscopy (TOCSY) and Nuclear Overhauser Effect 
Spectroscopy (NOESY), multi-dimensional spectra can be generated with several connections 
for the same nucleus (typically at least 2 different experiments are needed). The coupling can 
then be traced in a ‘connect-the-dots’ manner to assign the backbone nuclei, which can then be 
used to determine basic secondary structure using dipole couplings and knowledge of torsion 
angle constraints. Subsequently, through-space interactions (via NOESY) can be used to find 
non-bonded neighboring nuclei and a more detailed higher-order structure can be solved. The 
larger the number of NOEs and angle/distance constraints, the higher the quality of the structure 
that can be obtained. More generally, changes in chemical shifts of specific amino acids in a 
sequence can be indicative of a structural shift, possibly due to an interaction with a target 
peptide or protein. This can be observed with a simple HSQC with 
15
N
 
and/or 
13
C labeled 
proteins/peptides, which correlates the amide protons and nitrogen nuclei. Here, we use such 
information to discern the structural changes for each L-type channel peptide interaction with 
CaM. 
The HSQC spectra used in this and next chapter were acquired by Michael Piazza (Ph.D. 
candidate). 
 
3.2 Methods 
3.2.1 Isothermal Titration Calorimetry 
All titrations were performed at 25ºC using 0.5x gel filtration buffer  (25mM Tris-Cl pH 7.5, 
75mM NaCl) with added 1mM CaCl2 to avoid buffer artifacts and because peptide stocks were 
made up in MQ water, while CaM stocks were stored in gel filtration buffer after purification. 
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Mutant CaM concentrations were determined using a Bio-Rad Bradford assay with wild type 
CaM used as a standard, using a modified Bradford method (Ernst and Zor, 2010). Depending on 
the expected Kd and stoichiometry, the starting concentrations for cell and syringe varied from 
10 to 50 µM and 100 to 500 µM, respectively. Most experiments involved between 20 and 30 
injections of 1.2 to 1.8 µL at 2-3min intervals. L-type channel peptides with wild type CaM were 
titrated at a reference power of 11µcal/s; mutant CaMs were done at 5µcal/s. In all cases, high 
feedback gain and 1000rpm stir speed were selected. Mutant CaM experiments were performed 
in a 5mM HEPES (pH 7.0) with 1mM CaCl2 buffer, while for wild type CaM experiments the 
gel-filtration buffer at half strength (25mM Tris-Cl pH 7.5, 75 mM NaCl) with 0.5 mM CaCl2 
was used. HEPES appears to have a lower background heat, which was beneficial for titration of 
weakly interacting peptides. 
 
Table 3.1: L-type peptides and their properties.  
All peptides were synthesized by Genscript except RN, which is from CanPeptide, and specified to >98% 
purity and mass spectrometry verified. 
Name Origin Sequence MW pI 
RN rat NSCaTE (CaV1.2 or α1c) SWQAAIDAARQAKLMGS 1804.07 8.46 
LN snail NSCaTE (LCaV1) GWSTALAAAQGAATVRK 1658.89 11 
IQc rat α1c IQ (CaV1.2), L-type 
'cardiac' 
KFYATFLIQEYFRKFKKRKEQ 2799.34 10.12 
LIQ1 snail L-type IQ (LCaV1) KFYATFLIQDYFRRFKKRKEQ 2813.27 10.28 
IQa rat α1a IQ (CaV2.1) or P/Q type KIYAAMMIMEYYRQSKAKKLQ 2799.34 9.87 
     
3.2.2 Purification of Ca2+-deficient CaM proteins. 
Since the interaction of CaM with hydrophobic interaction chromatography (HIC) media 
depends on its exposure of the hydrophobic residues upon Ca
2+
 binding, the phenyl-sepharose 
method is not nearly as efficient for the purification of CaM12/34/1234. Instead, we used a 
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combination of ion-exchange chromatography and subsequent gel-filtration. The latter method is 
identical to the one described in Chapter 2. For ion exchange, a Q-sepharose (quarternary 
ammonium) 6mL column from Pharmacia (now GE Healthcare) was used. Lysis and low salt 
buffer were 5 mM bis-tris pH 6.0 with no Ca
2+
 or EDTA. Lysis buffer also had DTT added to 1 
mM final concentration to maintain CaM’s methionines in the reduced state. CaM12, 34 and 1234 
(in pET28a) were expressed and harvested the same way as wild type CaM (see section 2.2.2). 
Cells were lysed using the Avestin Emulsiflex homogenizer (>15000 psi), clarified by 
centrifugation at ~ 50000 g and applied to the column (ion exchange was done using the AKTA 
FPLC system, same as for gel filtration chromatography). The column was then briefly washed 
with low salt buffer (5-10 column volumes), and a shallow salt gradient was applied (100mM 
NaCl over 10 column volumes). Subsequently the column proteins were eluted with a steep 
gradient (1.6M NaCl over 2 CVs, held for 2 more CVs), after which the column was re-
equilibrated or cleaned. The resulting fractions were analyzed by SDS PAGE and absorbance at 
278nm, best candidates pooled and concentrated using YM-10 spin columns (Millipore) and 
further purified by gel filtration chromatography (section 2.2.2). Purity of the CaM proteins was 
confirmed by SDS PAGE and ESI MS and their concentrations were determined using the 
modified Bradford assay (Ernst and Zor, 2010) (with wild type CaM as the standard), aliquotted 
and stored in gel filtration buffer at -80ºC.  
 
3.2.3 NMR spectroscopy 
CaM for NMR experiments were expressed in M9 minimal media (11.03 g/L Na2HPO4·7H2O, 
3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM CaCl2, 5 mg/mL thiamine, 100 μg/mL 
kanamycin) containing 2 g/L 
13
C-glucose and 1 g/L 
15
NH4Cl. 
13
C-
15
N CaM was purified as 
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described above. The samples were prepared for NMR experiments via a buffer exchange into 
NMR solution (100 mM KCl, 10 mM CaCl2, 0.2 mM NaN3, 90% H2O/10% 
2
H2O) at pH 6.0 
using a YM10 centrifugal filter device (Millipore Corp., Billerica, USA). All NMR samples 
contained 300µM CaM in a total volume of 500 μL. The samples were transferred into 5 mm 
NMR sample tubes and stored at 4
o
C until required for NMR experiments. NMR experiments on 
the complexes were conducted on CaM samples titrated with each peptide to saturation in a 1:1 
CaM:peptide ratio. Complex formation was monitored after each addition by acquisition of a 
1
H-
15
N heteronuclear single-quantum coherence (HSQC) pulse sequence. NMR spectra were 
recorded at 25
o
C on Bruker 600 and 700 MHz DRX spectrometers equipped with XYZ-gradients 
triple-resonance probes (Bruker, Billerica, MA, USA).  Spectra were analyzed using the program 
CARA (Computer Aided Resonance Assignment) (Keller, 2004).  
3.3 Results 
Within the first few experiments involving wild type CaM and NSCaTE (both rat and snail) it 
was noted that an unusual 2 : 1 (peptide : CaM) stoichiometry was present in every titration. 
Upon further analysis and using competition titrations with IQ peptides, it was determined to be 
an authentic interaction stoichiometry, and not an experimental or concentration error-related 
artifact. Furthermore, subsequent nuclear magnetic resonance (NMR) experiments with NSCaTE 
and CaM revealed a similar result, that is, complete signal shift saturation occurring only after 
approximately 2 equivalents of peptide were added. Shortly before writing the manuscript 
explaining these unusual results (Taiakina et al., 2013), a paper was published by Liu and Vogel 
(2012) that provided a structure of each CaM-lobe individually bound to an NSCaTE peptide, 
thus supporting our results. In fact, they were unable to actually determine a structure of intact 
holo-CaM with 2 peptides, due to ‘severe peak broadening’, which we suspect is the result of a 
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rapid on-off equilibrium between free and CaM-bound peptide, as well as the distinct structural 
changes associated with binding of NSCaTE to the two sites.  
In an attempt to determine unambiguously the effects of individual CaM lobes on L-type 
peptide binding, titrations with Ca
2+
-deficient CaM mutants were performed. Additionally, 
competition experiments where either NSCaTE or IQ peptide was first pre-bound to CaM at 1 : 1 
(or 2 : 1 in the case of NSCaTE : CaM) stoichiometry and the competing peptide titrated in 
(Figure 3.4). We also used the Ca
2+
-deficient CaM mutants CaM12 and CaM34 to perform the 
same pre-bound peptide competition titrations to determine the relative lobe/Ca
2+
 preference of 
the two peptides (Table 3.2).  
 For the apo-CaM experiments, to ensure that no Ca
2+
 was bound to even just the C-lobe 
of CaM, a low background concentration of EDTA was used (up to 1mM) and CaM stock was 
buffer exchanged into water. While these experiments were successful for NSCaTE peptides, the 
IQ peptides apparently interact with EDTA and precipitate out of solution, likely owing to their 
extremely high isoelectric point (>10). Anecdotally, the same kind of aggregation was also seen 
when an inorganic acid buffer was used (sodium phosphate, as low as 10mM). This seems to 
support the idea that the IQ peptides are essentially forming insoluble salt complexes via their 
Arg and/or Lys residues. Such an interaction has also been shown between calcitonin (a small 
peptide hormone) and EDTA; interestingly, calcitonin is also known to bind CaM (Seyferth and 
Lee, 2003). Aggregation was not diminished in either EGTA or BAPTA. Reducing peptide 
concentrations and EDTA concentration alleviated the issue to an extent, but due to the 
sensitivity of ITC and the fitting algorithm, the EDTA-CaM titrations with IQ peptides were 
questionable. Instead, we opted to use the CaM1234 mutant as a proxy for apoCaM. 
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3.3.1 Isothermal Calorimetry 
3.3.1.1 Wild type CaM 
There was no interaction between NSCaTE and CaM in the presence of 1mM EDTA. In the 
presence of Ca
2+
, both rat and snail NSCaTE (RN and LN, respectively) bound CaM with a 2 : 1 
(NSCaTE : CaM) stoichiometry and weak affinity (~1.2 µM for rat and ~13 µM for snail 
NSCaTE). Both NSCaTE peptides had a much lower (over an order of magnitude higher Kd) 
affinity for CaM than their respective IQ peptides (Table 3.2, also Figure 3.2). As expected, both 
rat and snail IQ peptides had very similar affinity for CaM (sub-micromolar) and 1 : 1 
stoichiometry. All L-type peptides were found to be exothermic (negative ΔH) and had very 
weakly negative (mammalian) or positive (snail) entropy (ΔS), indicating that the interaction is 
primarily enthalpy-driven (Table 3.2). Enthalpy changes are often associated with electrostatic 
interactions and hydrogen bonding; this suggests a hydrophilic character of NSCaTE/CaM/IQ 
interactions. EDTA appears to form insoluble complexes with IQ peptides, thus we were unable 
to determine if wild type apo-CaM binds IQ peptides by ITC. Instead, we used CaM1234 (with all 
four EF hands containing a critical DA mutation) which is unable to bind Ca2+. It was found to 
be incapable of binding either IQc or LIQ1 at a detectable level.  
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Figure 3.2: Representative ITC results from wild type CaM and L-type peptides.  
Each panel contains the integrated peak heats as a function of added titrant (peptide): A): IQc (500 µM) 
into WT CaM (50 µM). B): LIQ1 (100 µM into 10 µM). C): RN (500 µM into 25 µM). D): LN (500 µM 
into 50 µM). All experiments fit the one-set-of-sites model in OriginLab. Each experiment was repeated 
at least twice. 
 
A B 
C 
D 
122 
 
3.3.1.2 Competition experiments with wild type CaM 
To elucidate the relevance of CaM binding to NSCaTE (and the 2 NSCaTE : 1 CaM 
stoichiometry) as well as test the possibility that both peptides might be binding CaM 
simultaneously, competition experiments were performed. The ITC sample cell was filled with 
an equimolar solution of CaM and peptide (either IQ or NSCaTE), and the opposing peptide 
titrated in to saturation. The results indicate that the stoichiometry for both peptides when titrated 
in this way (regardless of order) is 1 : 1, and the binding constants are relatively unaffected, 
strongly supporting a case for co-interaction (see Figure 3.4). These results indicate that CaM 
can bind the NSCaTE peptide at two different sites, but not if one of these sites is already 
occupied by an L-type IQ peptide.  
In addition, the NSCaTE ‘knock-in’ effect (see section 2.1.3), for which the motif was 
named (Dick et al., 2008), was tested by a competition analysis with the IQ peptide from a rat 
P/Q-type channel (CaV2.1), which bears little resemblance to L-type IQ peptides (Table 3.1). 
There is strong evidence that the previously described transforming effect of NSCaTE (on 
CaV2.2 channels) is due to its ability to out-compete the weaker binding IQ motif of this channel. 
We tested the IQa peptide (CaV2.1) for its interaction with CaM, by ITC and by gel shift 
experiments, and found that despite a strong gel-shift, its affinity for CaM is low (~1µM) and it 
is readily displaced by NSCaTE. Additionally, we see a 2 : 1 stoichiometry for IQa : CaM, and a 
persisting 2 : 1 stoichiometry for NSCaTE when titrated into CaM pre-bound to IQa, suggesting 
that NSCaTE fully displaces it from CaM (see Table 3.2 and Figure 3.3). No interaction was 
observed when IQa was titrated into CaM pre-bound to NSCaTE (data not shown). Effectively, 
this proves that the ‘transforming’ effect of NSCaTE is due to its ability to displace the native IQ 
peptide of non-L-type channels from CaM. Additional implications are discussed below. 
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Figure 3.3: NSCaTE (RN) fully displaces the P/Q IQ (IQa) peptide from CaM.  
500 µM RN was titrated into 30 µM CaM pre-bound with 30 µM IQa. The resulting isotherm fits the one-
sites model in Origin, with an N of approximately 2, and a Kd of  ≈ 1.0 ± 0.18 µM. 
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Figure 3.4: Competition experiments with L-type peptides and wtCaM.  
A): RN (500µM) into CaM prebound to IQc (both at 30µM). B): IQc (100 µM) into CaM prebound to RN 
(both 10µM). C): LN (500µM) into CaM prebound to IQc (30µM both). D): LIQ1 (100µM) into CaM 
prebound to LN (10µM both). We were unable to get a curve that could be fitted with LN into 
LIQ1+CaM, likely due to its low affinity for CaM; however the LIQ1 and IQc sequences and their 
properties are very similar.  
A B 
C D 
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3.3.1.3 EF hand CaM mutants 
To elucidate the contribution of each CaM lobe and dissect the putative NSCaTE-IQ-CaM 
complex, we used CaM mutants incapable of binding Ca
2+
 in either the N- or C- terminal EF 
hands (CaM12 and 34, respectively). These mutants have critical aspartate to alanine substitutions 
in their Ca
2+
-coordinating residues (D21A and D56A for the N-lobe, and D93A + D131A for the 
C-lobe), and approximate the Ca
2+
-deficient states of CaM. In addition, CaM1234, in which all 
four mutations are present, is often used as an apo-CaM proxy, although its in vivo relevance and 
conformational fidelity have become controversial (Jurado, 1999; Xiong et al., 2010). We find 
that both CaM12 and CaM34 are capable of binding to both IQ and NSCaTE peptides, albeit with 
varying effects on Kd and N; most notably, the stoichiometry of NSCaTE with either lobe mutant 
is altered to 1 : 1, meaning that each lobe is capable of binding an NSCaTE peptide 
independently, and only when bound to Ca
2+ 
(see Table 3.2). This was concurrently confirmed 
by a structural study (Liu and Vogel, 2012), which also found a preference of NSCaTE for the 
N-lobe of CaM (with ITC).   
 Both L-type channel peptides have similar or even slightly higher affinity for CaM12 
compared to wild type CaM (Table 3.2 and Figure 3.6). The titrations were done in HEPES to 
reduce the background associated with (de)protonation heat effects. The entropy term (ΔS) for 
IQc with CaM12 is actually slightly larger and positive (as opposed to wild type CaM), which 
might suggest that the N(0)-C(2) Ca
2+ 
CaM conformation is the preferred mode of binding to the 
IQ motif. In contrast, CaM12 and NSCaTE interaction loses entropy (ΔS becomes modestly 
negative) while gaining slightly in enthalpy (ΔH becomes more negative). Entropy is usually 
associated with van der Waals effects or solvation changes, often related to conformational 
rearrangements, or changes in the degrees of freedom of the macromolecular components.  
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 In contrast to CaM12 and wild type CaM, both IQ and NSCaTE peptides bind CaM34 with 
a greatly reduced affinity (almost 100-fold higher Kd in the case of IQc), and very large negative 
entropy, offest by substantial increases in enthalpy (Table 3.2 and Figure 3.6). Whether the result 
is indicative of the peptides binding to the lower affinity site in the N-lobe or a transitional, 
conformationally unfavorable state of CaM is uncertain. It may be that the conformational state 
of CaM is subject to disruption by the EF hand mutations and thus does not represent an 
authentic N(2)-C(0) Ca
2+ 
status of CaM (if such a conformation is even capable of existing 
outside of some very specific circumstances, such as when interacting with the CaM-binding 
domain of SK channels). The thermodynamic parameters (great loss in entropy in exchange for 
high heat of binding) hint at the greatly reduced conformational flexibility associated with CaM 
N-lobe binding the IQ motif alone. It is possible that the interaction is a non-specific electrostatic 
effect. Further competition experiments with the EF hand CaM mutants reveal an even more 
puzzling picture (next section). 
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3.3.1.4 Competition experiments with EF hand mutants 
To determine the relative Ca
2+
 and CaM lobe preference of the two peptides, similar competition 
experiments were performed with the Ca
2+
-deficient CaM mutants (see section 3.3.1.2 for 
rationale and methodology and Figure 3.5, Table 3.2 for results). Strangely, both peptides show a 
discernible isotherm with CaM34, albeit with a greatly reduced (≥10µM) affinity (see Table 3.2). 
In fact, the Kd for IQc with CaM34 pre-bound to RN is nearly at the detection limit of the 
calorimeter. Regardless of which one is pre-bound first, both IQ and NSCaTE show a 1 : 1 
stoichiometry and extremely negative entropy (far more than either peptide with CaM34 alone), 
offset by very large gains in enthalpy (over threefold, in the case of IQcRN+CaM34). 
 
Figure 3.5: ITC competition experiments with CaM34 and L-type peptides. 
Left: IQc (200µM) into CaM34+RN (20µM each). Right: RN (200µM) into CaM34+IQc (20µM each). 
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As for CaM12, it appears that competition experiments do not follow the same straight-
forward logic as with wild type CaM. We expected that due to the higher affinity of the IQc 
peptide for CaM12, it would outcompete RN, especially given their 1 : 1 stoichiometry; however, 
no such trend was observed (Table 3.2). There is no apparent interaction when RN is titrated into 
CaM12+IQc, suggesting it is unable to displace IQ if it is bound to CaM12 first (data not shown). 
We were also unable to obtain an interpretable isotherm with IQc titrated into CaM12 pre-bound 
to RN. This is difficult to reconcile with the previous result (CaM12 with either peptide alone), 
and suggests that the interaction isn’t strictly mutually exclusive, nor is it mutually independent. 
On the other hand, it further casts doubt on whether the EF hand mutants are viable 
representations of an authentic CaM conformation for biophysical studies.  
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Figure 3.6: Representative ITC results of EF hand CaM mutants with L-type peptides. 
Top left: IQc (200µM) into CaM12 (20µM). Top right: RN (300µM) into CaM12 (25µM). Bottom  left: 
IQc (200µM) into CaM34 (20µM). Bottom  right: RN (300µM) into CaM34 (25µM).   
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Table 3.2: Summary of ITC results with the L-type calcium channel peptides and CaM 
(mutant and wild type).  
Titration conditions are described in methods. In all case CaM was in the cell and peptide was in the 
syringe; in competition experiments CaM was pre-bound to the indicated peptide at stoichiometric ratios 
(1 : 1).  Each experiment was performed at least twice to ensure consistent results. 
 
Experiment  N (sites) ± Kd (µM) ± ΔH 
(cal/mol) 
± ΔS (cal/ 
mol/deg) 
Single peptides with wild type CaM 
RN 2.09 0.030 1.16 0.290 -8340 163 -0.784 
LN  2.05 0.081 13.51 2.831 -5694 387 3.2 
IQc 0.92 0.016 0.09 0.039 -11230 305 -5.33 
LIQ1 0.91 0.000 0.02 0.005 -9455 163 3.69 
IQa 1.90 0.022 0.95 0.162 -9246 155 -3.43 
Competition with wild type CaM: 
IQc into RN 1.06 0.016 0.13 0.049 -10810 286 -4.76 
RN into IQc 0.99 0.018 1.78 0.253 -9700 233 -6.23 
RN into IQa  1.95 0.023 1.00 0.180 -9274 160 -3.64 
LN into IQc  1.10 0.075 13.79 2.321 -7476 717 -2.84 
LIQ1 into LN  0.91 0.010 0.02 0.008 -9398 214 3.82 
+CaM12 
RN 0.95 0.011 0.40 0.065 -10110 172 -4.6 
IQc 1.02 0.005 0.03 0.009 -9941 103 0.855 
+CaM34 
RN 1.03 0.058 20.49 2.482 -14200 1225 -26.2 
IQc 1.07 0.008 1.92 0.148 -17240 202 -31.7 
RN into Iqc 0.92 0.070 13.07 2.461 -18450 2217 -39.5 
IQc into RN 0.94 0.249 36.23 10.555 -35480 13170 -98.7 
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3.3.2 Qualitative NMR analysis 
HSQC spectra of wild type 
15
N CaM with various peptide combinations were obtained. While no 
structure determination has been achieved yet, several interesting observations can be made. The 
overlaid spectra for CaM and each peptide alone, or sequential titrations of one then the other as 
indicated reveal distinct binding conformations for a number of combinations. Future work and 
additional spectra will allow full assignment and possibly a solution structure for one or more of 
these complexes. 
Predictably, CaM’s amide peaks shift when bound to either IQ or NSCaTE (only mammalian 
peptides were analyzed), with a greater number of distinct shifts seen with the IQ peptide, 
suggesting a greater degree of conformational change, consistent with our gel-shift results 
(Chapter 2). There is little obvious structural change in CaM upon binding NSCaTE, and a few 
small but significant changes upon binding the IQ peptide (Figure 3.7). What is far more 
interesting, the structural changes observed with binding either IQ or NSCaTE alone are only 
partly represented when IQ is first pre-bound to CaM and then titrated with NSCaTE (one 
equivalent of each). There are distinct peaks in this spectrum (Figure 3.8, purple) not seen with 
either peptide + CaM or CaM alone, and some peaks that are missing (Figure 3.7). With a few 
additional experiments (likely a NOESY at the very least), enough data can be gathered to solve 
a structure and determine with certainty whether or not a simultaneous co-interaction between 
CaM and both peptides is actually occurring.  
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Figure 3.7: 
15
N HSQC of holo-CaM alone (red), CaM + IQc (green) and CaM + RN 
(purple).  
X axis is proton chemical shift, Y axis is nitrogen chemical shift (in ppm). One equivalent of IQc and two 
equivalents of RN were used in their respective spectra. 
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Figure 3.8: 
15
N HSQC of holo-CaM alone (red), CaM titrated with IQc (green), and CaM 
pre-bound to IQc and titrated with RN (purple).  
Same axes as Figure 3.7. One equivalent of IQc was used and two equivalents of RN; however there was 
no change after the 1 : 1 (RN : CaM-IQc) ratio was achieved. Arrows indicate peaks that may be of 
interest (not yet assigned). 
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3.4 Discussion 
In this chapter, we sought to obtain a biophysical perspective and a possible mechanistic insight 
into the regulatory effect of CaM on L-type channels via its interaction with the IQ and NSCaTE 
motifs. Using isothermal calorimetry, we find major differences between the CaM-binding 
affinities of IQ and NSCaTE, as well as between the mammalian vs. snail NSCaTE. What is 
more, both NSCaTEs bind CaM with a 2 : 1 stoichiometry, which was confirmed by a 
concurrently published study (Liu and Vogel, 2012), and consistent with our NMR results. The 
L-type IQ peptide binds CaM with a more typical 1 : 1 stoichiometry and sub-micromolar 
affinity.  
This stoichiometry persists when NSCaTE is titrated into CaM pre-bound to an IQ motif 
from a P/Q channel (α1A or CaV2.1), which suggests that its dominant positive effect on CDI 
seen in (Dick et al., 2008) is due to the much weaker affinity of the CaV2.1 IQ motif for CaM 
(the IQA peptide cannot displace NSCaTE from CaM based on our ITC data). Interestingly, IQA 
also possesses a 2 : 1 stoichiometry with CaM. Obviously, there is little physiological relevance 
to such ratios because it is highly unlikely that two large, membrane-associated proteins (> 
250kDa) can be cross-linked by a single CaM molecule. Instead, this suggests conformational 
diversity and a presence of more than one binding mode as well as competing interactions from 
multiple CaM-binding sites. In other words, the same peptide may bind CaM differently 
depending on its local conformational terrain, CaM’s Ca2+ occupancy and any competing 
interactions. In a fascinating twist, CaM’s stoichiometry with NSCaTE is altered to 1 : 1 when an 
L-type IQ peptide is first pre-bound to CaM (or vice versa), suggesting that CaM is capable of 
co-interaction with both regions of the channel. Results with Ca
2+
-deficient CaM mutants also 
lend support to this theory. CaM12 and CaM34 both have a 1:1 stoichiometry with NSCaTE. 
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CaM34 appears to have poor binding to either IQ or NSCaTE, and may not be a true 
representation of the N(2)-C(0)Ca
2+
-CaM conformation. CaM12 is even more perplexing, 
because, while it binds with high affinity to either IQ or NSCaTE peptide alone (with an altered 
1 : 1 stoichiometry for the latter), there is no discernible interaction when either peptide is pre-
bound to CaM12 first. This somewhat confounds the notion that NSCaTE’s role is as a ‘global’ 
CDI regulator via the N-lobe of CaM, since its affinity for CaM12 is at least 50-fold higher than 
CaM34.  
Unfortunately, CaM12 and CaM34 likely do not truly represent the Ca
2+
/apo-lobe 
conformational states they are intended to, even if they are close approximations for the non-
mutated lobes. To really dissect the lobe contributions, half-CaMs
20
 and Ca
2+
 concentrations 
reminiscent of those found in vivo need to be tested. Controlling Ca
2+
 concentrations in vitro 
typically involves the addition of a set concentration of CaCl2 and a chelator 
(EDTA/EGTA/BAPTA etc). Much to our chagrin, the IQ peptides form insoluble complexes 
with chelating agents, making the latter strategy inapplicable. Competition ITC experiments with 
half-CaMs will be a valid alternative strategy in future experiments, and several such 
experimental designs are proposed in Chapter 5. 
Other than the ITC experiments, we have no other direct evidence to support a co-
interaction between IQ/CaM/NSCaTE; several experiments were attempted, but not successful, 
including formaldehyde cross-linking and native gel filtration; see Appendix (Figure A.4-Figure 
A.7). Fluorescence labeling of IQ peptides to attempt FRET experiments using tryptophan and 
dansyl as FRET pairs was problematic (or FITC and dansyl, which was worse); fluorescent 
labels appear to interfere with the peptides’ ability to bind CaM. The interaction between 
NSCaTE and CaM may be too weak and/or transient to allow for capture of a stable complex 
                                                 
20
 Constructs containing only one lobe of CaM and optionally, the central linker. 
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using standard separation techniques, which has led one previous study to conclude the absence 
of such a co-interaction (Benmocha et al., 2009). Taking our ITC data into account, we disagree. 
Indeed, a very recent study by the same group which initially characterized NSCaTE predicts the 
same model we describe here (N-lobe + NSCaTE/ C-lobe + IQ), albeit with a different 
mechanistic explanation and no direct biophysical evidence (Johny et al., 2013).  
 NMR spectra of both peptides bound to CaM may not represent a single population of 
CaM conformations; e.g. a spectrum may represent a combination of CaM bound to one or the 
other peptide, with peaks from either conformation. However, the presence of unique peaks in 
the HSQC spectrum containing both IQ and NSCaTE bound to CaM is promising. Solving a 
structure of CaM with both peptides bound may be necessary to unequivocally prove that the IQ-
NSCaTE bridging by CaM does indeed occur, and should be the focus of future experiments.  
If such a co-interaction were indeed real, and in fact occured in vivo (which would be 
substantially more difficult to show explicitly), the implications on our understanding of L-type 
channel regulation by CaM would be far-reaching. On the one hand it is difficult envision a 
physical process that would bring the two termini of the channel molecule into close proximity – 
that is, within a distance spanned by one CaM molecule, or about 40Å. But on the other hand it is 
even less plausible that CaM binds to NSCaTE independently from the IQ motif, for which it has 
a much higher affinity, when CaM is presumably limiting in the cell and is found pre-associated 
with CaV C-termini (Persechini and Stemmer, 2002; Erickson et al., 2003; Liang et al., 2003; 
Sanabria et al., 2008; Evans et al., 2011). A more likely scenario is that CaM first binds to the IQ 
motif, and a structural change in the holo-channel then allows the N-terminus to come in close 
enough proximity to the IQ-CaM complex for NSCaTE to bind to CaM, most likely at the N-
lobe. Exactly what this process entails and how it affects the open probability or inactivation 
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gating is far from clear, but considering the major effects of NSCaTE on ‘global’ Ca2+ feedback 
(see section 2.3.3), it likely involves a rapid closing mechanism that has yet to be described. The 
2 : 1 stoichiometry is probably due to a reduced selectivity of NSCaTE for CaM lobes; e.g. the 
secondary site is more or less an artifact due to its similarity to the bona fide interaction site. It 
may also explain the positive transforming effect of NSCaTE on CaV2.2 (α1B) (Dick et al., 
2008), which normally does not have buffer-resistant (e.g. ‘local’) CDI, a seemingly 
contradictory result due to NSCaTE’s presumed interaction with the N-lobe of CaM, which is 
presumably involved in ‘global’ or buffer-sensitive CDI. The most plausible explanation is that 
in this case, NSCaTE is not just binding the N-lobe of CaM, but also the C-lobe of CaM, because 
it can outcompete the indigenous IQ motif of CaV2.2, and subsequently act as a ‘surrogate’ L-
type IQ motif and produce a similar effect on CDI. In this sense, it would be interesting to see if 
there is a docking site somewhere on the channel (either CaV1.2 or 2.2) for CaM lobes bound to 
either IQ or NSCaTE.  
Based on previous studies and our own cursory bioinformatics scan using the CaM 
binding site prediction database (Ivanina et al., 2000; Yap et al., 2000; Pitt et al., 2001; Stotz et 
al., 2004; Findeisen and Minor, 2009), the most likely candidate is the distal I-II linker in the L-
type channels (downstream of the AID). Indeed, a few basic ITC experiments
21
 we performed 
(Appendix, Figure A.8) reveal that these are capable of binding CaM with low micromolar 
affinity. The fact that other studies show an effect of I-II linker mutations on CDI (Findeisen and 
Minor, 2009), as well as a confirmed biophysical interaction between the I-II linker and CaM 
(Ivanina et al., 2000; Pitt et al., 2001; Zhou et al., 2005; Christel and Lee, 2012), points to a 
‘hinged-lid’ type mechanism by which CaM may be exerting its effects, similar to the process in 
                                                 
21
 We did not attempt to do any competition or co-interaction experiments, but that data could become valuable in 
the future 
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NaVs that involves the III-IV linker of this channel (see section 1.7.1). Therefore, a possible 
mechanistic model (see Figure 3.9) is that 1) apoCaM is tethered at a C-terminal site upstream of 
the IQ motif, but then 2) progressively recruits various other channel regions upon Ca
2+
-binding 
first to the C-lobe (‘local’ CDI, via the IQ motif), and then 3) the N-lobe binds to either IQ 
and/or 4) NSCaTE), cross-links these different domains and 5) docks them near the I-II linker in 
a configuration that restricts channel opening (or physically blocks it). Whether the ‘lid’ process 
is shared for the ‘local’ and ‘global’ versions of CDI, whether the β-subunit may be involved, or 
how it proceeds at all, is unclear. A number of experiments can be used to test this hypothesis 
(see last chapter). 
 
 
Figure 3.9: Proposed mechanistic model of L-type calcium channel modulation by 
calmodulin.  
Open circles indicate absent Ca
2+
 ions, filled indicate bound Ca
2+
. Not to scale. 
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3.5 Conclusions 
The main objective of this chapter was to characterize the details of the molecular interaction of 
CaM and NSCaTE, as well as any possible co-interaction with the IQ motif. Although no direct 
biophysical evidence
22
 was obtained to confirm such a co-interaction, we present convincing 
calorimetric evidence that this is indeed a possibility. Unusual NSCaTE: CaM stoichiometry (2 
:1) that was also confirmed by (Liu and Vogel, 2012) is replaced by a more physiological 1 : 1 
stoichiometry when CaM is first pre-bound to the IQ motif peptide (or vice versa). The relative 
affinities of snail and mammalian NSCaTE, and IQ and NSCaTE peptides differ by about an 
order of magnitude each. The IQ motifs of mammalian and snail L-type channels are actually 
remarkably conserved and bind CaM with a very similar affinity and thermodynamic parameters 
(enthalpy and entropy). The dominant effects on CDI seen by NSCaTE fusion to a non L-type 
channel (α1B or N-type) reported in the formative NSCaTE study (Dick et al., 2008) can most 
likely be explained by the relatively higher affinity of NSCaTE for CaM, which we observe with 
another non L-type peptide (α1A or P/Q type). The latter can be fully displaced from CaM when 
NSCaTE is titrated into the complex.  
Additionally, we see a strong preference of both IQ and NSCaTE peptides for the Ca
2+
-C-lobe of 
CaM, as evidenced by their much higher affinity for the CaM12 mutant over CaM34. None of the 
peptides were capable of binding apo-CaM, suggesting their effects are tied solely to active 
channel regulation (e.g. post-Ca
2+
-entry). 
  
                                                 
22
 Such as an actual molecular complex captured, or structure solved 
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Chapter 4: Characterization of a novel CaM-binding site in the I-II 
linker of low-voltage activated channels 
4.1 Introduction 
T-type (‘transient’ and ‘tiny’ currents, also low-voltage activated “LVA”) channels are 
distinct from the high voltage activated (CaV1.x and   CaV2.x) channel group in many ways. 
They are evolutionarily distant from other CaVs (see Chapter 1), less conserved among 
themselves (there are 3 splice isoforms in mammals), and have distinct and sometimes cryptic 
physiological roles (Perez-Reyes, 1999, 2003; Senatore and Spafford, 2010). Generally speaking, 
there is far less known about them than the HVA channels, which have been studied for much 
longer. While the LVAs are categorized as ‘calcium’ channels, their actual selectivity for Ca2+ 
(over Na
+
) is often much lower than HVA channels, in most cases by over an order of magnitude 
(PCa/PNa < 100, while for HVAs it is typically  ≈ 1000) (Shcheglovitov and Shuba, 2006). Their 
Ca
2+
/Ba
2+
 selectivity varies by isoform. Interestingly, the selectivity filter that in HVA channels 
contains an invariable E-E-E-E, is altered in T-type channels to E-E-D-D, while in NaVs, it is D-
E-K-A in the equivalent positions (Talavera et al., 2003; Yu and Catterall, 2003; Talavera and 
Nilius, 2006; Park et al., 2013). More interestingly, substitution of the T-type selectivity filter 
residues to the ‘consensus’ E-E-E-E does not strictly convert the T-type channels into a more 
Ca
2+
-selective channel, in fact, for CaV3.2 it greatly increases the Ca
2+
/Ba
2+
 selectivity, the 
opposite of what is expected. In contrast, replacing only the first aspartate actually reduces the 
Ca
2+
 selectivity; in all cases, DE (of E-E-D-D) mutations reduced macroscopic currents from 
wild type CaV3.2 (Park et al., 2013). There is also some evidence that these residues not only 
control selectivity, but also the gating properties (depolarization of the I-V curve and slope 
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increase of activation) as well as sensitivity to protonation (Talavera et al., 2003; Talavera and 
Nilius, 2006).    
In most cells that express them, T-type channels act as ‘first responders’, opening at sub 
threshold voltages (-65 to -30mV, as opposed to the L-type -20 to +20 mV), and inactivating 
rapidly before the HVA channels activate. The overlap of voltage-dependence for activation and 
inactivation in T-type channels causes a ‘window’ current of Ca2+, thus allowing Ca2+ entry at 
basal levels (Cain and Snutch, 2010). In some neurons, the window current is sufficient to 
generate action potentials (‘burst firing’), such that the T-type channels in these cells contribute 
to their pacemaker activity (Perez-Reyes, 2003). Furthermore, inactivation rate and recovery are 
often dictated by preceding membrane potential changes, which suggests that these channels 
have a role in short-term synaptic plasticity (Cain and Snutch, 2010). Mutations in T-type 
channels are often associated with certain epilepsy disorders (Singh et al., 2007). Due to their 
ubiquity and importance, these channels present a new promising field for pharmacological 
development (Kochegarov, 2003), as well as basic biophysical and biochemical research.  
There is not much known about the regulatory mechanisms controlling the gating of T-
type channels; few unique conserved motifs have been described. Like other CaVs, there is a 
great deal of splice variation even within a single T-type isoform (some genes contain over 30 
exons) and several of these have highly variable biophysical effects (Perez-Reyes, 1999; 
Senatore and Spafford, 2012). Electrophysiological recording of T-type channels presents a 
challenge as well, since they are rather quick to inactivate, share a common activation voltage 
range with TRPs, HCNs and other channels, and lack the many pharmacological tools (specific 
channel blockers) that have been developed for HVAs.  
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A common approach for investigating the role of specific channel domains in their 
regulation involves the use of chimeric channels in which a signature region (e.g. the IQ motif, 
AID, I-II or II-III domain linkers, etc.) from the more commonly studied CaV1.x or CaV2.x 
channels is used to replace the native corresponding domains in a T-type channel. Such an 
approach has revealed some interesting results, for example the distinct role of the domain II S4 
segment in activation (Talavera and Nilius, 2006). However it is best to interpret such results 
with caution. NSCaTE is an excellent case in point: its effects on CaV2.2 (N-type, or α1B) 
channels, when fused as a chimera, are very striking, yet bear no physiological relevance or say 
much about the native regulation of the channel other than that its own IQ motif is dissimilar in 
its regulatory mechanisms from the L-type IQ motif. Thus, to really tease apart the contribution 
of the different domains, site-directed mutagenesis and isolated biophysical studies have to be 
undertaken with the channel’s own domains.  
One of the more interesting findings of the chimeric studies was that transferring the I-II 
linker of a CaV2.2 into CaV3.1 (α1G) channel, instead of conferring β-subunit regulation on the 
latter, presumably via AID, actually generated an ultra-low voltage gated channel (Perez-Reyes, 
2003, 2010; Arias et al., 2005). More generally, it has been observed that several mutations in 
the I-II linker of CaV3.2 (α1H) are often associated with childhood absence epilepsy (Khosravani 
et al., 2004), and those of CaV3.1 have been implicated in idiopathic generalized epilepsy (Singh 
et al., 2007). The proximal I-II linker is a putative helix-loop-helix motif, with the second helix 
being crucial to the gating/activation properties of the channel (Perez-Reyes, 2010); without it, 
the channel is able to open at more negative voltages. This gating brake is highly conserved 
across all three channel isoforms, and, more interestingly, even shows a high degree of similarity 
in its single Lymnaea homolog (LCaV3) (see Figure 4.1). Previous work in Dr. Spafford’s lab has 
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included a detailed characterization of the Lymnaea T-type homologue, which shows some 
distinct (and some similar) characteristics to its mammalian counterparts (Senatore and Spafford, 
2010, 2012).  
 
 
Figure 4.1: Alignment of the gating brake in human and Lymnaea T-type I-II linker.  
(Only the second helix is shown). Predicted CaM-binding region is in yellow. 
 
So far, no direct Ca
2+
-specific regulation such as CDI or CDF has been shown for T-type 
channels. Whether this is due to a genuine lack of such effects, or simply a limitation associated 
with recording of these channels, which (in)activate very rapidly, is uncertain. Several studies 
point to G-protein and tyrosine kinase (CaMKII in particular) regulation of CaV3.2, the latter 
being localized to the II-III linker (Welsby et al., 2003; Talavera and Nilius, 2006). T-type 
channels are thought to be monomeric; that is, they require no accessory subunits for efficient 
expression and activity (Walsh et al., 2009). They also lack a cognate IQ motif and EF hand in 
their C-termini, in contrast to HVAs. Since HVAs are also regulated by CaMKII
23
, we sought to 
determine whether a previously uncharacterized CaM-binding site may be involved in the 
interaction of CaM/CaMKII and CaV3 channels, or otherwise linked to their regulation.  
We expected to find a cryptic CaM-binding site, possibly in the C-terminus or the II-III 
linker of CaV3.2, with which CaMKII is thought to associate, so we submitted the entire protein 
sequence to the CaM binding site prediction tool (see section 2.2.3) (Yap et al., 2000). To our 
                                                 
23
 Directly in the case of CaV2.1 and indirectly via the phosphorylation of the β2a subunit of associated CaV1.2 or 
1.3 (Grueter et al., 2006; Jiang et al., 2008) 
CaV3.1 --SCYEELLKYLVYILRKAARRLAQV--------SRAAGVRVGLLSSPAP 
CaV3.2 ---CYEELLKYVGHIFRKVKRRSLRL--------YARWQSRWRKKV---- 
CaV3.3 PGDCYEEIFQYVCHILRKAKRRALGL--------YQALQSR-RQALGPE- 
LCaV3  PGGYYSELLKLVAQVYRRVKRKVIKTRGLQKINPEKSLSLR-RKKSKKKG 
           *.*::: :  : *:. *: *                *    
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greatest surprise, we found that the putative gating brake region of all T-type channels is a 
strongly predicted CaM binding site. This site directly spans the second helix of the helix-loop-
helix motif of the proximal I-II linker in all 3 mammalian as well as the Lymnaea CaV3 channels 
(Figure 4.1). Skeptical, we first obtained the LCaV3 I-II linker peptide (from Genscript: 
YSELLKLVAQVYRRVKRKVIKTYYKT) and tested it for binding to CaM. To our even 
greater surprise, we found it to bind CaM with nanomolar affinity and with a strongly positive 
enthalpy. Subsequently, we obtained linker peptides corresponding to the gating brake of the 
three mammalian isoforms, as well as a α1H (CaV3.2) linker mutant in which the helical 
structure is disrupted by several Pro-Gly residues in place of the native sequence. We 
characterized all these peptides using similar methods as in Chapter 2 & 3. There are interesting 
isoform specific differences but also similarities across all isoforms, which are relevant to the 
physiological characteristics of the channels and may have important biophysical and 
pharmacological implications. These findings will fundamentally alter the knowledge base of T-
type channel regulation. 
4.2 Methods 
Table 4.1: T-type gating brake peptides and their parameters.  
All peptides were synthesized by Genscript (specified to >98% purity, MS and HPLC verified), made up 
to 1mM stocks in MQ water shortly before use. 
Name Source Sequence MW pI 
LCaV3 Lymnaea T-type I-II 
linker gating brake 
YSELLKLVAQVYRRVKRKVIKTYYKT 3246.9 10.29 
CaV3.1(G) human α1G I-II linker 
GB 
YEELLKYLVYILRKAARRLAQVSRAA 3094.7 10.16 
CaV3.2(H) human α1H GB YEELLKYVGHIFRKVKRRSLRLYARW 3381.03 10.61 
CaV3.3(I) human α1I GB YEEIFQYVCHILRKAKRRALGLYQAL 3182.76 9.52 
CaV3.2mut mutant human α1G GB YEELLKPGPGPGRKVKRRSLRLYARW 3126.71 11.0 
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4.2.1 Gel shift mobility assays 
The assays were performed in both native conditions and with 4M urea (see Chapter 2 Methods 
section). Other than urea, the buffer and gel composition for the experiments were identical. For 
Ca
2+
-CaM experiments, 1mM CaCl2 was used in the gel and 0.1mM CaCl2 in the running buffer. 
For EDTA experiments, 0.1 mM EDTA was used in all solutions. As before, all experiments 
were run with ice bath and cooler jacketing set to 4ºC, at 120-200V. Pre-incubation buffer for all 
experiments was 10mM Tris-Cl (pH 7.5) with 0.1 mM CaCl2 or EDTA (no urea).  
4.2.2 NMR Spectroscopy 
Identical protocol and CaM/peptide concentrations were used as in Chapter 3 (Section 3.2.3).   
4.2.3 Spectropolarimetry 
The same JASCO-715 spectropolarimeter was used as in Chapter 2. Scans were done at 
50nm/min, over 250-190nm range with 1s response time, 1nm bandwidth and 16-25 
accumulations depending on signal quality. Buffer composition for LCaV3 and α1H mutant 
linkers was PBS (10mM sodium phosphate pH 7.3, 137mM NaCl, 2mM KH2PO4, and 2.7 mM 
KCl). The other linker peptides were characterized in low ionic strength buffers due to severe 
aggregation issues in PBS; for these 3 peptides (CaV3.1-3), 10mM HEPES (pH 7) was used. In 
all cases a 0.1cm quartz cuvette (Hellma) was used. CaM binding experiments were performed 
by adding increments of stock (1mM) peptide to the same cuvette containing 10 µM CaM (300 
µL). Subsequent scans would then have the CaM-only trace subtracted and be corrected for total 
peptide concentration, smoothed, converted to MRE units and exported to .csv format. 
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4.2.4 Isothermal Calorimetry 
Due to severe aggregation issues with some of the mammalian linker peptides in any amount of 
salt, we had to use a low ionic strength (10mM HEPES, pH 7.0, 0.1mM CaCl2) buffer in all 
cases. All the experiments were performed at 25ºC, with 1000rpm stirring, 5µcal/s reference 
power and high feedback gain. Injection conditions were typically 1.2-1.8µL each (22-28 
injections) and cell/syringe concentrations optimized for individual experiments (c value 
between 10 and 1000) (Turnbull and Daranas, 2003; Freiburger et al., 2009; Broecker et al., 
2011), but typically between 10 and 50 µM for cell and 100 to 500 µM for the syringe. 
Periodically, water-water and buffer-buffer controls were conducted to ensure the syringe and 
cell were clean and in good working order. Most of the endothermic titrations had to be baseline 
subtracted against the final injection heats (end-weighted auto-baseline or manual baseline for 
CaV3.3 to correct for the heat of dilution) due to fitting artifacts from the isotherm passing 
through the x-axis. Baseline-corrected curves were all fitted to a one-set-of-sites model in 
Originlab with satisfactory results.  
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4.3 Results 
4.3.1 Gel shift mobility assays 
We found urea to have an attenuating effect on the mobility shifts with all peptides (c.f. left and 
right panels of Figure 4.2), although LCaV3 peptide was least affected. Omitting urea in the 
experiment allowed a very weak (unobservable in the presence of urea) gel shift with α1I 
(CaV3.3) to be observed (bottom right panel). It also allowed for a more complete shift with α1H 
(CaV3.2) and α1G (CaV3.1). No shift was observed under any conditions with the mutant α1H 
peptide. No shift was observed with any of the peptides in the presence of EDTA. 
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Figure 4.2: T-type gating brake peptide gel shift results with Ca
2+
-CaM.  
Left side has urea present, right side is urea-free gels (Coomassie stained). A,B – LCaV3. C,D – α1G. E,F 
– α1H. G,H – α1H mutant. I,J – α1I. See methods for peptide sequences and properties. EDTA gels are 
not shown (none of the EDTA gels exhibited any shift; for example, see panel G and H and I). First lane 
in each gel is CaM alone; subsequent lanes have increasing amounts of indicated peptide (ratios: 0.5, 1, 
1.5, 2, 4, 8 molar excess of peptide).  
 
4.3.2 NMR: 
Only the Lymnaea gating brake peptide was analyzed by NMR due to scheduling and time 
constraints. The results are consistent with the gel shift and ITC results in that a 1 : 1 
stoichiometry was observed. There are several noticeable peak shifts in the 
15
N HSQC spectrum 
+UREA  -UREA 
0     0.5       1        1.5        2         4         8x 0     0.5    1     1.5    2      4      8x    
0     0.5      1       1.5       2       4      8x    
0    0.5      1        1.5        2        4       8x    
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of Ca
2+
-CaM bound to LCaV3 gating brake peptide, but the majority of the structure is 
unchanged (Figure 4.3). A complete structure solution will require additional types of 
experiments. Peptide structure solution will require a labeled peptide and several more NMR 
spectra. 
 
 
Figure 4.3: NMR results with LCaV3 gating brake peptide and Ca
2+
-CaM.  
X axis is proton chemical shift, Y axis is nitrogen chemical shift (in ppm). CaM alone is red; 
peptide+CaM is green. Backbone assignments are in progress. 
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4.3.3 Circular Dichroism: 
Secondary structure calculation (with the software algorithms from Chapter 2, e.g. K2D and 
SOMCD) was not feasible with many of the peptides with largely unstructured or partially 
structured spectra. The two algorithms also gave widely divergent results, with high levels of 
error for several spectra. We therefore forgo a detailed quantitative analysis of the secondary 
structure in this chapter.  
Qualitatively speaking, CaV3.1 had the most α-helical secondary structure of all the linker 
peptides (Figure 4.5), while the mutant CaV3.2 had virtually none (Figure 4.7). All other peptides 
were able to adopt at least some degree of α-helix upon TFE addition and CaM binding (Figure 
4.4-Figure 4.8). In most cases, the binding of each peptide to CaM is comparable to adding a low 
concentration of TFE.  
 
Figure 4.4: LCaV3 gating brake peptide CD spectra.  
20µM of wild type CaM in the cuvette was used; to this, increasing amounts of stock (1mM) peptide were 
added (1.5µL increments into a 300µL total volume, corresponding to 5µM concentration steps). From 
each peptide+CaM spectrum, the CaM-alone spectrum was subtracted, result converted to MRE and 
smoothed. For TFE experiments, 50µM peptide in PBS buffer was used (baseline corrected against PBS 
as background). Lymnaea gating brake peptide has little to no intrinsic secondary structure, but becomes 
progressively more α-helical with increasing amounts of added TFE. Adding a stoichiometric amount of 
CaM elicits modest structural change, in comparison.  
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Figure 4.5: CaV3.1 (α1G) secondary structure is primarily α-helical in solution.  
No CaM titrations were performed because the peptide is already α-helical (with little effect even at high 
%TFE), and would not provide meaningful analysis. Methods are the same as in Figure 4.4. 
 
 
Figure 4.6: CaV3.2 (α1H) gating brake peptide secondary structure is strongly affected by 
TFE and somewhat less by CaM.  
10µM CaM was used in the cuvette; 10mM HEPES as buffer. Methods are the same as in Figure 4.4. 
Similar to Lymnaea gating brake, human α1H has little to no intrinsic secondary structure, but is strongly 
affected by the addition of TFE, and substantially less by the addition of CaM. 
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Figure 4.7: Mutant CaV3.2 gating brake peptide has very little secondary structure.  
Same methods as Figure 4.6. The large ‘peaks’ below 200nm are likely subtraction/noise artifacts. This 
peptide has little to no α-helical propensity, owing to its Pro substitutions. 
 
 
 
Figure 4.8: CaV3.3 gating brake peptide secondary structure is strongly affected by both 
CaM and TFE.  
Human α1I is similar to α1H and Lymnaea gating brake peptides in that there is almost no intrinsic 
structure present, but it exhibits profound increase in α-helical content upon CaM and TFE addition. Same 
methods as in Figure 4.6. 40% TFE trace was not obtained due to peptide aggregation. 
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4.3.4 ITC 
The relative affinities of each gating brake peptide are summarized in Table 4.2 
 
Figure 4.9: Representative isotherms for the wild type CaM and gating brake peptide 
titrations.  
A: LCaV3. B: α1G (CaV3.1). C: α1H (CaV3.2). D: α1I (CaV3.3). All titrations were done in HEPES 10mM 
(pH 7) with 0.5mM CaCl2, with 200µM peptide (syringe) and 20µM CaM (cell). CaV3.3 had to be 
baseline corrected against the heat of dilution (to make all Y-values negative) in order to be fitted. 
A B 
C 
D 
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Wild type CaM was found to bind to the gating brake of LCaV3 with ~nanomolar affinity, the 
highest of any peptide characterized so far in this dissertation (Table 4.2 and Figure 4.9). The 
human isoforms had somewhat lower affinities; as well, the CaV3.2 isoform had an exothermic 
profile in contrast to CaV3.1 and LCaV3. CaV3.3 was found to aggregate at high concentrations 
(>200µM). At lower concentrations, a negative isotherm (endothermic) was observed but the 
heats of dilution have a high negative enthalpy (exothermic), which masks the interaction upon 
first inspection. Integration and baseline adjustment resulted in a more reproducible endothermic 
curve; however it was not easily fitted to a one-sites model and the SEM values are quite high.  
Table 4.2: Summary of ITC results with gating brake peptides.  
Each experiment was performed in at least triplicate. 
Experiment N ± Kd (µM) ± ΔH 
(cal/mol) 
± ΔS (cal/ 
mol/deg) 
 Wild type CaM with gating brake peptides 
LCaV3 0.989 0.00688 0.010 0.004 7245 108 60.6 
CaV3.1 0.992 0.00682 0.036 0.011 7703 105 59.9 
CaV3.2 1.15 0.00577 0.196 0.030 -15880 140 -22.6 
CaV3.3 1.25 0.0285 0.383 0.204 1576 58 34.6 
        
 LCaV3 gating brake with EF hand CaMs 
CaM12 1.08 0.0121 0.102 0.031 -7217 145 7.8 
CaM34  N/A 
CaM1234 0.949 0.109 4.329 3.561 -6084 964 4.2 
 
CaM34 does not appear to bind the LCaV3 gating brake, whereas CaM1234 clearly shows an 
interaction; these experiments were repeated several times to confirm this. The CaM1234 isotherm 
was strong but not typical for a one-set-of-sites interaction; in this case the heat of dilution is 
endothermic while the interaction appears exothermic, obscuring the analysis greatly. The data 
had to be baseline-corrected to negative values in order to be fitted.  
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Both CaM1234 and CaM12 were exothermic and had a weaker interaction with LCaV3 
gating brake than wild type CaM (Figure 4.10), with the overall order: wtCaM 
>CaM12>>CaM1234. Due to limits on time and equipment, only the Lymnaea gating brake peptide 
was analyzed with the EF hand CaM mutants; additional work is ongoing.  
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Figure 4.10: EF hand CaM mutants with LCaV3 gating brake peptide.  
A) Wild type CaM with LCaV3 (for comparison), including raw data (top panel). B) CaM12. C) LCaV3 
titrated into CaM34. Raw data in the top panel (for a sense of scale) and integrated data in the bottom panel 
D) CaM1234. Same methodology as Figure 4.9 
A B 
C D 
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4.4 Discussion: 
In this chapter, we sought to characterize the gating brake of LVA channels (Lymnaea CaV3, 
human CaV3.1, 3.2 and 3.3, as well as a mutant of CaV3.2). Much to our surprise, LCaV3 gating 
brake peptide has the highest affinity for Ca
2+
-CaM, followed by α1G (CaV3.1), α1H (CaV3.2) 
and finally α1I (CaV3.3). The latter has serious aggregation issues due to its hydrophobicity and 
did not produce a reliable isotherm with ITC, although it does have a weak but detectable gel 
shift effect on CaM in native PAGE. Urea attenuates the gel shift effects of the mammalian 
peptides, but does not appear to affect the interaction of LCaV3 gating brake and CaM. As a 
chaotropic agent, urea likely disrupts both the helical conformational transition of the peptides 
and destabilizes the hydrophobic interactions between CaM and peptide.  
An extremely puzzling observation in our ITC results was that, while having similar 
affinity, the two mammalian isoform peptides (α1G and α1H) have opposite signs for their 
enthalpy; i.e. the former is endothermic, like LCaV3, and the latter is exothermic, like all the 
previously described L-type channel peptides. Enthalpy changes usually accompany electrostatic 
and hydrogen bond formation, while entropy changes account for solvation and van der Waals 
effects (Muralidhara et al., 2007; Freyer and Lewis, 2008). Considering that only α1G gating 
brake peptide is significantly structured when free in solution, we can rule out helix formation as 
a factor contributing to this difference. Thus, while being fairly similar in sequence and 
physiochemical properties (i.e. size, isoelectric point, hydrophobicity), the different isoforms 
have rather distinct biophysical interaction parameters with CaM. It is clear that α1G has a high 
number of Ala residues, which are known for their alpha-helical propensity, while the other 
peptides are unstructured when free in solution, but easily converted to an alpha-helix by 
addition of TFE or somewhat less by CaM. Interestingly, the mutation of α1H with a 6-residue 
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replacement to the helix-disrupting Pro-Gly(x3) motif completely abolishes any α-helical 
propensity this motif has, and renders it insensitive to the addition of CaM. We were also unable 
to detect any binding of the CaV3.2 mutant peptide to CaM by ITC, and it failed to display a gel 
shift in either urea+ or urea-free PAGE. While secondary structure most definitely has a role in 
CaM binding, it is not strictly indicative of strong CaM binding, since LCaV3 has a much higher 
CaM affinity and does not form an α-helix on its own. Admittedly, the large PGPGPG 
substitution in α1H mutant peptide has other effects besides helical disruption. It would be 
interesting to see if milder helix-disrupting mutations, such as single Pro substitutions in key 
residues, or AG mutations in α1G or LCaV3 gating brake peptides would affect their affinity 
for CaM. Unfortunately, there was a large standard error in the association constant for CaV3.3 
(α1I) due to aggregation issues at high peptide concentrations (300-500µM). Lower 
concentrations of peptide (up to 300µM) did produce an isotherm, but it was not easily fitted, 
and the noise level is high due to the opposite signs for the binding and dilution enthalpies. Of 
course, it is also possible that the CaM binding site for this isoform is slightly different than the 
sequence contained within our synthetic peptide, which could be subject of a future study. 
Another highly interesting observation is that the gating brake peptide, at least the one 
from Lymnaea, appears to bind CaM1234, as well as CaM12, but not CaM34. The apparent 
interaction of LCaV3 gating brake with apo-CaM is completely unexpected.  
All of the EF hand CaM mutants produce exothermic peaks, in contrast to wild type 
CaM. CaM1234 transitions to endothermic peaks post-equivalence, likely a contribution of the 
heats of dilution of peptide, but the overall shape of the curve is exothermic. Whether this is 
indicative of multiple binding conformations (e.g. apo versus holo CaM) with different affinities 
or some kind of Ca
2+
 specific effect is unclear. This could potentially be due to the mutant CaM 
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not being representative of ‘real’ apo-CaM (much like the individual lobe mutants), since the 
gel-shift results fail to show altered CaM mobility with any of the gating brake peptides in the 
presence of EDTA. Unfortunately, the gating brake peptides are also subject to aggregation with 
EDTA, much like the IQ peptides, and thus we were unable to verify this with ITC (the 
concentrations used in gel shift studies are substantially lower). There is also a possibility that 
CaM34 is ultimately an ‘impossible’ CaM conformation for peptides to effectively interact with, 
as there are few cases of native N(2)-C(0) Ca
2+
 CaM conformations (Schumacher et al., 2001). 
This might mean that the cooperativity for a conformational change leading to holo-CaM’s open 
conformation is reliant on Ca
2+
 binding to the C-lobe (Linse et al., 1991; Ikura, 1996; Vetter and 
Leclerc, 2003; Yamniuk and Vogel, 2004; Wu et al., 2012). Thus, the gating brake might be pre-
associating to apo-CaM, and subsequently ‘locking’ it on when Ca2+ binds. A series of pull-down 
studies with CaM and mutants may be needed to verify this theory (e.g. using immobilized CaM 
or apoCaM as ‘bait’ for isolating whole T-type channels from whole or partially purified cell 
lysates).  
 Regrettably, we lack an experimental electro-physiological confirmation of our 
biochemistry results; T-type channels are notoriously hard to clone (Senatore and Spafford, 
2010). There are some interesting I-II linker studies with mammalian T-type channels, which we 
may attempt to replicate with LCaV3 in the future, as well as additional CaM-mutant experiments 
are outlined in the following chapter. There has only been one study suggesting a direct 
modulation of T-type channels by CaM  through the use of CaM synthetic antagonists, namely 
W7 and trifluoroperazine, which irreversibly altered the biophysical parameters of these channels 
and reduced the whole cell macroscopic currents in mouse spermatogenic cells (López-González 
et al., 2001). However, the exact molecular details for this effect have not been described. 
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Proximal (near IIS6) linker deletion strongly affects channel gating parameters 
(hyperpolarization of the I-V curve), but these residues precede the second helix of the cognate 
gating brake where CaM is predicted to bind, so it is unclear what exact role CaM may have on 
the mechanics of this channel. These effects are reminiscent of the effects of the IIS6-AID rigid 
helix in β-subunit regulation of HVAs, but there is no such effect known in LVAs. It is possible 
that the gating brake may have distinct roles for the two helices in its ‘helix-loop-helix’ motif, 
suggested by previous (unpublished, Dr. Adriano Senatore) work involving the deletion of distal 
YYKT residues, i.e. the last 4 residues in the Lymnaea gating brake peptide. There is very little 
biophysical data to describe the molecular effects of the gating brake or how it could produce the 
varying results in the three different isoforms, and only one relatively modern ‘gating brake 
model’ exists (Perez-Reyes, 2010), which places this motif in close contact to the voltage sensor 
paddle region (S4 helix and the S4-S5 linker coupling it to the activation machinery). As we are 
the first group to report the binding of CaM to this motif, there is little evidence to base our 
physiological model on. Tentatively, we predict that the CaM interaction is involved in Ca
2+
-
dependent effects on gating in these channels; this can be tested by various CaM mutant 
experiments which we will outline in the next Chapter.    
 
4.5 Conclusions: 
The main objective of this chapter was to characterize a novel CaM-binding site in the I-
II linker of both mammalian and snail T-type channels. This motif is actually part of a previously 
described ‘gating brake’ regulatory region in these channels. There is considerable difference in 
the binding parameters for the three mammalian and the one snail isoform peptides, both in their 
affinity and thermodynamics. The degree of amino acid conservation is lower for the CaM-
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binding sequence than the helix preceding it (Perez-Reyes, 2010). More importantly, the snail 
isoform, at least, is capable of binding apo-CaM, and may serve as a CaM tethering site in vivo. 
A solution structure of both Ca
2+
 replete and deficient CaMs bound to this peptide would be a 
promising future project. 
We propose that this motif is a novel, CaM-centric regulatory mechanism that may affect 
gating properties of these channels in response to Ca
2+
 entry.   
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Chapter 5: Conclusions, contributions, and future directions. 
5.1 Overview and Summary 
The general goals of this dissertation have evolved as a result of new knowledge and concurrent 
studies that have been published in the course of its completion. At the outset, the main goal was 
the development of a generalized, universal model of voltage-gated calcium channel (VGCC) 
regulation by calmodulin (CaM), in both molecular and physiological terms. Over the course of 
several years and hundreds of experiments, PubMed queries and literature searches, it has 
become clear that such a generalized model is extremely unlikely. The level of conservation of 
the putative regulatory sites among the different groups of VGCCs (CaV1, 2 and 3) is meager at 
best, and their biophysical parameters may vary widely, in many cases even within a group 
(Catterall et al., 1988; Catterall, 2000; Hille, 2001; Liang et al., 2003; Perez-Reyes, 2003; Van 
Petegem et al., 2005; Zamponi, 2005; Talavera and Nilius, 2006; Dunlap, 2007; Ohrtman et al., 
2008; Tuckwell, 2012; Christel and Lee, 2012; Senatore et al., 2012). Thus, a detailed molecular 
mechanism will have to be constructed independently for each distinct group or even isoform – 
an undoubtedly gargantuan scientific effort. Thankfully, certain regulatory motifs within groups, 
and the regulation that goes with them, appear to have been evolutionarily conserved from even 
before the isoform diversification seen in vertebrate channels. Isolating these elements in simple 
organisms (like Lymnaea) will lend important clues to these elements’ roles and modes of action.  
The IQ and NSCaTE motifs are prime examples of such elements, albeit the ubiquity and 
importance of the latter is still far from clear. The IQ motif is mostly synonymous with L-type 
channels; every metazoan genome containing an L-type channel sequence contains at least one 
exon with this motif (Taiakina et al., 2013). Its structure when bound to holo-CaM and many of 
the biophysical parameters are known. NSCaTE, in contrast, is more elusive and far less 
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conserved; possibly having arisen more than once through convergent evolution, although it is 
conspicuously absent in some invertebrates (see section 2.3.1). Other than basic biophysical 
properties of its interaction with CaM and some electrophysiology studies with missense and 
deletion mutants, not much is known about it, despite having been described over a decade ago 
(Ivanina et al., 2000). More recent research, including our own, points to a possible co-
interaction between NSCaTE, IQ and CaM (Johny et al., 2013), although any direct biophysical 
proof, such as a pull-down or two-hybrid screen, is yet to be reported. More importantly, any 
concept of how CaM binding to one or both of these motifs actually proceeds to channel 
inactivation is entirely unknown. There have been numerous attempts to answer this question, 
through mutagenesis, labeling studies, chimeric constructs, homology modeling with molecular 
dynamics simulations and so on, but we are  still no closer to a three-dimensional picture of how 
these channels inactivate in response to Ca
2+
 than when the phenomenon was first described 
(Brehm and Eckert, 1978). The major roadblock has been the inability to obtain a high resolution 
structure of an entire channel, due to the size limitations of NMR and solubility issues with 
crystallography. The model we can propose involves the construction of a very modest hierarchy 
of ‘if-then’ propositions based on all the different pieces of experimental evidence from 
numerous studies over the years. Below is an attempt at such a construct, where I also point out 
anywhere we have made contributions throughout this thesis, as well as how additional insights 
can be gained. 
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Figure 5.1: Summary of key channel motifs described/studied in this dissertation.  
Not to scale. 1) NSCaTE (L-type channels only, Chapter 2-3). 2) α-interaction domain (AID) in HVA 
channels OR the gating brake in T-type channels (Chapter 4). 3) Previously identified CaM-binding site 
in L-type channels (possible docking site for an IQ-CaM-NSCaTE complex, see sections 5.6.3 and 5.6.4, 
and also 3.4 and Figure 3.9). 4) IQ motif (HVA channels, Chapter 2-3 and relevant references). Adapted 
from (Rajakulendran et al., 2012) 
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5.2 CaM regulation of L-type channels: 
5.2.1 Inactivation as a concept 
Insofar as CaM-dependent, and therefore, Ca
2+
-dependent, regulation is observed, HVA channels 
are the best studied. They have been shown to have robust CDI and VDI, with the latter being 
strongly modulated by various exogenous factors involving phosphorylation and subunit 
composition, e.g. the β isoform, and the former being solely orchestrated by CaM24 and Ca2+ (Pitt 
et al., 2001; Dafi et al., 2004; Findlay, 2004; Cens et al., 2006; Barrett and Tsien, 2008; Minor 
and Findeisen, 2010; Tadross et al., 2010; Tekmen and Gleason, 2010; Poomvanicha et al., 2011; 
Tuckwell, 2012). Nonetheless, actual molecular details of these regulatory effects are less than 
clear. First and foremost, there is a major question of whether VDI and CDI share a common 
molecular endpoint – either via pore occlusion by a cytoplasmic channel motif akin to the 
‘hinged lid’ mechanism of NaVs, or pore collapse such as that seen in KcsA (Yellen, 1998). So 
far, most of the experimental evidence points to an allosteric (hinged lid) mechanism, although a 
combination of different pathways is possible (see Section 2.4). It is also likely that some of 
these mechanisms share certain molecular features, as well as have their own distinct ones 
(Findlay, 2004; Cens et al., 2006; Barrett and Tsien, 2008; Findeisen and Minor, 2009; Minor 
and Findeisen, 2010; Tadross et al., 2010). The majority of evidence supporting the hinged-lid 
model comes from mutagenesis and chimeric studies involving the I-II linker of L-type channels 
and its interaction elements with the β-subunits. There is also evidence for a CaM interaction in a 
distal region of the I-II linker (Findeisen and Minor, 2009; Oz et al., 2011; Christel and Lee, 
2012) as well as mutagenesis effects of some of these regions on CDI, a strong indication that 
                                                 
24
 While Ca
2+
-CaM (and the integrity of its binding sites, e.g. the IQ motif and neighboring sequences) is essential 
for CDI, several other motifs were shown to be essential for CDI, such as the EF hand. Other regions have more 
modest effects, e.g. the I-II linker (possibly through a common mechanism with VDI) and more recently, NSCaTE.  
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there is yet a third channel motif in the CaV-CaM interactome. One of the key goals of future 
studies in this field should be to isolate and characterize this interaction and its interplay with the 
other regulatory elements of these channels. 
5.2.2 Identification of apoCaM pre-association site(s): 
Shortly after CaM was identified as the principal factor in CDI (Peterson et al., 1999) and the 
isolation of the IQ motif as the cognate effector sequence (Peterson et al., 2000; Zühlke et al., 
2000; Pitt et al., 2001), it was also noted that apo-CaM is able to bind and pre-associate with 
several regions in the C-terminus of L-type channels (Erickson et al., 2001, 2003; Tang et al., 
2003; Kim et al., 2004a). It was noted that while the IQ motif was essential to CDI, it did not 
bind apo-CaM with strong affinity; however, it did appear to increase the Ca
2+
 affinity of CaM’s 
C-lobe (Tang et al., 2003; Halling et al., 2009). Despite extensive research efforts, so far there is 
still no clear picture of what constitutes an apo-CaM tethering site in CaV1 channels, although it 
has been narrowed down to a few discontiguous sites in the proximal C-terminus surrounding the 
IQ motif. These may form a complex tertiary structure that houses apo-CaM in the resting state 
of the channel, and rearranges significantly upon channel opening and Ca
2+
 entry and binding to 
CaM, at which point Ca
2+
(full or partial)-CaM also relocates to a higher affinity site on the 
channel and initiates an effector cascade. A logical experiment would be to substitute the native 
IQ motif of an L-type channel with one that binds apo-CaM (e.g. one from a sodium channel, or 
myosin) and note the effects on CDI.  
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5.2.3 CaM regulatory elements and their dynamic interplay 
5.2.3.1 NSCaTE, CaM and the ‘local/global’ model. 
The canonical (CaV1.2 and CaV1.3) L-type channels
25
 show robust CDI even in high internal 
buffering (10 mM BAPTA) (Budde et al., 2002), which is believed to proceed as a result of Ca
2+
 
binding to the C-lobe of CaM due to the transient elevation in ‘local’ Ca2+ immediately 
surrounding the pore vicinity (Tadross et al., 2008). The C-lobe of CaM has a higher affinity and 
a slower off-rate for Ca
2+
 than the N-lobe (Linse et al., 1991; Shepherd and Vogel, 2004; Zhang 
et al., 2012), which fits well with the ‘local’ concept of CDI; the transient Ca2+ spikes from 
single channel opening allow C-lobe of resident CaM to bind and effect channel closure before 
Ca
2+
 is able to unbind and dissipate from CaM. The N-lobe, in contrast, has faster Ca
2+
 kinetics 
and lower Ca
2+
 affinity, which presumably relegates it to the ‘global’ regulatory role whereby it 
senses a total accumulation of cellular Ca
2+
 from diffuse sources. This renders the N-lobe 
sensitive to high concentrations of chelators, either native or experimentally applied. At least, 
that’s the theoretical prediction of the ‘local/global’ model found in literature (Tadross, 2009). 
On the one hand, this is consistent with the NSCaTE peptide’s ability to bind either lobe of CaM 
independently (Liu and Vogel, 2012). However, the buffer-resistance effects are not abolished by 
EF hand mutations in CaM’s C-lobe (CaM34), especially in CaV1.3, suggesting that the N-lobe 
may also play a local role – presumably through its interaction with NSCaTE (Dick et al., 2008), 
although how this happens is not clear from their data. In order for such an effect to be possible, 
the interaction with NSCaTE would have to reciprocally affect the Ca
2+
 binding of the N-lobe of 
CaM, i.e. increase its affinity or reduce the dissociation rate for Ca
2+
. No such effect has yet been 
shown; however it is possible – fluorescence experiments with various Ca2+ gradients could test 
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 CaV1.1 (skeletal muscle, α1s) and CaV1.4 (retinal, α1F) channels have unique regulatory features that render them 
insensitive or incapable of CDI in their native states.  
168 
 
this hypothesis, for example, monitoring the Trp fluorescence change of NSCaTE at varying 
Ca
2+
 concentrations. Furthermore, our data actually shows a distinct buffer-sensitive component 
of CDI imparted to LCaV1 (the invertebrate L-type homolog) by its own NSCaTE (see section 
2.2.9). Additionally, we see a significantly lower affinity of both IQ and NSCaTE peptides for 
CaM34, over either CaM12 or wild type CaM, which contradicts the N-lobe preference of 
NSCaTE reported by (Liu and Vogel, 2012). Whether this is a fundamental difference between 
the different lengths of peptides used, or a shortcoming of using EF hand mutants instead of 
‘true’ partial-Ca2+ CaM conformations will have to be tested.  
 
5.2.3.2 Suggested future experiments with NSCaTE: 
To verify which lobe of CaM is most likely interacting with NSCaTE in vivo, additional 
experiments with LCaV1 and ΔNT-LCaV1, as well as EF hand CaM mutants and half CaMs will 
need to be performed. CaM12, CaM34 and CaM1234 have already been cloned into the eukaryotic 
expression/reporter vector pIRES-dsRED
26
 in our lab. Electrophysiology recordings on 
heterologously expressed LCaV1 and ΔNT-LCaV1 with over-expressed CaM mutants in various 
levels  of internal buffering will either confirm or refute the findings in (Dick et al., 2008). ITC 
experiments with half-CaMs instead of EF hand mutants and NSCaTE/IQ peptides may yield 
additional results and establish the validity of the EF hand mutant approach. Ultimately, an NMR 
solution structure of an NSCaTE-CaM-IQ complex would confirm or refute the co-interaction 
hypothesis we proposed in Chapter 3 (Taiakina et al., 2013) and also by (Johny et al., 2013). 
There is a possibility that binding of NSCaTE to the CaM-IQ complex is fundamentally 
different, both structurally and functionally, than binding of NSCaTE or IQ to CaM alone. For 
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 A bicistronic expression vector with a red GFP variant to monitor expression of the construct. 
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this question to be answered, an expression system for soluble NSCaTE and IQ motif constructs 
will have to be designed. Our own early work (section 2.2.2) and previous studies aiming to 
characterize the apo-CaM preassociation site in the C-terminus (Kim et al., 2004a) have shown 
this to be a challenging process due to inclusion body formation and expression problems in 
absence of CaM co-expression. While we were able to circumvent the issue somewhat by the 
addition of exogenous purified CaM during HIS-NSCaTE protein refolding, co-expression of 
wild type CaM is a viable alternative. An issue may arise if only one of the two has to be 
isotope-labeled for NMR; in this case the exogenous CaM method may be more desirable. 
Thus far, the majority of NSCaTE studies have sought to look for its function through 
disruptive mutagenesis and isolated in vitro peptide studies, like ours. None have yet looked at 
the possibility that its modest binding affinity and seemingly transient nature of interaction
27
 is 
actually required for its molecular role, whatever that may be. It would therefore be an 
interesting experimental approach to test if increasing the interaction strength, via improving the 
amphipathic nature of the peptide, changing the size of hydrophobic anchors or increasing its 
alpha-helical content/propensity through site-directed mutagenesis, would alter its physiological 
effects. Alternatively, the entire motif can be replaced with one that binds CaM strongly – for 
instance, the gating brake peptide of LCaV3. We cannot conceivably predict what such a 
mutation would do, but it should have a strong impact on CDI. 
   
5.2.3.3 Finding the ‘lid’: shotgun approach: 
 Even after (or if) the structure of CaM/IQ/NSCaTE and some of the physiological 
parameters of such an interaction are determined, it is still unclear what molecular process 
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 We have been unable to ‘capture’ a stable CaM-NSCaTE complex by formaldehyde cross-linking or even gel 
filtration chromatography; data can be found in the Appendix. 
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underlies their contribution to CDI. If indeed a ‘hinged lid’ mechanism is responsible for channel 
inactivation, the most likely answer is that this CaM-driven complex is driving the docking of an 
intracellular motif close to the channel pore or activation machinery, that is, at the S6 bundle 
crossing, or near the S4/5 sensor/linkers. If this is true, a comprehensive, high-throughput search 
for an interaction site for NSCaTE, IQ, or CaM bound to one or both of these, can be undertaken 
using a peptide array. Much like DNA microarrays, they aim to find possible leads for novel 
interactions through exposure of short peptides to a queried partner; in this case, either NSCaTE, 
IQ, or CaM bound to one or both peptides (Diehnelt, 2013; Hansen et al., 2013; Price et al., 
2013). Positive hits can then be further characterized with full length peptides using standard 
biophysical methods (Chapter 2-4) and mutagenesis for elucidation of a complete mechanism 
and mode of action. There is a strong possibility that the distal I-II linker of L-type channels will 
come up as a lead, which would be a triumph for the convergent CDI/VDI molecular endpoint  
camp of thought (Cens et al., 2006; Minor and Findeisen, 2010; Tadross et al., 2010).  
5.3 CaM regulation of non-L-type channels:  
5.3.1 Other HVAs: 
Unlike the L-type channels, the HVA neuronal (N, R, P/Q type) channels lack any coherent 
regulatory analysis models. Their molecular and physiological diversity has been as much a 
roadblock as the lack of structural data for CaVs in general. Chimeric studies and isolated 
biophysical experiments on channel motifs from these isoforms have had limited success in 
describing a universal regulatory model for any of these channels; only isolated details for each 
isoform have so far been described .  
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Figure 5.2: CLUSTALW Alignment of the 'IQ' motifs of various HVA channels.  
LCaV1 & 2 are Lymnaea homologs of CaV1.2 and CaV2.x, respectively. Red box indicates the peptide 
sequences analyzed in this dissertation.  
 
For CaV2 channels, there is some evidence for IQ-motif-mediated CDI; however it is not present 
under high internal buffering and in single channel recordings (Peterson et al., 1999; Lee et al., 
2003a; Kim et al., 2008; Christel and Lee, 2012). Additionally, the motif sequence conservation 
is much lower in non-L-type channels, to the point where calling them “IQ” motifs is not really 
meaningful; for instance, the Gln residue is typically a Phe or Met in these channels (see Figure 
5.2). Therefore, basing regulatory models on similarity to L-type channels is likely erroneous. 
Nonetheless, CaM is most definitely required for CDI in these channels, even if their CDI is 
limited to the ‘global’ mode and the CaM-IQ interaction is dissimilar to the more ‘canonical’ IQ 
motifs of L-type channels.  
We have observed binding of CaM to the IQ motif of α1A (CaV2.1, or P/Q-type) that has 
a 2 : 1 stoichiometry and relatively weak affinity (~1uM) (Chapter 3). Combined with the fact 
that there were structures published of both parallel and anti-parallel orientations of CaM-IQa, 
this may be an interesting clue as to how CaM is able to elicit both CDI and CDF within this 
channel: that is, through a structural rearrangement of the IQa-CaM complex in response to 
differing Ca
2+
 concentrations (Kim et al., 2008; Mori et al., 2008; Kovalevskaya et al., 2013).  
We also tested CaM for interaction with an IQ peptide of LCaV2 (Appendix, Figure A.9), 
and noted a 2 : 1 stoichiometry, but no CaM gel shift (data not shown). In the future, a 
comprehensive analysis of CaV2.x IQ peptides for interaction with CaM may be needed to 
  
172 
 
explain isoform-specific differences in Ca
2+
-CaM regulation. Alternatively, a bioinformatics 
scan of other possible CaM binding sites could reveal novel interactions, which will need to be 
verified with peptide experiments. Any confirmed interaction will then need to be characterized 
for its physiological relevance by electrophysiology experiments. 
 
5.3.2 T-type channels: 
Although they have been observed in recordings over three decades ago (Llinás and Yarom, 
1981), T-type channels are still fairly ‘new’ in the sense of what is known regarding their 
molecular mechanisms. Due to the lack of structural information common in this field, very little 
is known about the exact molecular details of their behavior. Several important features have 
been described, largely attributed to chimeric and mutagenesis studies involving various 
cytoplasmic regions of the channels.  
A high affinity divalent metal binding site in CaV3.2 (His191 in DIS3-4 linker), but not 
other T-type channels, has been used to identify this isoform using Ni
2+
 as a specific blocker 
(Talavera and Nilius, 2006).  
T-type channels are also subject to regulation by phospholipids, G-protein modulation, 
proton block, phosphorylation (notably, CaMKII) and alternative splicing – for a comprehensive 
review, see (Senatore et al., 2012). In turn, T-type channels are direct effectors for a number of 
different pathways involving Ca
2+
-signaling, such as low-threshold exocytosis, extracellular 
regulated kinase (ERK) pathways, nitric oxide synthase (NOS) and calcineurin/NFAT
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activation (Choi et al., 2005; Clapham, 2012; Oliveria et al., 2012; Weiss et al., 2012; Huang et 
                                                 
28
 Nuclear factor of activated T-cells, a family of transcription factors; calcium binding to calcineurin results in the 
translocation of both calcineurin and the associated NFAT to the nucleus. Several oncogenic pathways appear to be 
triggered by a derailment of NFAT regulation (Rusnak and Mertz, 2000) 
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al., 2013). There also appears to be a functional and possibly structural link between certain T-
type and calcium-gated small conductance (SK) potassium channels and even voltage gated 
potassium channels (KV4), although the implications for the latter are somewhat unclear (Wolfart 
and Roeper, 2002; Anderson et al., 2013) 
 Unfortunately we still do not fully understand how these channels perform their roles and 
what molecular features are responsible for their distinctly hyperpolarized (in)activation profiles. 
One of the more conserved features that has been identified, a gating brake in the I-II linker, 
appears to have varying effects depending on which region is deleted (or mutated) (Arias et al., 
2005; Talavera and Nilius, 2006; Baumgart et al., 2008). The gating brake is a helix-loop-helix 
motif in the proximal region of the I-II linker and is responsible for gating and activation kinetics 
of mammalian CaV3 channels. Several regions downstream of this motif affect surface 
trafficking of the channel in both human and Lymnaea models. We have described a completely 
novel interaction between CaM and this second helix in all CaV3 isoforms (human and snail), 
although we have not yet been able to characterize the physiological effects of this interaction. 
Previous studies have suggested a potential role for CaM via the phosphorylation of the II-III 
linker by CaMKII, as well as the calcineurin/NFAT pathway, but there has been no evidence to 
date to suggest a direct physical interaction of this channel family with CaM. What is more, this 
interaction appears to be variable among the three isoforms, at least in biophysical terms, which 
may explain some of the isoform-specific effects of linker truncations (Baumgart et al., 2008). It 
also appears that apo-CaM may be able to interact with the gating brake – in a different mode 
than with holo-CaM. Thus, there may actually be a calcium/CaM-dependent form of regulation 
for these channels that is universally conserved and has yet to be fully elaborated.  
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In the future, detailed EF-CaM and half CaM titrations with all of the gating brake 
peptides (CaV3.1-3.3), as well as electrophysiology recordings with gating brake/CaM mutant 
combinations (for human and snail isoforms) will confirm or refute this theory. Additionally, a 
solution structure of the gating brake-CaM complex can be solved and provide more detailed 
structural insights into how this interaction occurs, as well as reveal key interacting residues 
which will be strong candidate for mutagenesis studies. The structure will require a labeled 
gating brake peptide or a recombinant protein construct, and several different NMR experiments 
(HSQC/COSY and NOESY) and full residue assignments, all of which will require a 
considerable time investment. At the present, with such a limited pool of evidence, we cannot 
conceivably say what role CaM has on the biophysical properties of these channels. 
 
5.4 Other Ca2+-binding proteins: 
While CaM is undoubtedly important in the regulation of seemingly every calcium channel, it 
may not be the only protein capable of such regulation. There are dozens of EF hand proteins 
with varying degree of similarity to CaM (Ikura, 1996; Gifford et al., 2007). There are also three 
conservative amino acid changes (Y99F, Q143T and A147S) in Lymnaea CaM that are also 
shared with Drosophila and C.elegans CaM, which may have small but significant differences in 
the corresponding CaM-channel interactions in those species – a question perhaps for a future 
study. 
Indeed, CaBP1(calcium binding protein 1, a CaM homolog) has been shown to attenuate 
CDI in a Ca
2+
-independent manner and instead causes CDF of CaV1.2 and enhances its VDI 
(Findeisen and Minor, 2010; Oz et al., 2011). Interestingly, CaBP1 also binds the C-terminal IQ 
motif that overlaps the CaM binding site, and also the N-terminus of CaV1.2, however at a site 
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distal to NSCaTE. CaBP1 and CaM appear to compete for the C-terminal site in their apo-state, 
although Ca
2+
-CaM easily outcompetes CaBP1 regardless of the latter’s Ca2+ state (Findeisen et 
al., 2013). 
 Much additional characterization of the interplay between CaM and CaBP1 will be 
necessary to determine the molecular mechanism by which they elicit their effects and their 
physiological importance. However, as CaBP1 is primarily a neuronal protein unique to 
vertebrates (Haeseleer et al., 2000), its relevance to the conserved mechanisms of L-type CDI 
across other phyla or non-neural tissues is questionable. We have not looked at CaBP1 as a 
candidate for regulation of heterologously expressed channels, although it may be interesting to 
see if there is any effect with its co-expression with various CaVs.   
 
5.5 Summary of Original Contributions: 
5.5.1 Lymnaea NSCaTE is a global regulator of CDI 
We have characterized the NSCaTE motif of an invertebrate L-type homolog (LCaV1) and its 
binding to CaM under various conditions. Prior to this study, there has been no indication that 
NSCaTE may be present in non-vertebrate phyla, or that its role may differ based on isoform. 
Mammalian NSCaTE appears to have a ‘local’ regulatory effect as evidenced by the seminal 
work with CaM EF hand and NSCaTE deletion mutants (Dick et al., 2008), in contrast to our 
results with the invertebrate NSCaTE, which we find to have an increased ‘global’ effect on 
CDI. Further studies with Lymnaea NSCaTE paralleling these experiments may be necessary to 
confirm its distinct role as a global regulator of CDI.  
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5.5.2 NSCaTE as an optional motif: 
Through qRT-PCR, we show no difference in NSCaTE-containing transcripts (e.g. 
approximately every channel transcript contains an NSCaTE sequence), suggesting that the 
downstream Met, if used, is solely a translational regulatory mechanism. To confirm this fully, 
detailed histo-immunochemical studies with NSCaTE-specific antibodies will be necessary.  
 
5.5.3 NSCaTE may form a tertiary complex with IQ-CaM: 
While we lack direct biophysical evidence for such a complex (e.g. a structure), we have 
convincing thermodynamic data to support that a co-interaction between all three partners (CaM, 
NSCaTE, IQ) is occurring (see section 3.4 and Figure 3.9). A previous study refuted such a 
complex because they were unable to facilitate a pull-down with such a complex by native 
PAGE (Benmocha et al., 2009), although neither were we (see Appendix Figure A.4-7). The 
complex is likely affected by other parameters in vivo, and may be of a weak/transient nature, 
which makes it very difficult to capture using standard biophysical methods, consistent with 
rapid channel inactivation and recovery. A solution structure or a pull-down study of such a 
complex would likely settle the debate. 
5.5.4 CaM is capable of interaction with T-type channels directly via the gating 
brake: 
The helix-loop-helix motif in the proximal I-II linker of LVA channels that has been 
previously described as important for their inactivation and gating properties was also found to 
bind CaM in vitro. The peptide corresponding to the second helix from each of the three 
mammalian isoforms as well as LCaV3 was subjected to a detailed biophysical analysis using 
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spectropolarimetry, native PAGE and ITC; all evidence supports a strong interaction with CaM. 
This novel interaction appears to be variable by isoform, which may hold clues as to its 
mechanism and role in vivo.  
EF hand mutant CaM experiments suggest that at least the Lymnaea isoform gating brake 
is capable of binding apo-CaM. Much additional work to determine the physiological impact of 
these interactions is still needed (see next section).  
 
5.6 Recommendations for future studies: 
5.6.1 NSCaTE mutagenesis: 
Although the NSCaTE motif has been convincingly established as a regulatory element in L-type 
channel CDI, the exact molecular mechanism of how it exerts its effects is still unclear. One 
possible avenue of investigation is chimeric studies with NSCaTEs from different isoforms (or 
species). If mammalian NSCaTE is a ‘local’ regulator and the Lymnaea NSCaTE is ‘global’, 
then a chimeric snail channel with a mammalian NSCaTE should exhibit increased buffer-
resistant CDI compared to wild type.  
There have been several attempts in our lab to create mammalian-snail NSCaTE/channel hybrids 
(data not shown); however, none of the partial constructs were able to be cloned into a full-
length channel.  
Furthermore, instead of deletion and loss-of-function mutants to analyze NSCaTE effects, 
it would be interesting to see if an increased NSCaTE-CaM affinity would affect CDI. Altering 
the sequence to create a stronger α-helical propensity, or simply replacing it with a higher-
affinity CaM binding sequence altogether may be a viable study. 
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5.6.2 NSCaTE and CaM binding to Ca2+ 
It is entirely possible that the ‘local’ effects of mammalian NSCaTE are actually a result of 
CaM’s altered affinity for Ca2+ upon binding NSCaTE. Previous studies, including the IQ motif 
of other channels, have shown similar properties for other CaM-binding peptides. Biophysical 
experiments (e.g. ITC or fluorescence) using the NSCaTE peptides and CaM under varying Ca
2+
 
concentrations should answer this question.  
5.6.3 NSCaTE and co-interaction with IQ-CaM: 
To confirm that such a complex exists, either a pull-down of the complex or a solution structure 
of the peptides in complex with CaM is required. For the former, one can use standard 
biophysical methods to isolate a complex via CaM, by using an immobilized C- or N-terminal 
protein construct (e.g. IQ, or NSCaTE, respectively) as ‘bait’ to isolate the opposing construct in 
the presence vs. absence of CaM (and Ca
2+
 vs. EDTA). For the latter, isotope-labeled peptides in 
various combinations (e.g. 
15
N/
13
C labeled IQ and NSCaTE) will be required, which may also 
require expression optimization if they are to be produced in-house. Currently we do not have 
optimized expression constructs for either of these regions. In either scenario (e.g. NMR or 
protein ‘fishing’), an extensive time course for the project is recommended. 
 
5.6.4 Peptide ‘fishing study’ for the possible docking site of IQ/RN-CaM complex: 
To test whether CaM bound to one or more of the CDI effectors (IQ or NSCaTE) is actually a 
physical component of the ‘hinged lid’ inactivation particle, a high throughput screen for its 
binding target in L-type channels can be undertaken. A peptide array consisting of a large 
number of 10-20 contiguous residues corresponding to a stretch of a cytoplasm-exposed region 
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of the channel can be generated; these would then be ‘probed’ for interaction by a fluorescently 
labeled CaM/IQ/NSCaTE ‘bait’. Positive hits can be identified on a standard fluorescence 
imager and further characterized as potential interactions using larger length peptides. 
Considering the time and cost involved in such a project, this is a rather risky endeavor but will 
be most exceptionally fulfilling if the docking hypothesis is indeed correct. 
 
5.6.5 T-type channel recording with CaM mutants: 
To verify the role of the gating brake and CaM interaction and its physiological 
relevance, a combination of gating brake mutants and EF hand CaM mutants, and/or varying the 
internal buffering conditions will be needed. We have already cloned the necessary CaM mutants 
(CaM12, 34 and 1234) into a mammalian expression vector, but the gating brake mutations in either 
mammalian or snail isoforms will have to be made. These mutants can then be recorded in 
standard whole-cell voltage clamp or patch-clamp mode in various combinations of CaM and 
channel mutants. Theoretically, altering the CaM-gating brake interaction should affect channel 
gating.  
In addition to electrophysiological data, a solution structure of CaM in complex with the 
gating brake peptide could be solved; an HSQC spectrum of such a complex (holoCaM and 
LCaV3 gating brake) is already available (see Figure 4.3). 
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 Appendix 
Sequence of the HIS-RN construct (in pET22b) used in Chapter 2: 
 
tttaagaaggagatataccatgggcagcagccatcatcatcatcatcacagcagcggcctg 
  L  R  R  R  Y  T  M  G  S  S  H  H  H  H  H  H  S  S  G  L  
gtgccgcgcggcagccatatggtgaacgaaaacacccgcatgtatgtgccggaagaaaac 
 V  P  R  G  S  H  M  V  N  E  N  T  R  M  Y  V  P  E  E  N  
catcagggcagcaactatggcagcccgcgcccggcgcatgcgaacatgaacgcgaacgcg 
 H  Q  G  S  N  Y  G  S  P  R  P  A  H  A  N  M  N  A  N  A  
gcggccggcctggcgccggaacatattccgaccccgggcgcggccctgagctggcaggcg 
 A  A  G  L  A  P  E  H  I  P  T  P  G  A  A  L  S  W  Q  A  
gcgattgatgcggcgcgccaggcgaaactgatgggcagcgcgggcaacgcgaccattagc 
 A  I  D  A  A  R  Q  A  K  L  M  G  S  A  G  N  A  T  I  S  
accgtgagcagcacccagcgcaaacgccagcagtatggcaaaccgaaaaaacagggcggc 
 T  V  S  S  T  Q  R  K  R  Q  Q  Y  G  K  P  K  K  Q  G  G  
accaccgcgacccgcccgccgcgcgcgctgctgtgcctgaccctgaaaaacccgattcgc 
 T  T  A  T  R  P  P  R  A  L  L  C  L  T  L  K  N  P  I  R  
cgcgcgtgcattagcattgtggaatgggtcgacaagcttgcggccgcactcgagcaccac 
 R  A  C  I  S  I  V  E  W  V  D  K  L  A  A  A  L  E  H  H  
caccaccaccactgagatccggctgctaacaaagcccgaaaggaagctgagttggctgct 
 H  H  H  H  -  D  P  A  A  N  K  A  R  K  E  A  E  L  A  A  
gccaccgctgagcaataactagcataaccccttggggcctctaaacgggtcttgaggggt 
 A  T  A  E  Q  -  L  A  -  P  L  G  A  S  K  R  V  L  R  G  
tttttgctgaaaggaggaactatatccggattggcgaatgggacgcgccctgtagcggcg 
 F  L  L  K  G  G  T  I  S  G  L  A  N  G  T  R  P  V  A  A  
cattaagcgcggcgggtgtggtggttacgcgcagcgtgaccgctacacttgccagcgccc 
 H  -  A  R  R  V  W  W  L  R  A  A  -  P  L  H  L  P  A  P  
tagcgcccgctcctttcgctttcttcccttcctttctcgccacgttcgccggctttcccc 
 -  R  P  L  L  S  L  S  S  L  P  F  S  P  R  S  P  A  F  P  
gtcaagctctaaatcgggggctccctttagggttccgatttagtgctttacggcacc 
 V  K  L  -  I  G  G  S  L  -  G  S  D  L  V  L  Y  G  T  
 
NSCaTE is highlighted in red. Expressed construct start site Met is in bold black (extra residues 
left over from cloning). Start site found in native CaV1.2 sequences (Met1) is blue and the 
‘alternative’ start site omitting NSCaTE (Met2) is in red. 
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Figure A.3: Sequence of LCaV1 with primers.  
The two possible start Met are boxed. 
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Figure A.4: Gel filtration chromatogram of wild type Ca
2+
-CaM with IQ and NSCaTE 
peptides (at stoichiometric ratios).  
Hi-Load Superdex 75 (10/60) from GE Healthcare was used; holoCaM alone reliably elutes at ~67mL on 
this column. Due to their small size (both <3kDa), both IQ and NSCaTE, when unbound to CaM, elute at 
well past the resolution limit (peak near 110mL), thus the only other resolvable peaks should contain 
various CaM-bound peptides. Only one such peak was noted (~77mL), and collected for analysis by ESI 
MS. Due to the salt used in gel filtration protocols (which interferes with ESI MS), this sample had to be 
extracted with Zip Tip (C18 reverse-phase media-containing pipette tip used for 2D gel spot extraction, 
Millipore) before submitting the sample for MS analysis. Subsequently, only CaM and the IQ peptide (but 
not NSCaTE) mass peaks were found in the ESI MS spectrum (see Figure A.5 and Figure A.6).  
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Figure A.5: Deconvoluted MS spectrum of CaM.  
Desalted (using the Zip Tip protocol) samples from the gel filtration treatment of CaM-RN-IQc mixture (Figure A.4) were analyzed by ESI MS 
(Waters Q-TOF Ultima Global at University of Waterloo, under the supervision of Dr. Richard Smith) .  
CaM 
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Figure A.6: Deconvoluted spectrum (peptide range) of CaM/IQc/RN (same raw data as Figure A.5).  
The same sample as in Figure A.5 but using the peptide algorithm for peak integration /deconvolution. The ~2.8 kDa peak corresponds to the IQc 
peptide; no peaks were obtained for the RN peptide (MW ~1.8 kDa). Judging by the presence of IQc and a rather low absorbance of this fraction at 
280nm, corresponding to Trp fluorescence, which should be high for NSCaTE (Figure A.4), we judged that RN was not co-eluting with CaM 
under the gel filtration conditions used. 
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Figure A.7: Formaldehyde cross linking time trial.  
Equal molar amounts of peptide and Ca
2+
-CaM (300pmol each, in gel filtration buffer with 1mM CaCl2) 
were pre-incubated for 20-30 minutes on ice. Incubation times (indicated at the top) were started upon 
adding up to 0.5% w/v paraformaldehyde (from dissolved 10% stock made fresh) to the CaM-peptide 
complex, and terminated by quenching with excess Tris-Cl. To the quenched samples (kept on ice), 1 : 1 
loading dye was added and they were then run on a native PAGE (same protocol as for gel-shift mobility 
assays, see section 2.2.4). Initially, the goal was to identify a tripartite complex by chromatography and 
then ESI-MS, but the PAGE was performed as a preliminary screen for successful cross-linking. 
Unfortunately no higher-MW bands can be seen except for the IQc-CaM control (which is expected based 
on the results covered in Chapter 2). The last three lanes are overnight incubations in 1% formaldehyde of 
CaM and a single peptide each lane (CaM + RN, CaM + IQc, CaM alone), ran as controls.  
5’         15’          30’          60’         3h        __________O/N________ 
                                      RN+CaM  IQc+CaM  CaM  
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Figure A.8: Preliminary binding of the L-type channel I-II linker peptides to Ca
2+
-CaM.  
CaV1.2 (LHLQKLNRRYRRFCRRIVKS, left) and LCaV1 (GENCRARLAHRISKSKFSRY, right) 
peptides (Genscript, >98% purity) were titrated into CaM (500µM peptide in the syringe, 50µM CaM in 
the cell). Clear exothermic interaction was observed for both, but the stoichiometry for LCaV1 appears to 
be non 1 : 1 (although this could be due to insufficient peptide resuspension; the experiment has not since 
been repeated). LCaV1 I-II linker peptide also appears to have a higher affinity for CaM (~0.4µM) than 
CaV1.2 (1.8µM). Further characterization of these fragments is recommended. 
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Figure A.9: ITC results (fitted) of LCaV2 IQ peptide (KIYAGLLISENWKAYKASQNA) 
with holoCaM.  
Same methods as L-type peptides; see section 3.1.1. 
